Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,transmitter-gated ion channel activity (GO:0022824),0.7976959464429788,2.565079644639156,0.0,0.0,0.0,16/29,9.51%,GRID2;GRIK5;GRIK2;GRID1;GLRA3;GABRG3;GABRB1;GRIA4;GABRB3;HTR3A;GABRB2;GABRA2;GRIK1;GRIA2;GABRA3;GABRA1
prerank,glutamate receptor activity (GO:0008066),0.8541596171772798,2.513644917987635,0.0,0.0,0.0,12/19,8.90%,GRID2;GRM5;GRIK5;GRIK2;GRID1;GRIA4;GRM8;GRIA1;GRM1;GRIK1;GRIA2;GRM7
prerank,ligand-gated ion channel activity (GO:0015276),0.7566413697914224,2.5010703283413487,0.0,0.0,0.0,12/30,8.83%,GRID2;GRIA3;GRIK5;GRIK2;GRID1;GABRB1;GRIN2B;GRIA4;GRIN2A;GRIA1;GRIK1;GRIA2
prerank,ligand-gated channel activity (GO:0022834),0.7601932654665952,2.478301192121605,0.0,0.0,0.0,12/29,8.83%,GRID2;GRIA3;GRIK5;GRIK2;GRID1;GABRB1;GRIN2B;GRIA4;GRIN2A;GRIA1;GRIK1;GRIA2
prerank,voltage-gated cation channel activity (GO:0022843),0.5999012380592901,2.4763570438324862,0.0,0.0,0.0,39/97,15.02%,KCND2;KCNC2;KCNQ3;HCN1;KCNMA1;GRIN2B;KCNA6;KCNH8;KCNQ5;KCNH7;OPRM1;KCNA5;CACNA1B;CATSPER4;CACNA2D1;KCNH4;GRIN2A;KCNH5;CACNA1A;KCNA2;NCS1;CACNB3;CACNG8;TMC1;CACNA1D;CACNA2D3;CACNG3;CACNB4;CACNA1E;CACNG2;CACNG4;TMC2;KCND1;CACNG5;GRIN3A;CACNA2D4;KCNS2;KCNC4;KCNA4
prerank,ionotropic glutamate receptor activity (GO:0004970),0.793435252350742,2.2729791364081633,0.0,0.0,0.0,9/17,8.83%,GRIA3;GRIK5;GRIK2;GRIN2B;GRIA4;GRIN2A;GRIA1;GRIK1;GRIA2
prerank,ligand-gated anion channel activity (GO:0099095),0.7805843175105918,2.2209503257642007,0.0,0.00025173229720694125,0.002,9/17,9.51%,GLRA3;GABRG3;GABRB1;GABRB3;GLRA1;GABRB2;GABRA2;GABRA3;GABRA1
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.7535422392353167,2.1969179755262873,0.0,0.0002202657600560736,0.002,9/19,9.51%,GRID2;GRIK5;GRIK2;GRID1;GABRG3;GABRA2;GRIK1;GABRA3;GABRA1
prerank,potassium channel activity (GO:0005267),0.5441690203236361,2.1775443528434018,0.0,0.00029368768007476484,0.003,16/89,4.61%,KCND2;KCNC2;KCNQ3;GRIK5;GRIK2;HCN1;KCNMA1;KCNA6;KCNH8;KCNQ5;KCNH7;KCNA5;KCNH4;KCNH5;KCNN2;KCNA2
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.6801828296089636,2.1628343716051783,0.0,0.00044053152011214717,0.005,9/28,9.51%,GRID2;GRIK5;GRIK2;GRID1;GABRG3;GABRA2;GRIK1;GABRA3;GABRA1
prerank,GABA receptor activity (GO:0016917),0.7164205034507265,2.13134465431179,0.0,0.0009611596802446849,0.012,10/21,14.23%,GABRG3;GABRB1;GABRB3;GABRB2;GABRA2;GABBR2;GABRA3;GABRA1;GABBR1;GABRE
prerank,voltage-gated potassium channel activity (GO:0005249),0.5431355073916945,2.115428913170468,0.0,0.0008810630402242946,0.012,15/80,4.61%,KCND2;KCNC2;KCNQ3;HCN1;KCNMA1;KCNA6;KCNH8;KCNQ5;KCNH7;KCNA5;KCNJ3;KCNH4;KCNH5;KCNN2;KCNA2
prerank,GABA-A receptor activity (GO:0004890),0.7239512984163707,2.075129726389844,0.0,0.0014910297603795751,0.022,7/18,9.51%,GABRG3;GABRB1;GABRB3;GABRB2;GABRA2;GABRA3;GABRA1
prerank,neuropeptide receptor activity (GO:0008188),0.6320366366667203,2.022078717701257,0.0022172949002217295,0.0039018506067075892,0.057,9/29,11.23%,NPSR1;OPRM1;SORCS1;SORCS3;GPR37;NPY2R;KISS1R;TACR1;NMUR2
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.7764943144725067,1.9858710410274023,0.0,0.00634365388961492,0.095,7/12,9.51%,GABRG3;GABRB1;GABRB3;GABRB2;GABRA2;GABRA3;GABRA1
prerank,sodium channel activity (GO:0005272),0.5724438508829552,1.9845372087284552,0.0,0.006167441281570062,0.098,11/37,8.21%,GRIK5;GRIK2;ASIC2;HCN1;SCN8A;SCN1B;SCN1A;SCN3A;SCN2A;GRIK1;SCN5A
prerank,voltage-gated calcium channel activity (GO:0005245),0.5843213563787123,1.9750877468981984,0.0,0.006893022608813598,0.113,22/37,17.93%,OPRM1;CACNA1B;CATSPER4;CACNA2D1;CACNA1A;NCS1;CACNB3;CACNG8;TMC1;CACNA1D;CACNA2D3;CACNG3;CACNB4;CACNA1E;CACNG2;CACNG4;TMC2;CACNG5;CACNA2D4;CACNB1;CACNA1G;CACNA1I
prerank,cadherin binding (GO:0045296),-0.4228825739958795,-1.9658987579658869,0.0,0.06346078555927474,0.051,116/315,18.00%,PTPRB;SPTBN1;CLINT1;TJP1;DAB2IP;DOCK9;PTPRM;ESYT2;CTNNA1;ITGA6;SPTAN1;WASF2;CAST;COBLL1;LIMA1;ITGB1;BSG;MRTFB;ASAP1;ERC1;STXBP6;ABI1;BAIAP2L1;MPP7;CDH11;MYH9;CD2AP;PPFIBP1;BMPR2;PARVA;EPS15;IQGAP1;EIF4H;ANXA2;PROM1;PTPN1;TRIM25;F11R;ZC3HAV1;PKP4;FNBP1L;PAK2;EIF3E;DDX3X;RAB1A;AHNAK;KDR;YWHAE;PTPRJ;EGFR;GIGYF2;NOTCH3;EMD;EPS8L2;IDH1;PDLIM5;LARP1;CBL;PLCB3;AFDN;NCK1;DLG1;STK24;TRPC4;TMOD3;MACF1;EPS15L1;EZR;SNX9;CDH5;TJP2;MRE11;FXYD5;PDLIM1;CTNND1;CEMIP2;YWHAZ;CDH1;PICALM;CHMP4B;FLNA;PUF60;SERBP1;ARHGAP1;EHD1;PSEN1;EEF2;STK38;LASP1;LRRFIP1;CSNK1D;NDRG1;CHMP2B;PDXDC1;PKN2;RPL7A;NUMB;HCFC1;MARK2;SH3GL1;CLIC1;FMNL2;ABCF3;EHD4;CHMP5;SLK;GCN1;ANXA1;CTNNB1;SWAP70;CALD1;DBNL;VAPA;CAPZB;GIPC1;CCS
prerank,clathrin adaptor activity (GO:0035615),-0.7333467475553711,-1.945554062628549,0.0,0.041577756056076554,0.067,11/15,20.03%,HIP1;DAB2;STON1;LDLRAP1;AP2B1;AP2A2;AP2S1;AP1G1;HIP1R;STON2;AP2M1
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.7276410629511234,1.920348610002652,0.0,0.013852268910193075,0.224,7/13,14.23%,GLRA3;GABRG3;GLRA1;GABRA2;GABRA3;GABRA1;GABRE
prerank,delayed rectifier potassium channel activity (GO:0005251),0.5861450588525858,1.9045936639808247,0.002242152466367713,0.01641559559154738,0.273,6/32,4.61%,KCNC2;KCNQ3;KCNA6;KCNQ5;KCNA5;KCNA2
prerank,ligand-gated cation channel activity (GO:0099094),0.4737985812185553,1.8528236046351687,0.0,0.028766708263323212,0.431,19/75,14.59%,GRIA3;GRIK5;GRIK2;ASIC2;GRIN2B;GRIA4;HTR3A;KCNJ3;GRIN2A;KCNN2;GRIA1;GRIK1;KCNJ6;GRIA2;KCNN3;P2RX3;GRIN3A;P2RX5;ASIC1
prerank,cell adhesion mediator activity (GO:0098631),0.5884959553370809,1.843750914239922,0.0020833333333333333,0.030040054133361655,0.452,14/24,15.73%,LRRC4C;CNTN6;CNTN4;DSCAML1;DSCAM;NTNG1;MYPN;VSTM2L;EMB;CNTN2;JAM3;ROBO3;CD47;SIRPA
prerank,ion channel activity (GO:0005216),0.4622822090773199,1.8140690243943616,0.0,0.04024856161024618,0.567,17/80,8.83%,TRPM3;GRID2;GRIA3;GRIK5;GRIK2;GRID1;GABRB1;GRIN2B;UNC80;GRIA4;GRIN2A;GRIA1;TMC1;TMEM63A;GRIK1;TRPM1;GRIA2
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.5614521031261579,-1.7948572823245614,0.0,0.2735378687899774,0.514,16/34,22.11%,CYTH3;PARD3;MYO10;FERMT2;IQGAP1;ARAP3;AKT1;ARAP1;FCHSD2;ZFYVE1;HIP1R;GAB2;ZFYVE16;OGT;PHLDA3;KIF16B
prerank,chloride channel activity (GO:0005254),0.4712883778581828,1.7849704630194054,0.0,0.05236579026028741,0.682,13/59,9.51%,GLRA3;GABRG3;GABRB1;GABRB3;CLCNKA;ANO3;GLRA1;GABRB2;GABRA2;ANO4;CLCN2;GABRA3;GABRA1
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.6381652695391051,-1.782843156144072,0.005504587155963303,0.2355161050281705,0.563,9/18,15.62%,ENG;FERMT2;TGFBR3;TGFBR2;TGFB2;SMAD2;SMAD7;USP15;SMAD6
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.6502456148160639,-1.7715717190586062,0.0,0.21707965267172608,0.61,4/17,1.27%,ATP10A;PITPNC1;ATP8B1;PLTP
prerank,androgen receptor binding (GO:0050681),-0.5764950275928666,-1.7587040106262235,0.003656307129798903,0.21335953765618235,0.668,6/25,10.80%,FOXP1;NSD1;ZBTB7A;PRPF6;WIPI1;KDM3A
prerank,thyroid hormone receptor binding (GO:0046966),-0.551393083623296,-1.7491959301319704,0.0018552875695732839,0.20273063761177176,0.7,16/28,29.30%,TACC1;NSD1;MED1;TRIP12;TAF11;MED13;JMJD1C;MED17;HMGN3;TAF7;NCOA6;ZNHIT3;THRAP3;GAS2L1;OASL;BRD8
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.6296061965604196,-1.745527805419426,0.0017301038062283738,0.1846380614332347,0.714,9/18,23.64%,STXBP6;BAIAP2L1;ANXA2;PDLIM5;TMOD3;PDLIM1;ANXA1;CDC42EP1;PPP1CA
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.40647775054902147,-1.7440966953533832,0.0,0.16667574138269287,0.719,56/147,21.47%,RAPGEF5;PREX2;CYTH3;DOCK9;RAPGEF2;DOCK1;FGD5;AKAP13;BCR;RIN3;FGD6;RAB3GAP1;RCBTB2;ARHGEF28;DOCK4;ELMO1;FARP1;EPS8L2;RASGRF2;HPS4;ARHGEF15;MON1A;CYTH1;DENND5B;RAP1A;PLCE1;ITSN1;DENND3;SH3BP5L;RASGRP2;ARHGEF2;DENND6A;EIF2B2;RAB3GAP2;RAPGEF1;IQSEC2;ARHGEF11;ARFGEF1;RIN2;ARHGEF10;DENND4C;DENND2C;ABR;ARHGEF18;HERC2;PREX1;ALS2;ANKRD27;RGL1;WDR41;RGL2;SPATA13;ARHGEF5;NUCB2;RABIF;VAV2
prerank,retinoic acid receptor binding (GO:0042974),-0.6367582407995693,-1.7428160195165772,0.007155635062611807,0.15219647019474342,0.725,9/17,20.11%,TACC1;NSD1;ASXL1;NRIP1;RARG;MED1;ACTN4;NCOA6;PPARG
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.7092525282663553,1.7380283603270386,0.004301075268817204,0.07826776673992482,0.845,6/10,18.61%,GABRG3;GABRA2;GABRA3;GABRA1;GABRE;GABRA5
prerank,I-SMAD binding (GO:0070411),-0.6898298426424113,-1.7306108813919001,0.0018796992481203006,0.16143707674404847,0.779,8/13,19.65%,SMURF1;SMAD1;SMAD2;SMAD4;SMAD7;SMAD6;CTNNB1;SMAD9
prerank,tau-protein kinase activity (GO:0050321),-0.6035610811918171,-1.724233467349258,0.01444043321299639,0.15983729466294344,0.8,11/20,16.69%,DYRK1A;GSK3B;MARK1;ROCK1;GSK3A;SIK3;PRKAA1;MARK2;ROCK2;FYN;MARK3
prerank,histone-lysine N-methyltransferase activity (GO:0018024),-0.49906641915636646,-1.7221277099636714,0.001834862385321101,0.1502354140892645,0.807,19/44,15.61%,MECOM;NSD1;ASH1L;SETD2;PRDM16;KMT2E;KMT5B;NSD3;SETD5;SUV39H1;SETD3;EHMT1;DOT1L;ASH2L;KMT5A;SMYD1;N6AMT1;PRDM9;KMT2C
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.6818051272075424,1.717136004333545,0.00904977375565611,0.09141910105367279,0.888,4/11,9.15%,DDAH2;PADI1;ARG2;PADI2
prerank,high voltage-gated calcium channel activity (GO:0008331),0.7140004769279544,1.7098022758581237,0.01627906976744186,0.09332490818375795,0.906,5/10,7.77%,CACNA1B;CACNA1A;CACNB3;CACNA1D;CACNB4
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.6214875909520358,1.7087262369228406,0.017897091722595078,0.09068422921419682,0.908,5/14,13.80%,SLC7A11;SLC25A13;SLC1A2;SLC17A6;SLC1A3
prerank,R-SMAD binding (GO:0070412),-0.6022634957588313,-1.7063633558903577,0.007207207207207207,0.16810855879064035,0.851,9/18,21.03%,SMURF1;LDLRAD4;JUN;SMAD2;SMAD4;RGCC;SMAD6;PMEPA1;DROSHA
prerank,GTPase binding (GO:0051020),-0.38633372352911977,-1.7011403795792446,0.0,0.16594630706591962,0.863,56/195,15.56%,SPTBN1;UNC13B;GNB1;FGD5;AKAP13;RIN3;EPS8;ERC1;FGD6;CAV1;RUSC2;RAB3GAP1;SH3BP4;IQGAP1;DOCK4;DVL3;RALBP1;RANBP9;FNBP1L;PAK2;LRRK2;EXOC4;RANBP2;AFDN;RASIP1;STRN3;AMBRA1;HPS4;BNIP3;RAB11FIP3;PLCE1;USP6NL;TBC1D30;ARHGEF2;RAF1;EXOC2;PICALM;MTSS2;PDE6D;FLNA;RAB3GAP2;TNFAIP1;ARHGAP1;EHD1;BRAF;RASA1;ANKFY1;GOLGA4;LCP1;NDRG1;RTKN;AP1G1;MLPH;NCKAP1;EXOC8;TBC1D20
prerank,GTPase activator activity (GO:0005096),-0.363812731561741,-1.6940369966533078,0.0,0.16754194463386113,0.88,113/313,22.62%,RAPGEF5;PREX2;CYTH3;DOCK9;CHN2;ARHGAP31;TBC1D4;RAPGEF2;DOCK1;FGD5;AKAP13;BCR;RGS3;RIN3;ASAP1;RALGAPA1;FGD6;RAB3GAP1;RCBTB2;RGS5;ARHGEF28;STARD8;IQGAP1;DOCK4;RALBP1;ARHGAP10;ELMO1;FARP1;LRRK2;ARAP3;EPS8L2;RANBP2;TBC1D1;RASGRF2;CHN1;TBC1D2B;PLCB1;HPS4;ARHGEF15;MON1A;CYTH1;DENND5B;RAP1A;TBC1D8B;JUN;PLCE1;ITSN1;USP6NL;SIPA1L3;DENND3;SH3BP5L;RASGRP2;TBC1D30;BNIP2;ARHGEF2;TBC1D14;MTSS2;ARHGAP17;DENND6A;STARD13;EIF2B2;TBC1D22B;RASA4;RAB3GAP2;RAPGEF1;ARAP1;ARHGAP1;IQSEC2;TBC1D22A;ARHGEF11;ARFGEF1;RASA1;RIN2;ARHGAP28;WNT11;ARHGEF10;LARS1;DENND4C;SEC23B;TBC1D20;SMAP2;DENND2C;ARHGAP22;ABR;ARHGEF18;HERC2;PREX1;ALS2;ARHGAP29;ANKRD27;ARHGAP35;TBC1D8;RGL1;TBC1D17;ARHGAP26;TBC1D25;WDR41;RGL2;SPATA13;ARHGAP42;NF1;ARHGEF5;ASAP3;NUCB2;RABIF;VAV2;SYDE1;PREB;TBC1D12;ALDH1A1;EVI5;ARFGEF2;ARHGAP11A
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",-0.3892952281409598,-1.6928585014171096,0.0,0.1594886679674268,0.88,51/173,18.46%,FOXP1;KLF12;FOXP2;ETV6;ZBTB16;ZBTB20;ZEB1;ZFHX3;PRDM5;PRDM16;NFATC4;MITF;NR3C1;ZBTB37;SOX13;PLAGL1;ZNF148;ELK3;CTCF;NFKB1;HES1;PPARA;FOXO3;GTF2IRD1;MAX;SKIL;JUN;ZBTB4;ZFP90;TBX2;DACH1;ZBTB39;PRDM2;PPARD;ZNF25;ETS2;LRRFIP1;ZBTB6;MZF1;ZBTB25;ZBTB34;TCF3;TRPS1;HIC1;SKI;ZNF692;ZBTB14;PATZ1;HEY1;HEY2;ZBTB12
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",-0.3674999562873137,-1.6859307868220732,0.0,0.15998926014560452,0.899,62/254,15.01%,MECOM;LEF1;KLF7;NFIA;RREB1;ZBTB16;NFIB;ERG;FOXO1;MEF2A;NFAT5;ELF1;KLF4;ETS1;ESR1;TCF12;IRF2;PRRX1;NFATC1;PRDM16;FOSL2;ZSCAN21;MITF;NR3C1;PLAGL1;SOX17;SP1;ELK3;NFKB1;PPARA;MEOX2;SIX1;UBP1;FOXO3;STAT6;NFYC;E2F4;MEF2C;JUN;SMAD1;SMAD2;PRDM2;IRF1;SMAD4;GLIS2;TP53;KLF10;NFIC;GMEB1;FOXF2;FOXJ3;CREBRF;PLSCR1;TFCP2L1;SMARCD3;ZIC3;ATF4;MZF1;GRHL1;TCF3;FOXC1;MYBL2
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.6681979368847621,-1.6811826841177002,0.012704174228675136,0.16009163689181832,0.913,6/12,12.30%,ENG;ACVRL1;BMPR2;TGFBR3;TGFBR2;LTBP4
prerank,metallocarboxypeptidase activity (GO:0004181),0.5390610401804402,1.6763255392347838,0.00904977375565611,0.11438086254340393,0.961,9/26,14.22%,AGBL4;CPB2;CPA2;CPE;AGBL1;CPN1;AEBP1;CPA4;CPA3
prerank,SH3 domain binding (GO:0017124),-0.457444518579147,-1.6736686781992096,0.0,0.16390389097895444,0.923,16/62,6.07%,AFAP1L1;DAB2IP;WASF2;SHANK3;AFAP1L2;RUFY1;ABI1;CD2AP;ELMO1;CRK;PTPN12;ADAM9;CBL;CNTNAP1;ABL1;DNM2
prerank,calcium:sodium antiporter activity (GO:0005432),0.68960982208701,1.650336576374729,0.01991150442477876,0.13513684147991936,0.981,6/10,16.03%,SLC24A4;SLC24A2;SLC8A2;SLC8A3;SLC8A1;SLC8B1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),-0.3286564302834345,-1.641487116135368,0.0,0.21268220579060718,0.968,179/731,18.46%,FOXP1;MECOM;KLF12;LEF1;PBX1;KLF7;NFIA;RREB1;FOXP2;ZBTB16;NFIB;ZNF423;TEF;ERG;ZBTB20;FOXO1;MEF2A;NSD1;ZEB1;NFAT5;ELF1;KLF4;ETS1;NR3C2;DACH2;PKNOX2;ESR1;FOXN3;TCF12;HIVEP2;ZFHX3;TEAD4;NRIP1;PRDM5;ZNF260;KLF2;CHD2;IRF2;RXRA;PRRX1;KLF3;NFATC1;TBX15;PRDM16;FOSL2;TEAD1;NFATC4;ZSCAN21;TBX1;MITF;NR3C1;THRB;ZBTB37;SOX13;NFIX;PBX3;TIPARP;PLAGL1;SOX17;MKX;SP1;ZNF148;ELK3;CTCF;MGA;HDAC1;NFKB1;HES1;PPARA;MEOX2;RARG;SIX1;UBP1;ZBTB7A;FOXO3;ZIC4;IKZF2;HIVEP1;HOXB6;STAT6;NFYC;E2F4;GTF2IRD1;MEF2C;SKIL;ZNF182;JUN;ZBTB4;SMAD1;SMAD2;TBX2;KDM6A;DACH1;BACH2;ZBTB39;PPARD;EBF1;IRF1;GLI3;SMAD4;ZIC5;HSF5;HOXC6;SP3;TAL1;GLIS2;TP53;ZBTB40;KDM6B;KLF10;ETS2;STAT2;NFIC;PRRX2;GMEB1;SOX7;ZBTB7C;MAZ;ZSCAN25;FOXF2;FOXJ3;HDAC4;ZNF394;LRRFIP1;PROX2;ZBTB6;KLF9;TFCP2L1;ZIC3;ATF4;PGBD1;MZF1;GRHL1;ZBTB25;NR1D2;ZBTB34;HIF3A;H3-3A;TCF3;TCF7L1;FOXC1;MYBL2;ZKSCAN1;ZNF32;NR2C1;RUVBL2;ETV1;FOXO4;CC2D1B;ZFP1;HIC1;SKI;ZNF235;SIX4;RARA;ZNF692;HOXA2;HDAC6;ZNF691;ZBTB14;FOXQ1;TFAP4;ZNF250;ZNF83;NLRC5;ARNT;PATZ1;CEBPG;HEY1;ZFP28;HEY2;ZSCAN12;NRF1;WBP2;ELK4;HOXB9;ZIC1;ZBTB12;HLF
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),-0.32751373001110207,-1.6348655330963446,0.0,0.21614465050204396,0.974,179/730,18.46%,FOXP1;MECOM;KLF12;LEF1;PBX1;KLF7;NFIA;RREB1;FOXP2;ZBTB16;NFIB;ZNF423;TEF;ERG;ZBTB20;FOXO1;MEF2A;NSD1;ZEB1;NFAT5;ELF1;KLF4;ETS1;NR3C2;DACH2;PKNOX2;ESR1;TCF12;HIVEP2;ZFHX3;TEAD4;NRIP1;PRDM5;ZNF260;KLF2;CHD2;IRF2;RXRA;PRRX1;KLF3;NFATC1;TBX15;PRDM16;FOSL2;TEAD1;NFATC4;ZSCAN21;TBX1;MITF;NR3C1;THRB;ZBTB37;SOX13;NFIX;PBX3;PLAGL1;SOX17;MKX;SP1;ZNF148;ELK3;CTCF;MGA;HDAC1;NFKB1;HES1;PPARA;MEOX2;RARG;SIX1;UBP1;ZBTB7A;FOXO3;ZIC4;IKZF2;HIVEP1;HOXB6;STAT6;NFYC;E2F4;GTF2IRD1;CREB3L2;MAX;MEF2C;SKIL;ZNF182;JUN;ZBTB4;SMAD1;SMAD2;TBX2;KDM6A;DACH1;BACH2;ZBTB39;PPARD;EBF1;IRF1;GLI3;SMAD4;ZIC5;HSF5;HOXC6;SP3;TAL1;GLIS2;TP53;ZBTB40;KDM6B;KLF10;ETS2;STAT2;NFIC;PRRX2;GMEB1;SOX7;ZBTB7C;MAZ;ZSCAN25;FOXF2;FOXJ3;HDAC4;ZNF394;LRRFIP1;PROX2;ZBTB6;KLF9;TFCP2L1;ZIC3;ATF4;PGBD1;MZF1;GRHL1;ZBTB25;NR1D2;ZBTB34;HIF3A;H3-3A;TCF3;TCF7L1;FOXC1;MYBL2;ZKSCAN1;ZNF32;NR2C1;RUVBL2;ETV1;FOXO4;CC2D1B;ZFP1;HIC1;SKI;ZNF235;SIX4;RARA;ZNF692;HOXA2;HDAC6;ZNF691;ZBTB14;FOXQ1;TFAP4;ZNF250;ZNF83;NLRC5;ARNT;PATZ1;CEBPG;HEY1;ZFP28;HEY2;ZSCAN12;NRF1;WBP2;ELK4;HOXB9;ZIC1;ZBTB12;HLF
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.68618651392702,-1.6290692719495152,0.017793594306049824,0.22001959011367744,0.976,6/10,10.19%,MECOM;ASH1L;PRDM16;SETD5;SUV39H1;EHMT1
prerank,amino acid:sodium symporter activity (GO:0005283),0.6460856191763107,1.6258040636726105,0.026490066225165563,0.15841513463232812,0.994,4/11,13.80%,SLC6A15;SLC6A11;SLC1A2;SLC1A3
prerank,UDP-galactosyltransferase activity (GO:0035250),0.6412932186445194,1.6202269465288868,0.04415011037527594,0.15984188832972362,0.994,4/10,7.57%,B3GALT1;B3GALT4;B3GALT5;B4GALT7
prerank,protein phosphatase 1 binding (GO:0008157),-0.5539897426760404,-1.619731876834364,0.03019538188277087,0.22986298907317765,0.981,6/21,8.96%,AKAP11;PPP1R3B;SHOC2;PHACTR4;KCNQ1;PPP1R3C
prerank,retinoid X receptor binding (GO:0046965),-0.6725390772934956,-1.618973482019975,0.0186219739292365,0.222156515516468,0.981,4/11,5.58%,TACC1;NSD1;NRIP1;RARG
prerank,voltage-gated sodium channel activity (GO:0005248),0.5298366549018949,1.6175304524904142,0.015184381778741865,0.158591347240373,0.994,7/22,8.21%,HCN1;SCN8A;SCN1B;SCN1A;SCN3A;SCN2A;SCN5A
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.6868210571693216,-1.6154707863005513,0.020446096654275093,0.22042943949567717,0.983,4/10,8.86%,SLCO2A1;SLCO1C1;SLCO3A1;SLCO2B1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.6814239960890432,-1.6107425371858188,0.017825311942959002,0.22057283256649585,0.986,6/10,8.26%,NSD1;ASH1L;SETD2;NSD3;SETD5;SETD3
prerank,transcription regulatory region nucleic acid binding (GO:0001067),-0.36640600915589505,-1.6076512742438633,0.0,0.21875214135518473,0.987,70/188,24.95%,PBX1;SMARCA2;FLI1;ZBTB20;BNC2;KLF4;ETS1;TCF12;PRDM5;RXRA;PRDM16;SOX13;SOX17;PSPC1;SP1;VSX1;CTCF;NFKB1;SIX1;FOXO3;NFYC;GABPB2;CREB3L2;MEF2C;JUN;SUV39H1;YAP1;IRF1;SMAD4;TAL1;GLIS2;TP53;PER3;SOX7;CHD3;HDAC4;SFPQ;GABPB1;ASH2L;ATF4;MZF1;GRHL1;FOXC1;BCOR;PRDM9;SMAD6;TAF7;ARID5B;ZBTB14;TFAP4;CARM1;RNF10;SOX4;TCF7L2;NONO;TBL1X;PPARG;BRCA1;NFE2L2;GABPA;RELA;KCNH2;YY1;ATF6;RBBP5;CEBPA;ATF5;TAF9;HMGB1;DHX9
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.5667436962203031,-1.6069994246119013,0.02127659574468085,0.2124917623482969,0.987,7/18,12.30%,ENG;ACVRL1;BMPR2;TGFBR3;TGFBR2;ACVR2A;LTBP4
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.6570692379586838,-1.6039782577035977,0.023679417122040074,0.21175478215928115,0.988,6/11,25.68%,MAP3K20;MAP3K5;EGFR;MAP3K6;MAP3K7;MAP3K15
prerank,vinculin binding (GO:0017166),-0.6523276332353134,-1.5897217119566132,0.01607142857142857,0.23354839713332648,0.992,7/11,23.66%,UTRN;CTNNA1;PXN;ACTN1;SORBS3;RTCB;TLN1
prerank,protein tyrosine kinase activator activity (GO:0030296),0.542289011006214,1.5886019125806408,0.02534562211981567,0.19038971332846796,0.996,4/19,1.83%,GRM5;NRG3;NRG1;DGKQ
prerank,small GTPase binding (GO:0031267),-0.3662316223185187,-1.5837030201141868,0.0,0.23855921381845901,0.995,48/170,15.56%,UNC13B;FGD5;AKAP13;RIN3;EPS8;ERC1;FGD6;CAV1;RUSC2;RAB3GAP1;SH3BP4;IQGAP1;DOCK4;DVL3;RALBP1;RANBP9;PAK2;LRRK2;EXOC4;RANBP2;AFDN;STRN3;HPS4;RAB11FIP3;PLCE1;USP6NL;TBC1D30;ARHGEF2;RAF1;EXOC2;PICALM;MTSS2;PDE6D;FLNA;RAB3GAP2;TNFAIP1;ARHGAP1;EHD1;BRAF;ANKFY1;GOLGA4;NDRG1;RTKN;AP1G1;MLPH;NCKAP1;EXOC8;TBC1D20
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),-0.36065954311795795,-1.5823500269249273,0.0,0.23424788400014424,0.995,62/181,23.07%,TACC1;MEF2A;CREBBP;RB1;KLF4;MIER1;NRIP1;GSK3B;RXRA;PRRX1;NFATC1;LMO2;DTX3L;SP1;TACC2;HDAC1;HES1;PPARA;NFKBIA;MED1;SPEN;JUN;MDFIC;ANXA4;SMARCE1;LDB1;PPARD;RBBP8;TAL1;TP53;RNF25;SIN3A;RERE;ZFPM1;BCAS3;MTDH;HDAC4;ACTB;ACTN4;PIAS2;SMARCD3;ATF4;TCF3;TADA3;MIER2;MAD2L2;GTF2I;CTNNB1;ARNT;CDK5RAP3;HEY2;MIER3;PIAS4;TCF7L2;PPARG;WWP2;CREB1;TAF4B;NFE2L2;RELA;MYOCD;TBX3
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.48150921754577647,-1.5808082659210199,0.008928571428571428,0.23019016181820096,0.996,18/38,26.64%,HIP1;DAB2IP;PARD3;SH3PXD2B;PLA2G4A;ZFYVE26;TECPR1;WIPI1;SNX12;PLEKHA4;ZFYVE1;WDR45B;PHLDA3;SNX13;KIF16B;ATG2A;PLEKHF1;ATG2B
prerank,nuclear localization sequence binding (GO:0008139),-0.562501702944585,-1.58027402350929,0.030965391621129327,0.2248012359392831,0.996,7/18,17.87%,BRAP;KPNA4;NFKBIA;KPNA3;NUP153;KPNA1;NUP214
prerank,G protein-coupled amine receptor activity (GO:0008227),0.5355205865256851,1.5795092912841955,0.022271714922048998,0.18592877546066572,0.998,8/22,17.27%,CHRM2;HTR2C;CHRM3;HTR4;HTR1D;HTR1F;HRH1;HRH2
prerank,serotonin receptor activity (GO:0099589),0.5355205865256851,1.5795092912841955,0.022271714922048998,0.18592877546066572,0.998,8/22,17.27%,CHRM2;HTR2C;CHRM3;HTR4;HTR1D;HTR1F;HRH1;HRH2
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.5355205865256851,1.5795092912841955,0.022271714922048998,0.18592877546066572,0.998,8/22,17.27%,CHRM2;HTR2C;CHRM3;HTR4;HTR1D;HTR1F;HRH1;HRH2
prerank,insulin-like growth factor I binding (GO:0031994),-0.6068202055870269,-1.5733736915817984,0.026785714285714284,0.2318385403477719,0.998,5/13,4.35%,IGF1R;ITGA6;INSR;IGFBP4;ITGB4
prerank,anion channel activity (GO:0005253),0.4129157890432275,1.5686673325356584,0.00954653937947494,0.1954054948129881,0.998,13/61,10.55%,GLRA3;GABRG3;GABRB1;GABRB3;ANO3;GLRA1;GABRB2;GABRA2;LRRC8E;ANO4;GABRA3;GABRA1;VDAC2
prerank,calcium channel activity (GO:0005262),0.3937551342132444,1.5664423363981865,0.004454342984409799,0.19292961993964086,0.998,24/84,11.72%,SLC24A4;SLC24A2;OPRM1;CACNA1B;CATSPER4;CACNA2D1;CACNA1A;PKD1L2;NCS1;CACNB3;CACNG8;TMC1;CACNA1D;CACNA2D3;RYR2;TMCO1;CACNG3;CACNB4;CACNA1E;TRPM1;PKD1L1;CACNG2;CACNG4;TMC2
prerank,calcium ion binding (GO:0005509),0.3281849112352977,1.5637235046090685,0.0,0.19121327108867767,0.998,69/323,12.82%,KCNIP4;NRXN1;CDH18;BGLAP;SYT1;PCLO;SYT5;KCNIP1;CDH8;CDH20;CDH9;CDH10;ENPP2;ADGRL3;CABP4;SLC25A23;MMP12;RYR3;SLC25A13;SPOCK1;DNER;ASTN2;SYT12;SYT11;TKT;HPCA;CLEC3B;DCHS1;CDH19;PCDHA4;NCS1;PITPNM1;CALM2;CDH12;GSN;PADI1;RYR2;RPH3A;CDH7;GJB2;ENPP3;PPP3CA;S100A6;CDH17;PLA2G4E;PADI2;PGS1;CDH24;TESC;CPNE1;SLIT3;SLIT1;ANXA8;ANXA8L1;CDHR3;C2CD5;MCTP2;TNNC1;CIB2;SYT4;CDH2;PPP3R1;SLC8A1;TCHH;SRI;HRC;RASGRP1;MYL2;CASQ1
prerank,sialyltransferase activity (GO:0008373),-0.5515416434328846,-1.561259262969361,0.025089605734767026,0.24911167639856965,0.998,7/20,9.03%,ST3GAL6;ST3GAL4;ST3GAL1;ST8SIA4;ST6GAL1;ST6GALNAC3;ST3GAL2
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.5203114274199337,-1.5582132655539824,0.02376599634369287,0.2492073951976057,0.998,4/24,4.31%,DAB2IP;CERT1;PLA2G4A;GOLPH3L
prerank,lipid phosphatase activity (GO:0042577),0.5831896173876153,1.5534154002054068,0.02643171806167401,0.2008383200191279,0.999,5/14,8.92%,PLPPR4;PLPPR1;PLPP2;SGPP1;PLPPR5
prerank,5'-nucleotidase activity (GO:0008253),-0.5993842928127715,-1.5532283271683034,0.031914893617021274,0.2534223147466529,0.999,7/13,26.79%,NT5C2;NT5E;NT5C1A;NT5C3B;ACP3;NT5DC1;NT5C
prerank,phosphatidic acid binding (GO:0070300),-0.5489292995069419,-1.549839118657597,0.03207547169811321,0.25455434069595295,0.999,4/19,3.26%,PITPNC1;RAPGEF2;PLTP;MARK1
prerank,phosphatidylinositol binding (GO:0035091),-0.3887529726316811,-1.5457140078734544,0.005253940455341506,0.25664523747836215,0.999,25/91,15.96%,PARD3B;PITPNC1;HIP1;ESYT2;PARD3;ITPR1;FCHO2;MCF2L;WDFY1;ITPR2;SNX9;SCARB1;PICALM;WDFY3;SNX12;BCAS3;PLEKHF2;ANKFY1;SNX24;ZFYVE1;EXOC8;HIP1R;MITD1;SNX8;TNFAIP8L3
prerank,histone demethylase activity (GO:0032452),-0.4912482798854923,-1.5442177059190487,0.04753199268738574,0.253843142237099,0.999,10/27,16.87%,KDM2A;KDM6A;KDM6B;KDM3A;JMJD1C;HR;RIOX2;KDM7A;JMJD6;KDM5B
prerank,phosphatidate phosphatase activity (GO:0008195),0.6001236252794193,1.5439686040261804,0.0379746835443038,0.20833917499937887,1.0,6/13,8.92%,LPIN1;PLPPR4;PLPPR1;PLPP2;PLPP4;PLPPR5
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.5685940073395455,1.5394079993491856,0.045454545454545456,0.20969300357338208,1.0,6/15,7.94%,HS6ST3;HS3ST6;HS3ST5;NDST4;HS6ST2;HS3ST2
prerank,GTPase regulator activity (GO:0030695),-0.34150628831896795,-1.535857258153048,0.0,0.2656498000155687,0.999,74/212,22.62%,PREX2;CHN2;ARHGAP31;TBC1D4;RAPGEF2;DOCK1;BCR;RGS3;ASAP1;RALGAPA1;RAB3GAP1;RGS5;SH3BP4;STARD8;IQGAP1;RALBP1;ARHGAP10;LRRK2;ARAP3;RANBP2;TBC1D1;RGS12;CHN1;TBC1D2B;SLIT2;PLCB1;TBC1D8B;JUN;WASL;USP6NL;SIPA1L3;TBC1D30;BNIP2;TBC1D14;MTSS2;ARHGAP17;STARD13;PDE6D;TBC1D22B;RASA4;RAB3GAP2;ARAP1;ARHGAP1;TBC1D22A;ARFGEF1;GDI1;RASA1;RIN2;ARHGAP28;RTKN;WNT11;LARS1;SEC23B;TBC1D20;SMAP2;ARHGAP22;ABR;PREX1;ALS2;ARHGAP29;ARHGAP35;TBC1D8;TBC1D17;ARHGAP26;TBC1D25;ARHGAP42;NF1;ASAP3;SYDE1;PREB;TBC1D12;ALDH1A1;EVI5;ARHGAP11A
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),-0.3047739498539581,-1.5337755136031122,0.0,0.26349156888169095,0.999,195/830,18.47%,FOXP1;MECOM;KLF12;LEF1;PBX1;KLF7;NFIA;RREB1;FOXP2;ETV6;ZBTB16;NFIB;ZNF423;TEF;ERG;ZBTB20;FOXO1;MEF2A;NSD1;RB1;ZEB1;NFAT5;ELF1;KLF4;ETS1;NR3C2;DACH2;PKNOX2;ESR1;CUX1;TCF12;HIVEP2;ZFHX3;TEAD4;NRIP1;PRDM5;ZNF260;KLF2;CHD2;IRF2;RXRA;PRRX1;KLF3;NFATC1;TBX15;PRDM16;FOSL2;TEAD1;NFATC4;ZSCAN21;TBX1;MITF;NR3C1;THRB;ZBTB37;SOX13;NFIX;PBX3;PLAGL1;SOX17;MKX;ZBTB46;SP1;ZNF148;ELK3;CTCF;MGA;HDAC1;NFKB1;HES1;LHX6;PPARA;MEOX2;RARG;SIX1;UBP1;ZBTB7A;FOXO3;ZIC4;IKZF2;HIVEP1;HOXB6;BBX;STAT6;NFYC;E2F4;GTF2IRD1;MAX;MEF2C;SKIL;ZNF182;JUN;ZBTB4;SMAD1;SMAD2;ZFP90;TBX2;KDM6A;DACH1;BACH2;ZBTB39;PRDM2;PPARD;EBF1;IRF1;GLI3;ZNF25;SMAD4;ZIC5;HSF5;HOXC6;SP3;TAL1;GLIS2;TP53;ZBTB40;KDM6B;KLF10;ETS2;STAT2;NFIC;PRRX2;GMEB1;SOX7;ZBTB7C;MAZ;TWIST2;ZSCAN25;FOXF2;FOXJ3;HDAC4;ZNF394;LRRFIP1;ACTN4;PROX2;ZBTB6;KLF9;CREBRF;CIC;TFCP2L1;ZIC3;ATF4;PGBD1;MZF1;GRHL1;ZBTB25;NR1D2;ZBTB34;HIF3A;H3-3A;TCF3;TCF7L1;FOXC1;MYBL2;ZKSCAN1;ZNF32;NR2C1;RUVBL2;ETV1;FOXO4;CC2D1B;ZFP1;TRPS1;HIC1;SKI;ZNF235;SIX4;RARA;ZNF692;HOXA2;HDAC6;ZNF691;ZBTB14;FOXQ1;ZBTB8A;TFAP4;ZNF250;ZNF83;NLRC5;ARNT;PATZ1;CEBPG;HEY1;ZFP28;HEY2;ZSCAN12;RPS3;NRF1;WBP2;ELK4;HOXB9;ZIC1;ZBTB12;HLF;EPAS1
prerank,glycine binding (GO:0016594),0.6192699725887092,1.5292294936305386,0.07209302325581396,0.22004037183648137,1.0,4/11,5.34%,GLRA3;GRIN2B;GLRA1;GNMT
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.6320098895318178,-1.5272110532947358,0.04452690166975881,0.26972049586553054,0.999,5/11,13.40%,UBR5;UBE2K;RBX1;UBE4B;UBE4A
prerank,diacylglycerol kinase activity (GO:0004143),0.6075523967356157,1.5269428023709006,0.046620046620046623,0.21834344069558423,1.0,3/11,1.83%,DGKK;DGKI;DGKQ
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.38413985506193105,-1.5247388527496697,0.0036036036036036037,0.2690661192828021,0.999,25/100,15.43%,HIP1;CYTH3;DAB2IP;PARD3;MYO10;CERT1;FERMT2;IQGAP1;SH3PXD2B;PLA2G4A;ARAP3;GOLPH3L;ZFYVE26;TECPR1;AKT1;WIPI1;SNX12;ARAP1;FCHSD2;ANKFY1;PLEKHA4;SNX24;ZFYVE1;HIP1R;GAB2
prerank,protein kinase C activity (GO:0004697),-0.5668393895727829,-1.5081358230971897,0.044642857142857144,0.2990292701793412,0.999,5/14,8.54%,PRKCH;PRKCE;PRKD3;PRKCD;PRKD1
prerank,vitamin D receptor binding (GO:0042809),-0.5611397016367978,-1.5053631081741565,0.05850091407678245,0.2993416077458319,0.999,6/14,16.25%,RXRA;MED1;TAF11;MED13;MED17;TAF7
prerank,sequence-specific double-stranded DNA binding (GO:1990837),-0.3038769835373631,-1.4991165876402506,0.0,0.3072779275443982,0.999,177/597,25.02%,FOXP1;KLF12;LEF1;PBX1;SMARCA2;FLI1;MBNL2;NFIB;TEF;ERG;ZBTB20;BNC2;NFAT5;ELF1;KLF4;ETS1;NR3C2;PKNOX2;ESR1;CUX1;TCF12;PRDM5;KLF2;IRF2;RXRA;KLF3;NFATC1;TBX15;PRDM16;TEAD1;NFATC4;TBX1;NR3C1;THRB;ZBTB37;SOX13;NFIX;SOX17;PSPC1;SP1;VSX1;ELK3;CTCF;NFKB1;HES1;LHX6;MEOX2;RARG;SIX1;UBP1;ABL1;ZBTB7A;FOXO3;ZIC4;HIVEP1;HOXB6;BBX;NFYC;E2F4;GABPB2;CREB3L2;MAX;MEF2C;JUN;TBX2;SUV39H1;MCM9;BACH2;YAP1;PPARD;IRF1;GLI3;SMAD4;ZIC5;HSF5;SP3;TAL1;MCM4;GLIS2;ELF2;TP53;KLF10;HMBOX1;PER3;ETS2;NFIC;ORC5;PRRX2;GMEB1;SOX7;CHD3;FOXJ3;HDAC4;SFPQ;GABPB1;ASH2L;TFCP2L1;ZIC3;ATF4;MZF1;GRHL1;NR1D2;TCF7L1;FOXC1;MYBL2;BCOR;ZNF32;NR2C1;PRDM9;SMAD6;ETV1;FOXO4;ZFP1;TAF7;HIC1;ORC2;KDM5B;SIX4;RARA;HOXA2;ARID5B;ZBTB14;FOXQ1;TFAP4;ZNF250;ARNT;CEBPG;HEY1;HEY2;CARM1;ELK4;HOXB9;ZIC1;ZBTB12;HLF;ORC4;RNF10;GATA2;SOX4;TCF4;TCF7L2;NONO;TBL1X;PPARG;PRDM1;BCL6;RARB;BRCA1;FOXL2;GLIS1;HSF4;CREB1;ELF4;NFE2L2;GABPA;RELA;KCNH2;YY1;MCM3;TBX3;ATF6;MSX1;RXRG;RBBP5;CEBPA;BEND3;KLF16;ATF5;E2F7;GMEB2;E2F3;TAF9;ZNF276;HMGB1;EGR3;DHX9;IRF7
prerank,tau protein binding (GO:0048156),-0.43913372945715723,-1.4944075686869644,0.03756708407871199,0.31200823465659977,0.999,18/40,19.25%,DYRK1A;GSK3B;MARK1;SMAD2;ROCK1;GSK3A;PICALM;PRKAA1;DCTN1;ACTB;MARK2;ROCK2;LGMN;PPP2CB;FYN;MARK3;HDAC6;PPP2CA
prerank,potassium ion antiporter activity (GO:0022821),0.5458962864325406,1.4931677556067349,0.04288939051918736,0.2636923783497955,1.0,4/15,5.25%,SLC24A4;SLC24A2;SLC9A7;SLC9A9
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.4939277134360739,-1.4881131914990855,0.033582089552238806,0.3196638623506402,1.0,7/23,9.00%,PLCB4;EDNRA;PLCG1;PLCB3;PLCB1;PLCE1;PLCG2
prerank,protein serine/threonine kinase activity (GO:0004674),-0.31955345663450807,-1.4879247395637119,0.0,0.31404251474541633,1.0,96/335,17.01%,GRK5;PRKCH;SNRK;MAP3K20;ACVRL1;BCR;DYRK1A;CSNK1A1;NEK7;DAPK1;FAM20A;PRKCE;BMPR2;TLK2;GSK3B;CDK13;ATM;MARK1;RPS6KA5;LIMK2;PAK2;SIK1;LRRK2;MAP3K5;MAP4K3;PRKD3;NEK6;MTOR;PRKD2;CAMK2G;CDK12;EGFR;TLK1;CSNK1G3;TGFBR2;STK3;STK24;MAST4;MAST2;STK35;PRKCD;BRD2;CDK10;ERN1;MAPKAPK2;CDC42BPA;AAK1;PLK2;MAPK1;ROCK1;PRKD1;AKT3;RAF1;GSK3A;ACVR2A;ALPK1;LATS2;MYLK;AKT1;SIK3;TAOK3;PRKAA1;WNK4;GAK;STK10;ILK;STK32C;IKBKE;BRAF;STK38;IRAK1;RPS6KA1;CSNK1G1;CSNK1D;CLK3;ULK2;MAP3K8;CDK6;MKNK2;MAPK8;PKN2;TRIO;RPS6KA3;MAP4K4;MARK2;PKN3;ROCK2;NUAK1;MAPK12;SRPK2;SLK;MARK3;RPS6KC1;HIPK1;IRAK2;CDC42BPB
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.5347439580015678,-1.4850991359322325,0.05762081784386617,0.31437242761764345,1.0,6/18,14.44%,XIAP;TNFAIP8;BIRC3;GAS6;RPS6KA1;RPS6KA3
prerank,AMP binding (GO:0016208),0.6009070124049194,1.483577921073849,0.07126948775055679,0.273340231457411,1.0,2/11,2.28%,MPPED2;ACSS2
prerank,DNA-binding transcription factor binding (GO:0140297),-0.3378664133091097,-1.4812642175514465,0.0017730496453900709,0.3175268105042767,1.0,66/189,24.95%,MEF2A;CREBBP;RB1;KLF4;MIER1;TCF12;PRDM5;GSK3B;PRRX1;NFATC1;PRDM16;LMO2;SIK1;NEK6;SP1;HDAC1;HES1;PPARA;ZBTB7A;SPEN;MEF2C;JUN;SMAD2;YAP1;YWHAZ;LDB1;PPARD;RBBP8;TAL1;TP53;ZMYND8;SIN3A;RERE;ZFPM1;MTDH;HDAC4;KAT5;PIAS2;ATF4;HCFC1;TCF3;MIER2;FOXO4;MAD2L2;SKI;GTF2I;CTNNB1;HEY2;MIER3;PIAS4;TCF7L2;PPARG;WWP2;HDAC7;CREB1;PTMA;NFE2L2;GABPA;RELA;MYOCD;TBX3;CRTC1;TAF9;TLE6;HMGB1;DHX9
prerank,acetyltransferase activity (GO:0016407),-0.46544256226352543,-1.4807637205508182,0.02877697841726619,0.3126289169479632,1.0,9/31,11.31%,CREBBP;KAT6B;KAT2B;KAT6A;NAA16;NAA80;SMARCE1;NAA15;GNPNAT1
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.5211285217737751,1.4805308594533595,0.06359649122807018,0.2665582806278584,1.0,5/17,5.50%,EPHA6;EPHB1;EPHA5;EFNA3;EFNB3
prerank,ephrin receptor activity (GO:0005003),0.5211285217737751,1.4805308594533595,0.06359649122807018,0.2665582806278584,1.0,5/17,5.50%,EPHA6;EPHB1;EPHA5;EFNA3;EFNB3
prerank,kinase binding (GO:0019900),-0.30723634876200123,-1.4796886108820755,0.0,0.30937132960146435,1.0,140/435,24.36%,UTRN;DAB2IP;TTC28;GHR;SLC12A7;SP100;ACVRL1;RB1;FERMT2;PPP2R5A;CAV1;RAC1;ESR1;RHOBTB1;LIMS1;GSK3B;IQGAP1;KIF13B;PTPN1;KAT2B;CENPJ;RND3;CRK;PAK2;WWC2;SPRED2;SIK1;NR3C1;NBEAL1;NEK6;PLCG1;LRBA;PTPRJ;EGFR;SLC12A2;TFRC;CDKN1B;NISCH;TAX1BP1;MSN;HNRNPA0;RICTOR;AP2A2;DLG1;FOXO3;FAS;CCND3;CEP250;PTK2;IRGM;PRKCD;PTPRK;CNTLN;ZBTB4;SMAD1;ACTA2;MAML1;PRKRIP1;TBC1D14;YWHAZ;EXOC2;PLCG2;NBEAL2;CSPG4;CTBP2;BCAR1;ADAM10;MYOM1;TP53;FLNA;PPP1R12A;RGCC;ILK;PEBP1;TRIM14;EEF2;JAK2;DCTN1;FRMD5;RPTOR;RHOA;IRAK1;ACTB;CEACAM1;DUSP3;MTCP1;CHP1;GYS1;RHOC;RHOG;ATF4;PARN;PIK3IP1;GRB2;KIF11;SKI;CTNNB1;TNS2;CDK5RAP3;MAVS;CACUL1;SASH1;RPS3;RAD23A;TRPV4;CEP152;IKBKB;NOD2;CCND1;PRKAB1;PTPRC;VRK2;TCF7L2;PRC1;ERCC6L2;PTPN11;WARS1;CDKN2C;SIKE1;PDGFRB;HDAC7;MAP2K3;TOM1L2;CDC25A;IFNAR2;RPS7;GADD45A;RELA;PTN;PARP16;PIP5K1A;BECN1;CASP1;TPCN2;CEBPA;FZD5;TRIM68;TRIB3;ATF5;CCNK
prerank,5'-3' exonuclease activity (GO:0008409),-0.5756625389638763,-1.478144457216968,0.059625212947189095,0.30713023864137806,1.0,10/14,36.58%,XRN1;MRE11;XRN2;EXOG;DCLRE1B;DCLRE1A;DXO;EXO1;FAN1;DCP2
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.5199111227662436,1.4777782670812714,0.07407407407407407,0.2655595926749511,1.0,3/18,7.18%,AKR1C1;HSD17B7;HSD17B14
prerank,insulin-like growth factor binding (GO:0005520),-0.5579323412279319,-1.4753521949061914,0.0521415270018622,0.3083997985502448,1.0,6/15,9.44%,IGF1R;ITGA6;INSR;IGFBP4;ITGB4;IGF2R
prerank,neurexin family protein binding (GO:0042043),0.6139632899838867,1.4752512093799584,0.0675990675990676,0.2641426994592435,1.0,6/10,19.35%,NLGN1;SYTL2;CPE;NLGN2;SYTL1;NLGN3
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.47546587264258566,1.4737434382245211,0.04943820224719101,0.2614511382500877,1.0,7/24,10.34%,AK9;ITPKA;AK7;AK3;AK5;NME2;IP6K2
prerank,protein kinase binding (GO:0019901),-0.30344374150387915,-1.4683250984619305,0.0,0.3190100623000129,1.0,151/480,22.67%,UTRN;GRK5;DAB2IP;GHR;SLC12A7;ITGB1;ACVRL1;FERMT2;CAV1;RAC1;ESR1;CAVIN2;BMPR2;RHOBTB1;LIMS1;GSK3B;IQGAP1;KIF13B;PTPN1;KAT2B;CENPJ;RND3;CRK;PAK2;SPRED2;SIK1;NR3C1;NBEAL1;NEK6;PLCG1;PRKD2;LRBA;PTPRJ;ACE;SLC12A2;TFRC;CDKN1B;NISCH;MSN;ADAM9;PDLIM5;HNRNPA0;RICTOR;AP2A2;IRS1;DLG1;ABL1;FOXO3;PPEF2;PARD6G;CCND3;CEP250;GCH1;PTK2;KCNQ1;IRGM;PRKCD;PTPRK;CNTLN;EZR;MAPKAPK2;CDH5;TJP2;ZBTB4;SMAD1;ACTA2;ADCY4;MAML1;EPHA4;PRKRIP1;TBC1D14;YWHAZ;EXOC2;PLCG2;NBEAL2;GSK3A;CSPG4;CTBP2;BCAR1;ADAM10;TP53;PPP1R12A;RGCC;ILK;PEBP1;TRIM14;EEF2;JAK2;DCTN1;FRMD5;RPTOR;STK38;RHOA;IRAK1;ACTB;CEACAM1;PRKCSH;DUSP3;MTCP1;NEDD9;GYS1;RHOC;CSK;RHOG;ATF4;PARN;GRB2;TCF3;KIF11;TPR;MAD2L2;SKI;NOX4;RARA;HINT1;CDK5RAP3;MAVS;CACUL1;SASH1;RPS3;TRPV4;CEP152;IKBKB;NOD2;PPM1D;DUSP16;CCND1;DUSP22;PRKAB1;PTPRC;VRK2;TCF7L2;PRC1;ERCC6L2;PTPN11;WARS1;CDKN2C;ROR2;SIKE1;PDGFRB;HDAC7;SPAG9;MAP2K3;TOM1L2;CDC25A;MAPK7;IFNAR2;RPS7;HSP90AA1;RELA;PTN
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.4528977002815979,-1.4671557799878503,0.043233082706766915,0.31628271975289113,1.0,15/35,24.56%,FOXP1;NR3C1;HDAC1;TP53;KLF10;TAF1B;TAF1C;AGO2;H3-3A;DR1;RUVBL2;UBTF;RELA;SNAPC3;SMARCB1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.5025502434077217,1.4659033626302924,0.07017543859649122,0.2681650911082674,1.0,3/21,6.92%,GRM5;GRIA1;GRM1
prerank,transcription cis-regulatory region binding (GO:0000976),-0.306085867880587,-1.4642654470175884,0.0016722408026755853,0.3171783694303718,1.0,124/406,24.68%,FOXP1;LEF1;PBX1;RREB1;SMARCA2;FLI1;ETV6;ZBTB20;MEF2A;RB1;BNC2;KLF4;ETS1;CUX1;FOXN3;TCF12;PRDM5;IRF2;RXRA;PRDM16;FOSL2;TEAD1;NR3C1;SOX13;TIPARP;PLAGL1;SOX17;PSPC1;ZBTB46;SP1;VSX1;ELK3;CTCF;HDAC1;NFKB1;LHX6;SIX1;FOXO3;BBX;STAT6;NFYC;GABPB2;CREB3L2;MAX;MEF2C;JUN;ZBTB4;SMAD2;ZFP90;SUV39H1;DACH1;YAP1;PRDM2;IRF1;GLI3;ZNF25;SMAD4;SP3;TAL1;GLIS2;TP53;KLF10;PER3;SOX7;CHD3;TWIST2;XRN2;FOXF2;HDAC4;SFPQ;GABPB1;ACTN4;CREBRF;ASH2L;CIC;ATF4;MZF1;AGO2;GRHL1;HIF3A;TCF3;FOXC1;BCOR;PRDM9;SMAD6;DR1;TAF7;TRPS1;RARA;ARID5B;ZBTB14;ZBTB8A;TFAP4;ARNT;CARM1;RPS3;EPAS1;RNF10;SOX4;TCF7L2;NONO;TBL1X;PPARG;BRCA1;PBX2;NFE2L2;GABPA;RELA;KCNH2;YY1;SNAPC3;ATF6;MSX1;RFXANK;RBBP5;CEBPA;ATF5;ZFP3;E2F7;E2F3;TAF9;TFDP1;HMGB1;RBAK
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.3822293394282067,-1.4637406351507882,0.02910958904109589,0.31312144554455285,1.0,20/71,12.96%,PTPRG;PTPRB;PTPRM;PTPN14;PTP4A2;EYA4;MTMR3;PTPN1;PTPN9;PTPRJ;PTPN12;PTPDC1;CDC14A;PTPRK;PALD1;MTMR6;PTPN3;DUSP23;DUSP3;PTPN13
prerank,organic cation transmembrane transporter activity (GO:0015101),0.5137021173111265,1.462471493172997,0.07223476297968397,0.26827538383282384,1.0,4/16,8.28%,SLC22A4;SLC22A1;SLC7A8;SLC29A4
prerank,transcription coregulator binding (GO:0001221),-0.406398261117603,-1.462415383589858,0.028985507246376812,0.311155838554999,1.0,14/50,10.52%,ZBTB16;ESR1;LMO2;THRB;NEK6;VGLL4;CTCF;ZBTB7A;SUZ12;PPARD;SMAD4;CTBP2;EHMT1;PER3
prerank,death receptor binding (GO:0005123),-0.555011193662103,-1.4622801193690087,0.0582010582010582,0.30661885479676526,1.0,6/15,23.22%,DAB2IP;EDA;NGF;FEM1B;CASP8AP2;RIPK1
prerank,neuropeptide binding (GO:0042923),0.5131514093847261,1.4547238978355055,0.0675990675990676,0.27551167587458214,1.0,5/18,16.85%,OPRM1;GPR37;SORL1;NMUR2;GPR149
prerank,peptide hormone receptor binding (GO:0051428),0.5778690326660172,1.4367842090752965,0.08898305084745763,0.3006187093245293,1.0,2/11,10.26%,PSMC5;CCK
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.47111970844227125,-1.4327726911490992,0.05405405405405406,0.3674160653586976,1.0,7/26,10.66%,ABCG2;SLC6A6;SLC16A12;SLC5A6;SLC16A9;SLC16A1;SLC16A6
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.44240027099308527,-1.4294266377116374,0.05420560747663551,0.3694253253403549,1.0,13/34,16.06%,SETD2;KMT2E;KMT5B;NSD3;SUV39H1;SETD3;EHMT1;DOT1L;KMT5A;SMYD1;N6AMT1;PRDM9;ANTKMT
prerank,phospholipase C activity (GO:0004629),-0.45893809347087555,-1.42715570798456,0.06642728904847396,0.36980686798501716,1.0,8/25,13.14%,PLCB4;EDNRA;PLCG1;PLCB3;PLCB1;PLCE1;PLCG2;PDIA3
prerank,histone deacetylase binding (GO:0042826),-0.3668089735874543,-1.42696539743808,0.014209591474245116,0.3648834265029598,1.0,32/88,23.08%,LEF1;MEF2A;MIER1;KAT2B;YWHAE;SP1;NIPBL;HDAC1;HES1;MEF2C;GLI3;TAL1;TP53;HDAC4;SFPQ;MAPK8;PKN2;PHF6;BCOR;MIER2;HIC1;HDAC6;TFAP4;HDAC10;HEY2;MIER3;CCND1;PRDM1;NACC1;HSP90AA1;RELA;SUDS3
prerank,death receptor activity (GO:0005035),-0.5796153250748273,-1.4234146222343198,0.09647495361781076,0.36793618374109244,1.0,5/11,20.19%,TNFRSF1B;FAS;TNFRSF19;TNFRSF1A;TNFRSF25
prerank,voltage-gated ion channel activity (GO:0005244),0.5316997274192399,1.4225252825066779,0.07600950118764846,0.3191650863212507,1.0,4/14,10.55%,KCND2;HCN1;CACNA1E;VDAC2
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.5543475830055411,-1.4175616538594897,0.078125,0.3762161693660552,1.0,8/13,25.35%,PIP4K2A;PIP4K2B;PIP5K1B;PIK3C2A;PIK3CD;PIK3CB;PIP5K1A;PIK3CA
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.5696224456323619,1.4128018011017827,0.111358574610245,0.3314497328338517,1.0,3/11,8.87%,SLC22A4;SLC22A1;SLC25A45
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.5458962849029196,-1.4111517642712688,0.09769094138543517,0.38632793423639117,1.0,7/13,27.33%,BMP5;BMP6;BMP4;CDH5;BMP7;BMP2;BMP3
prerank,protein phosphatase binding (GO:0019903),-0.3439266196807204,-1.406556599446217,0.020869565217391306,0.39201015907256975,1.0,28/117,12.97%,DAB2IP;FOXO1;MFHAS1;IQGAP1;MTMR3;JAK1;ITGA1;MAP3K5;EGFR;AKAP11;CDKN1B;PPP1R3B;PXN;STRN3;PIK3R1;SHOC2;PHACTR4;PTK2;KCNQ1;STAT6;CDH5;FLT4;PPP1R3C;TP53;IKBKE;CEACAM1;PPP6R3;CTTNBP2NL
prerank,ubiquitin protein ligase activity (GO:0061630),-0.31477126049984266,-1.4008665297243417,0.0066555740432612314,0.40068426555410763,1.0,86/228,29.34%,WWP1;PELI1;XIAP;UBR5;KCMF1;BRAP;NEDD4L;CBLL1;ZNRF1;SMURF2;UBE2K;TRIM25;TRIM56;RNF139;RNF111;DTX3L;ZNRF3;SMURF1;RNF125;BIRC3;RBX1;CBL;RNF43;UBE4B;CUL3;NEDD4;LTN1;RNF115;RNF144B;UHRF2;PDZRN3;HECTD1;SH3RF1;TRIP12;ZNRF2;UBE2D3;UBR2;RNF25;AREL1;TRIM14;UBR4;UBE4A;ASB1;RC3H1;RNF167;TRIM59;MYLIP;DTX3;PELI2;HERC2;TRIM13;RFWD3;RNF10;UBR1;SIAH1;RNF152;RNF2;TRIM3;RNFT2;WWP2;HUWE1;FANCL;MDM2;SH3RF2;RNF216;HACE1;TRIM39;TRIM68;RCHY1;TRIM7;RNF38;FBXL22;FBXO17;TRIM44;ARIH2;RNF122;NEURL3;NEURL1B;RNF34;TRIM6;RNF114;NEURL2;TRIM35;RNF14;RNF187;ANAPC11
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.4455273139942309,-1.4008139551004986,0.06457564575645756,0.39544704328583485,1.0,8/30,14.44%,CAST;XIAP;TNFAIP8;BIRC3;GAS6;BIRC6;RPS6KA1;RPS6KA3
prerank,histone methyltransferase activity (GO:0042054),-0.4361058901628892,-1.3964829056189536,0.0749063670411985,0.40072203626256525,1.0,14/32,18.02%,SETD2;KMT2E;KMT5B;NSD3;SUZ12;SUV39H1;EHMT1;DOT1L;KMT5A;SMYD1;N6AMT1;PRDM9;KMT2C;CARM1
prerank,transaminase activity (GO:0008483),0.5666385986500402,1.3918571493343315,0.12162162162162163,0.3667197043802533,1.0,2/11,3.11%,GOT1L1;OAT
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.4316918892042861,-1.3909983410011633,0.07167832167832168,0.40911187460025195,1.0,16/34,27.03%,PAN3;ERI3;EXOSC2;EXOSC3;XRN2;PARN;PDE12;USB1;EXOSC5;ANGEL2;DIS3L2;CNOT2;EXOSC7;TOE1;CNOT8;CNOT1
prerank,transcription coactivator binding (GO:0001223),-0.47750622288728206,-1.3904173027064384,0.09330985915492958,0.40544706546412596,1.0,5/20,9.29%,ESR1;THRB;VGLL4;PPARD;SMAD4
prerank,sodium channel regulator activity (GO:0017080),0.41393399217350463,1.390317387235387,0.08189655172413793,0.3636998363502151,1.0,12/37,17.92%,FGF14;FGF12;SCN1B;ATP2B4;PKP2;GPD1L;GPLD1;SGK1;FXYD4;SCN2B;SGK3;SGK2
prerank,syntaxin-1 binding (GO:0017075),0.458690608698826,1.384515521515864,0.09237875288683603,0.36959126099008777,1.0,7/22,7.81%,SYT1;SNAP25;SNPH;SYNPR;PRRT2;SYP;STXBP2
prerank,estrogen receptor binding (GO:0030331),-0.42649423708394285,-1.3836538068721362,0.08419243986254296,0.41785364284696647,1.0,12/32,19.09%,LEF1;TACC1;NSD1;ESR1;NRIP1;MED1;WIPI1;RERG;DCAF13;CTNNB1;WBP2;NCOA6
prerank,transforming growth factor beta binding (GO:0050431),-0.4594187442434601,-1.3824892621498035,0.09208103130755065,0.4151958597765034,1.0,5/23,5.09%,ENG;ACVRL1;THBS1;TGFBR3;TGFBR2
prerank,G protein-coupled receptor activity (GO:0004930),0.29602760858976956,1.3812104813731654,0.01084010840108401,0.3703642373349403,1.0,38/239,12.02%,GRM5;ADGRB3;HCRTR1;PROKR1;OPRM1;ADGRL3;GRM8;NPFFR2;GPR101;ADGRG4;GABBR2;CNR1;GPR135;MTNR1B;GPR37;ELOVL4;MTNR1A;GPR22;GRM1;NPY;KISS1R;TRHR;ADRA2C;C3AR1;GIPR;ADRB3;ADRA2A;GPR83;GPR65;TSHR;LGR5;VIPR2;ADRA1D;ADRA1A;NMUR2;GPR45;CELSR2;GABBR1
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.40428913132672273,-1.3794680662884258,0.06551724137931035,0.41754187981446095,1.0,16/42,16.18%,CRK;SHE;LDLRAP1;YWHAE;YES1;PIK3R1;IRS1;ABL1;NEDD4;SHB;PLCG2;NCK2;PTPN3;RASA1;GRB2;PIK3R3
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.5266978281062065,-1.373220300486655,0.09739130434782609,0.4283130243749433,1.0,6/14,19.47%,USP9X;MINDY1;USP13;USP15;ATXN3;USP7
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.5483853268230625,1.3709419475619191,0.12195121951219512,0.3853513945445515,1.0,4/11,10.43%,FBXO11;PRMT9;PRMT6;PRMT5
prerank,BMP receptor binding (GO:0070700),-0.5459134260408023,-1.3676670517633978,0.11934900542495479,0.43759387351060036,1.0,7/12,27.33%,BMP5;BMP6;BMP4;CDH5;BMP7;BMP2;BMP3
prerank,sequence-specific DNA binding (GO:0043565),-0.27969528120795484,-1.3672614752546925,0.0016835016835016834,0.4333498969027916,1.0,125/590,18.47%,FOXP1;KLF12;LEF1;PBX1;FOXP2;FLI1;MBNL2;NFIB;ZNF423;TEF;ERG;ZBTB20;FOXO1;MEF2A;CBFB;NFAT5;ELF1;KLF4;NR3C2;PKNOX2;ESR1;CUX1;TCF12;PRDM5;KLF2;IRF2;RXRA;STN1;KLF3;NFATC1;TBX15;PRDM16;TEAD1;NFATC4;TBX1;NR3C1;THRB;KDM2A;ZBTB37;SOX13;NFIX;SP1;ZNF148;VSX1;ELK3;CTCF;HES1;LHX6;PPARA;MEOX2;RARG;SIX1;UBP1;ABL1;ZBTB7A;FOXO3;ZIC4;HIVEP1;HOXB6;BBX;E2F4;MAX;MEF2C;UPF2;JUN;ZBTB4;TBX2;BACH2;PRDM2;PPARD;GLI3;SMAD4;ZIC5;HSF5;SP3;GLIS2;ELF2;KLF10;HMBOX1;ETS2;NFIC;PRRX2;GMEB1;SOX7;FOXF2;FOXJ3;SNAPC1;HDAC4;SIRT3;CTC1;TFCP2L1;MECP2;ZIC3;ATF4;GRHL1;NR1D2;TCF7L1;FOXC1;MYBL2;ZNF32;NR2C1;PRDM9;ETV1;FOXO4;TERF2;ZFP1;HIC1;KDM5B;SIX4;RARA;HOXA2;ZBTB14;FOXQ1;TFAP4;ZNF250;ARNT;CEBPG;HEY1;HEY2;ELK4;HOXB9;ZIC1;ZBTB12;HLF;EPAS1
prerank,actin monomer binding (GO:0003785),-0.46526852664042584,-1.36604494280517,0.07468123861566485,0.43131711663059624,1.0,5/22,5.93%,LIMA1;NOS3;PRKCE;TMSB4X;ABL1
prerank,peptide N-acetyltransferase activity (GO:0034212),-0.585676778842281,-1.3638327603058285,0.12658227848101267,0.43172642735750827,1.0,3/10,10.04%,NAA16;NAA80;NAA15
prerank,bHLH transcription factor binding (GO:0043425),-0.47818097378315,-1.3632012781690934,0.10854092526690391,0.4283730252166762,1.0,4/19,4.96%,CREBBP;TCF12;LMO2;SP1
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.37138219770416386,-1.362884848772931,0.06989247311827956,0.4243043961947704,1.0,14/60,9.44%,FLT1;TEK;IGF1R;NRP2;TIE1;ROR1;INSR;CRIM1;KDR;MERTK;EGFR;EPHA4;FLT4;IGF2R
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.3684535485193383,-1.3608662040701782,0.0542907180385289,0.42440643696714037,1.0,14/60,9.17%,FLT1;TEK;IGF1R;ACVRL1;TIE1;ROR1;INSR;KDR;MERTK;EGFR;TGFBR2;EPHA4;FLT4;ACVR2A
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.5178222203875156,-1.3602272937998938,0.11965811965811966,0.42142043165175885,1.0,7/15,16.18%,ATM;PI4KB;PIK3C2A;PIK3CD;PIK3CB;PI4K2B;PIK3R3
prerank,histone acetyltransferase activity (GO:0004402),-0.43543663073588745,-1.3601301240795527,0.09107806691449814,0.416920340990377,1.0,9/30,15.40%,CREBBP;KAT6B;KAT2B;KAT6A;BAZ1A;SRCAP;KAT5;MCM3AP;TADA3
prerank,dipeptidyl-peptidase activity (GO:0008239),0.5516682345111831,1.3531616929126968,0.11674008810572688,0.4168267287918269,1.0,2/10,1.82%,DPP10;DPP6
prerank,methyl-CpG binding (GO:0008327),0.4539776403397087,1.353133013589388,0.10909090909090909,0.41039641081447564,1.0,11/22,24.38%,ZCWPW1;CXXC4;UHRF1;ZBTB21;PRMT5;TET1;CXXC5;CHTOP;ERH;WDR77;LHX4
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.539509161953296,1.352723981092238,0.13228699551569506,0.4048959088390754,1.0,1/11,0.61%,HCN1
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.45116693485281334,-1.3522151466140884,0.09706959706959707,0.43227399818625345,1.0,10/25,22.11%,HIP1;ARAP3;AKT1;FCHSD2;PLEKHA4;ZFYVE1;HIP1R;GAB2;PHLDA3;KIF16B
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.5502624479287783,-1.3514552191386187,0.14100185528756956,0.4294663469510814,1.0,7/12,31.74%,KDM3A;JMJD1C;HR;KDM7A;KDM3B;KDM4D;KDM4A
prerank,growth factor activity (GO:0008083),0.34682229450867064,1.349663383504811,0.05,0.4049419130630871,1.0,13/74,13.39%,NRG3;NRG1;OSGIN1;CLEC11A;FGF6;GRN;FGF5;VEGFA;PDGFA;IL12A;THPO;BDNF;FGF20
prerank,DNA binding (GO:0003677),-0.270552511895874,-1.349622900112484,0.0,0.4295309269528294,1.0,204/694,25.19%,MECOM;KLF12;LEF1;PBX1;FOXP2;SMARCA2;FLI1;ZBTB16;NFIB;ZNF423;ERG;FOXO1;MEF2A;CREBBP;CBFB;ETS1;CUX1;HIVEP2;PDS5B;PRDM5;KLF2;CHD2;IRF2;RXRA;STN1;APP;RBMS1;PRDM16;TEAD1;TBX1;THRB;DDX3X;SOX13;KAT6A;PLAGL1;PARP4;EGFR;SP1;DMC1;ZNF148;CRLF3;CTCF;TOP3A;ZMYM6;HES1;PPARA;MEOX2;RARG;SIX1;RBM5;RYBP;ABL1;ZBTB7A;SAMHD1;FOXO3;ZIC4;XRCC4;NFYC;E2F4;XRN1;MAX;JUN;ZBTB4;SMAD2;MRE11;TSHZ2;TBX2;POLR2G;NABP1;MCM9;PRDM2;PPARD;IRF1;SMAD4;ERCC2;RBBP8;SPTY2D1;CLSPN;MCM4;TP53;BCLAF3;WDR76;HMBOX1;ETS2;RTF2;DDX60;ENDOV;CHD3;YAF2;FOXF2;FOXJ3;RAD18;SNAPC1;RTF1;HDAC4;SFPQ;ZNF638;OGG1;ZMYM4;LRRFIP1;RPA3;DNA2;JRKL;ZBTB6;RPA1;SIRT3;CTC1;PNKP;XPC;MECP2;ZIC3;ATF4;NHEJ1;ARID3B;GRHL1;ERCC3;HNRNPA1;TCF3;TCF7L1;POLR3F;FOXC1;CGAS;NR2C1;PRDM9;TRIM16;PALB2;FOXO4;HIC1;DNMT1;KDM5B;RPS27;ARID5B;ZBTB14;TFAP4;FANCG;ARNT;PATZ1;FUBP1;CEBPG;ZMYND11;HEY2;TSHZ1;WRN;RPS3;RAD23A;ELK4;SDE2;HLF;EPAS1;RPA2;ZDHHC1;RNF4;SMARCAD1;PRKDC;TCF4;TCF7L2;TIMELESS;PPARG;BCL6;RARB;HUWE1;LIG4;BRCA1;RAD51AP2;NR2F2;TRIM28;FOXL2;DCLRE1B;TERT;BLM;RBM6;TSHZ3;TAF4B;NFE2L2;RELA;RPS15;YY1;MBD6;MCM3;TOP1;NTHL1;SNAPC3;TBX3;ATF6;RFC1;PCBP1;GTF3C4;CEBPA;MSH3;THRAP3;ATF5;MAU2;ARID3A;E2F3;TAF9;SMARCB1;HMGB1;KHDRBS1;DHX9;INO80;IRF7;DCLRE1A;HIC2;FOXF1
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.48425358094960064,1.34935830160376,0.11283185840707964,0.39352421555429806,1.0,8/16,22.88%,ATP6V1B2;ATP6V0C;ATP6V0D2;ATP6V0A2;ATP6V0D1;ATP6V1C1;ATP6V1A;ATP6V0E1
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.48425358094960064,1.34935830160376,0.11283185840707964,0.39352421555429806,1.0,8/16,22.88%,ATP6V1B2;ATP6V0C;ATP6V0D2;ATP6V0A2;ATP6V0D1;ATP6V1C1;ATP6V1A;ATP6V0E1
prerank,nuclear receptor binding (GO:0016922),-0.331845603023797,-1.3492754712118935,0.05217391304347826,0.425799522476858,1.0,29/111,17.12%,FOXP1;LEF1;TACC1;NSD1;ESR1;ASXL1;NRIP1;RXRA;TACC2;ZBTB7A;MED1;PRPF6;SMARCE1;TRIP12;TAF11;MED13;WIPI1;KDM3A;JMJD1C;BCAS3;MED17;ACTN4;HMGN3;SMARCD3;TADA3;RERG;TAF7;DCAF13;CTNNB1
prerank,phosphatase activity (GO:0016791),0.34971321875537653,1.3480094513058427,0.06502242152466367,0.39056630741073184,1.0,20/73,15.83%,ATP1A2;BPNT2;LPIN1;PLPPR4;PPP5C;PLPPR1;PLPP2;DUSP4;SBF1;PLPP4;PLPPR5;HDHD2;OCRL;APTX;DUSP8;NUDT16;DUSP15;PSPH;PTPRO;FRA10AC1
prerank,ubiquitin-like protein ligase activity (GO:0061659),-0.3020625062405669,-1.3470726013924643,0.02159468438538206,0.42701852729504003,1.0,86/232,29.34%,WWP1;PELI1;XIAP;UBR5;KCMF1;BRAP;NEDD4L;CBLL1;ZNRF1;SMURF2;TRIM25;TRIM56;RNF139;RNF111;DTX3L;ZNRF3;SMURF1;RNF125;BIRC3;RBX1;CBL;RNF43;CUL3;NEDD4;LTN1;RNF115;RNF144B;UHRF2;PDZRN3;HECTD1;SH3RF1;TRIP12;ZNRF2;UBE2D3;UBR2;RNF25;AREL1;TRIM14;NSMCE2;PIAS2;UBR4;ASB1;RC3H1;RNF167;TRIM59;MYLIP;DTX3;PELI2;HERC2;TRIM13;RFWD3;RNF10;UBR1;SIAH1;RNF152;RNF2;TRIM3;RNFT2;PIAS4;WWP2;HUWE1;FANCL;MDM2;SH3RF2;RNF216;HACE1;TRIM39;TRIM68;RCHY1;TRIM7;RNF38;FBXL22;FBXO17;TRIM44;ARIH2;RNF122;NEURL3;NEURL1B;RNF34;TRIM6;RNF114;NEURL2;TRIM35;RNF14;RNF187;ANAPC11
prerank,filamin binding (GO:0031005),-0.5466500504351133,-1.3429950665424883,0.14,0.4326571265473471,1.0,8/11,36.40%,NEBL;CEACAM1;SYNPO2;CRMP1;RFLNB;RFLNA;DPYSL4;FBLIM1
prerank,double-stranded DNA binding (GO:0003690),-0.2748881718087337,-1.338635413359402,0.0033112582781456954,0.4388788205723893,1.0,113/531,18.46%,FOXP1;KLF12;LEF1;PBX1;FLI1;MBNL2;NFIB;TEF;ERG;ZBTB20;NFAT5;ELF1;KLF4;NR3C2;PKNOX2;ESR1;CUX1;TCF12;KLF2;IRF2;RXRA;KLF3;RBMS1;NFATC1;TBX15;TEAD1;NFATC4;TBX1;NR3C1;THRB;ZBTB37;NFIX;EGFR;SP1;DMC1;VSX1;ELK3;HES1;LHX6;MEOX2;RARG;SIX1;UBP1;ABL1;ZBTB7A;FOXO3;ZIC4;HIVEP1;HOXB6;BBX;E2F4;MAX;MEF2C;JUN;SMAD2;MRE11;TBX2;BACH2;PPARD;GLI3;RBBP8;ZIC5;HSF5;SP3;GLIS2;ELF2;KLF10;HMBOX1;ETS2;NFIC;DDX60;PRRX2;GMEB1;SOX7;FOXJ3;ZNF638;PNKP;TFCP2L1;MECP2;ZIC3;ATF4;GRHL1;NR1D2;TCF7L1;POLR3F;MYBL2;CGAS;ZNF32;NR2C1;ETV1;FOXO4;TERF2;ZFP1;HIC1;KDM5B;SIX4;RARA;HOXA2;ZBTB14;FOXQ1;TFAP4;ZNF250;ARNT;CEBPG;HEY1;ZMYND11;HEY2;RPS3;ELK4;HOXB9;ZIC1;ZBTB12;HLF
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.3993782317417375,-1.3383359919028714,0.10338680926916222,0.4351373427845134,1.0,13/37,21.49%,YARS1;WARS2;NARS2;CARS2;FARS2;TARS3;LARS1;HARS2;DARS2;VARS2;FARSA;IARS2;WARS1
prerank,Wnt-activated receptor activity (GO:0042813),-0.5021730648662289,-1.3368177957239367,0.12903225806451613,0.4345328641299208,1.0,9/15,26.46%,ROR1;LRP5;FZD6;FZD4;FZD7;FZD5;FZD10;TSPAN12;FZD1
prerank,SH2 domain binding (GO:0042169),-0.41777980855022595,-1.33527438140093,0.09659090909090909,0.43437813563848404,1.0,8/31,6.61%,AFAP1L2;RUFY1;CRK;SH3PXD2B;ARHGAP5;IRS1;ABL1;PTK2
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.43231701447943316,-1.3351295947805375,0.10320284697508897,0.43047818978642893,1.0,21/29,40.42%,NFATC1;PTPRJ;ACE;ABL1;GCH1;MAPKAPK2;TPR;CDK5RAP3;PPM1D;DUSP16;MAPK7;TNIP1;DUSP1;MAPK14;DUSP6;DIRAS1;ATF7;DUSP5;MAPKAPK5;DUSP2;SIRT1
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.5375282056620773,-1.3341426019372598,0.13884007029876977,0.4285641150547912,1.0,6/12,16.18%,ATM;PIK3C2A;PIK3CD;PIK3R6;PIK3CB;PIK3R3
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.5193456819257019,-1.3308265577124996,0.13774597495527727,0.432359797965859,1.0,4/13,7.35%,IL1R1;PDGFD;PTPRJ;ERN1
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.4400417280536712,-1.3306651086069747,0.12477396021699819,0.42858123695758876,1.0,11/25,26.17%,ZC3HAV1;TIPARP;PARP4;SIRT5;PARP14;SIRT3;PARP11;ART3;PARP16;PARP6;PARP9
prerank,calcium-activated potassium channel activity (GO:0015269),0.5345575658457334,1.3306370227712214,0.15246636771300448,0.42240679471324744,1.0,3/11,11.47%,KCNMA1;KCNN2;KCNN3
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.44042127526539,1.3303051257007739,0.10425531914893617,0.4173012382628531,1.0,5/20,5.53%,DLG2;AK9;AK7;AK3;AK6
prerank,syntaxin binding (GO:0019905),0.3535543358259075,1.330264328029367,0.07004830917874397,0.41159104663811313,1.0,11/61,7.81%,STXBP5L;SYT1;SYT5;SNAP25;SNPH;SYNPR;SYT12;CACNA1A;PRRT2;SYP;STXBP2
prerank,metallopeptidase activity (GO:0008237),0.3147101711682988,1.3291604447137233,0.0332541567695962,0.4082580602551642,1.0,21/113,9.77%,ADAM12;OMA1;ADAM23;ADAM29;MMP12;MME;ADAM11;MMP16;MMP24;MMP28;MMP25;PAPPA2;ADAMTS15;METAP2;ADAMTSL4;ADAM2;DPEP1;MPND;PSMD14;ADAM19;ADAMTS16
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.37450124533360923,-1.3287504680248556,0.07473309608540925,0.42886569630172605,1.0,18/49,20.36%,TAB3;EPS15;UIMC1;RNF169;MINDY1;IKBKE;RAD18;BABAM2;RNF168;ZFAND6;TNFAIP3;AGAP3;TAB2;HDAC6;BRCC3;RAD23A;IKBKG;PSMD4
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.5099910849681223,-1.3256594594587108,0.13562386980108498,0.43235498762781105,1.0,5/13,13.36%,GSK3B;KCNQ1;EZR;GSK3A;CSK
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.4400759421274536,1.3252937947345125,0.116331096196868,0.41076587686132643,1.0,7/23,10.02%,PDE4B;PDE3B;PDE1B;PDE10A;CNP;PDE1A;PDE11A
prerank,signal sequence binding (GO:0005048),-0.4037403201607488,-1.3252429064281421,0.11942959001782531,0.4292448268484815,1.0,19/35,31.99%,BRAP;KPNA4;AP2B1;NFKBIA;KPNA3;KDELR3;NUP153;CAT;BABAM2;KPNA1;NUP214;AP2M1;RANBP6;TOMM20;SEC61A1;TOMM70;KDELR1;TNPO2;CEMIP
prerank,nucleotide diphosphatase activity (GO:0004551),-0.5126928575316144,-1.325095838314042,0.1224105461393597,0.42563505486938225,1.0,5/14,18.95%,FHIT;NUDT13;ENPP4;NUDT6;NUDT12
prerank,actin binding (GO:0003779),-0.30400146052567784,-1.3248254949345803,0.04085257548845471,0.422332431324797,1.0,38/170,13.34%,UTRN;ABLIM1;MYRIP;SORBS1;LIMA1;ITGB1;FERMT2;NOS3;EPS8;PARVB;PHACTR2;MYH9;PRKCE;PARVA;TMSB4X;MICAL2;LRRK2;SYNE1;SYNE2;EMD;EPS8L2;PDLIM5;ABL1;PHACTR4;MACF1;PTK2;EZR;MYO1F;FXYD5;PDLIM1;SHROOM2;PHACTR1;CEACAM1;SYNPO2;LCP1;TPM1;ACTN4;PDLIM3
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.5436809189015332,-1.3224938650749405,0.13676731793960922,0.4237748131610252,1.0,6/11,18.94%,STN1;RPA1;CTC1;HNRNPA1;TERF2;RPA2
prerank,metalloexopeptidase activity (GO:0008235),0.3658604460947849,1.3219784691289411,0.09111617312072894,0.41192634007286505,1.0,14/51,14.22%,AGBL4;CPB2;TRHDE;MMP16;CPA2;CPE;METAP2;AGBL1;DPEP1;CPN1;AEBP1;NUDT16;CPA4;CPA3
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.42656698018989864,-1.3218725673710916,0.10181818181818182,0.4215046056694855,1.0,10/30,20.73%,SLC39A10;SLC40A1;SLC31A1;SLC30A10;SLC39A8;SLC39A11;SLC30A5;SLC25A28;SLC39A6;SLC30A1
prerank,cytokine receptor binding (GO:0005126),-0.33880754539276575,-1.3198844710134627,0.05699481865284974,0.4221666236389315,1.0,16/83,11.75%,KITLG;OSMR;JAK1;SPRED2;CCL25;IL6ST;TGFBR3;IL6R;IL34;TGFB2;SMAD2;LIFR;VEGFC;SOCS2;JAK2;USP15
prerank,RNA binding (GO:0003723),-0.2556417992541606,-1.3148657101739512,0.0,0.42961421948115064,1.0,460/1321,29.26%,SPTBN1;MBNL1;TNS1;CTNNA1;RBPMS;MBNL2;CAST;MAP3K20;MSI2;SRSF11;EIF3H;FNDC3B;ANKHD1;MYH9;FNDC3A;ZCCHC7;ANKRD17;YARS1;ZNFX1;TNRC6B;TUT7;HADHB;ERI3;RBFOX2;SUGP2;CHD2;TMSB4X;EIF4H;IFIH1;ZNF326;ANXA2;CDK13;TENT4B;PTPN1;TRIM25;RBMS1;TRIM56;RRBP1;PRPF3;NUP42;DEK;CNOT4;ZC3HAV1;ANXA11;RPS21;DAP3;EIF3E;METTL14;ARCN1;SYNE1;UTP11;DDX3X;DIAPH1;MAP4;RPL37;AHNAK;YWHAE;RAE1;FBRSL1;SARNP;RPL31;GIGYF2;PSPC1;TFRC;ZC3H4;SUCLG1;MSN;RTRAF;HNRNPA0;EIF3C;LARP1;THOC2;RPL9;PPIG;RBM5;RPS14;PRRC2B;WDR75;SAMHD1;NOVA2;HNRNPR;HOXB6;KHNYN;FARS2;SORBS2;RPF1;MACF1;UPF3B;FUS;NOL10;AATF;PRPF6;DDX10;SNTB2;RBM33;ACIN1;NUP98;SF3B6;EIF3B;SPEN;XRN1;ZCCHC9;RPSA;TCP1;RBMS2;SAMD4A;PUM1;EZR;JUN;TOP3B;MYO18A;RBM19;HNRNPM;ZC3H7B;FAM120C;S100A16;AGFG1;SECISBP2;ZGRF1;DDX50;POLR2G;PRKRIP1;HNRNPAB;NOP2;YWHAZ;EXOSC2;PHF5A;EXOSC1;ADK;CELF1;PTCD3;DDX39B;ZNF106;RPL3;SF3B1;MRPL32;GTF2E2;SRPRA;GPATCH8;RPL26;ESF1;NAA15;TASOR;DNTTIP2;FLNA;PUF60;PPP1R10;PRPF31;CPSF7;RPS11;SNIP1;NDUFV3;SRP9;HNRNPA3;SLC25A11;DICER1;FAM120A;HNRNPUL1;HELZ2;EXOSC3;TDRD3;SERBP1;EFTUD2;PRRC2C;DDX60;RBM39;PEBP1;DHX38;DBR1;EEF2;ENDOV;MAZ;MRPS23;OTUD4;HNRNPF;CHD3;XRN2;TUT4;SON;RPL13;MTCL1;ACTN1;ALDH18A1;MTDH;SPATS2L;RTF1;SFPQ;ZNF638;PA2G4;STRBP;LLPH;LRRFIP1;KCTD12;UTP3;ACTN4;TIAL1;DNA2;RPL38;CLK3;PDIA3;EIF5A;RRP1;RPL27;NIP7;RPS16;LARP4B;APOBEC1;XPOT;RPS4X;MECP2;PKN2;MRPL2;PARN;GSPT1;NUFIP2;AGO2;RPL10;MRPS24;RBM20;RPL7A;RPUSD4;RC3H1;FAM98A;GRB2;SF3A1;FAU;MARK2;HNRNPA1;LARP1B;CCDC9;N4BP1;PHF6;MRPS27;MRPL12;SYNCRIP;CCDC9B;ROCK2;ZC3H14;PABPC4L;HARS2;JMJD6;KMT2C;USP10;DARS2;TPR;RPL5;UBE2L3;PUS10;ALG13;CAVIN1;TEP1;SRSF12;LBR;PSTK;DCAF13;SRP14;UTP14A;MOV10;SRPK2;SUMO1;GCN1;RPS27;CCDC86;API5;ADARB1;RPL27A;TRMT9B;EDC3;FUBP1;PPHLN1;DIDO1;LSM10;RPL7L1;RPS3;ATP5F1C;RBM4B;DHX57;NCOA5;STAU1;TES;BUD13;HMGN2;RPL36A;COA6;RPL35A;TNRC6A;FIP1L1;DDX31;UTP4;PRKDC;SRRM1;FARSA;BOP1;MRPS14;TXN;NONO;DCP1A;CAPRIN1;RNPS1;CDK11B;RPL37A;SRSF3;NQO1;PSMD4;HUWE1;BRCA1;PTBP3;DUSP14;PES1;RTCB;MRPS21;TRIM28;STRAP;RRS1;DROSHA;BZW1;RBM3;SRSF10;TERT;RPL32;TRA2B;FASTKD5;NKAP;MEX3A;SLC3A2;PRPF38B;ARHGEF1;LSM3;RBM6;MEX3B;EBNA1BP2;CWC22;METTL16;UBTF;RPS7;MRPL54;HSP90AA1;TPD52L2;KTN1;RPS15;RBM25;YY1;TOP1;RPS8;ALKBH5;RPL28;RPL22;AKAP1;RPL13A;MRPL13;NPM3;MRPL9;RPL36;EIF3A;RPL30;ZCCHC24;RBM15;NOP16;PCBP1;RPS23;TRMT1;THRAP3;POLDIP3;SMG6;SF3B5;HSPA1B;NXF1;TAF15;HMGB1;NEMF;SRBD1;ELAC2;GLRX3;IMMT;NOA1;RPS17;EIF3I;PINX1;KHDRBS1;DHX9;MRPS28;MRPS35;NOL8;EXOSC7;UBAP2;WDR46;FXR1;NCBP3;RPS2;MRPL43;PRPF40B;RBM28;FAM32A;IGF2BP2;TOE1;PEF1;EIF2AK4;TUFM;ZFP36L1;ENDOU;RPP30;LRP1;RTCA;TRNT1;RBM47;RPL39;MRPL11;RPS26;NAF1;RPS15A;HNRNPL;HNRNPD;DXO;RAN;RBPMS2;MRPS31;NANOS1;BYSL;SELENOH;LARP6;RPL15;RPL34;CNOT1;EIF5B;EMG1;PABPC1;BAG4;NMD3;HNRNPU;SCAF11;SLTM;RPL22L1;SMG1;HDLBP;PCDH20;POP4;RDX;HTATSF1;LSM2;TDRD7;SCG3;OASL;BST2;DMGDH;NUFIP1;DHX40;UTP23;UBE2I;DDX28;KHDC4;NUDT7;UBA1;UTP20;MTIF2;RPUSD2;SPATS2;PPIE;RAD51AP1;ZFR;EIF4G3
prerank,glycerophospholipid flippase activity (GO:0140333),-0.5416757308586718,-1.3118204119785133,0.152014652014652,0.4329576582847677,1.0,2/11,0.63%,ATP10A;ATP8B1
prerank,protein serine/threonine phosphatase activity (GO:0004722),-0.3608045700307304,-1.3102480628826045,0.08983050847457627,0.4328748666552209,1.0,15/60,11.07%,PPM1H;MTMR3;LRRK2;CAMK2G;PPEF2;LRRK1;PPM1L;CDC14A;ILKAP;MTMR6;PPM1F;CTDSPL2;PPP1R3C;PPM1B;UBLCP1
prerank,acylglycerol lipase activity (GO:0047372),-0.543245289224927,-1.309068776098271,0.1374764595103578,0.4319068624790712,1.0,3/11,14.81%,ABHD2;MGLL;LIPE
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.4633039598080246,1.309031899423057,0.1337579617834395,0.4341669989400006,1.0,7/17,17.00%,AK9;AK7;AK3;AK5;NME2;CLP1;AK1
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.5079513303216574,1.3078097800368256,0.1648590021691974,0.4312631946240735,1.0,5/12,16.83%,AKR1C1;DCXR;CBR1;NDUFS7;CRYZL1
prerank,E-box binding (GO:0070888),-0.4095917322920674,-1.3075021152153412,0.11439114391143912,0.4320776120240453,1.0,9/34,20.11%,ZEB1;MITF;HES1;MAX;TAL1;TCF3;TFAP4;TCF4;PPARG
prerank,amino acid binding (GO:0016597),0.39908372636762046,1.3050172052997804,0.12264150943396226,0.431924211949956,1.0,6/31,8.90%,GLRA3;GRIN2B;DDAH2;GLRA1;GNMT;GRM7
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.5035714936429371,1.3049005287595312,0.17286652078774617,0.4267021761896393,1.0,2/12,3.86%,B3GALT1;B3GALT5
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.48149926488195516,1.3047444709720186,0.13771186440677965,0.42176487735536966,1.0,4/14,9.70%,AK9;AK7;AK5;NME2
prerank,triglyceride lipase activity (GO:0004806),-0.45397384028773935,-1.3040121794626456,0.13732394366197184,0.43671479811085945,1.0,7/20,29.48%,LPL;LIPE;DAGLB;DDHD2;LCAT;PNPLA2;LIPH
prerank,ubiquitin-protein transferase activity (GO:0004842),-0.2816049409887198,-1.3033100384090839,0.02023608768971332,0.4346079993937697,1.0,126/346,29.34%,WWP1;PELI1;XIAP;UBR5;KCMF1;BRAP;NEDD4L;CBLL1;ZNRF1;SMURF2;TRAF5;UBE2K;TRIM25;TRIM56;CNOT4;RNF139;RNF111;DTX3L;ZNRF3;SMURF1;RNF125;FBXL3;BIRC3;RNF213;RBX1;CBL;RNF43;LMO7;CUL3;NEDD4;LTN1;RNF40;RNF115;RNF144B;CUL2;BIRC6;UHRF2;PDZRN3;HECTD1;SH3RF1;TRIP12;UBE2J2;ZNRF2;UBE2D3;MIB1;UBA7;UBR2;RNF25;FBXW8;AREL1;TNFAIP1;KLHL13;TRIM14;RMND5A;TSPAN17;UBE2E2;OBI1;UBR4;ASB1;FBXW11;RNF168;RC3H1;RNF167;TRIM59;MYLIP;DTX3;TNFAIP3;BCOR;UBE2M;ERCC8;UBE2L3;PELI2;HERC2;TRIM13;MIB2;RFWD3;KCTD10;RNF10;UBR1;SIAH1;RNF152;AKTIP;RNF2;TRIM3;RNF4;RNFT2;TRIM47;WWP2;HUWE1;FANCL;BRCA1;TRIM28;UBE2R2;MDM2;SH3RF2;RNF216;HACE1;TRIM39;TRIM68;RCHY1;TRIM7;RNF146;MAEA;RNF38;FBXL22;FBXO17;DTL;TRIM44;ARIH2;RNF122;TRIM45;RNF103-CHMP3;NEURL3;NEURL1B;RNF34;RNF103;TRIM6;RNF114;ASB4;NEURL2;RNF214;TRIM35;RNF31;RNF14;RNF187;ANAPC11
prerank,histone acetyltransferase binding (GO:0035035),-0.45579989413836924,-1.30222173809653,0.10564663023679417,0.4337398806113074,1.0,10/21,23.93%,MEF2A;ZBTB7A;GLI3;TP53;BCAS3;TAF7;EPAS1;CITED2;KANSL1L;TRIM68
prerank,organic anion transmembrane transporter activity (GO:0008514),-0.3107567336770643,-1.3022080997597505,0.04529616724738676,0.4301914237955168,1.0,24/134,9.97%,ABCC4;ABCG2;SLC6A6;SLC26A7;SLCO2A1;SLCO1C1;SLC7A1;SLC7A5;SLC26A2;SLCO3A1;SLC16A12;SLC25A32;SLC5A6;SLC19A2;SLC38A5;SLC16A1;SLC25A25;SLC39A8;SLC1A5;SLCO2B1;SLC13A3;SLC35A3;MFSD2A;SLC52A1
prerank,metal ion binding (GO:0046872),0.2638892726609596,1.2980205713125696,0.0106951871657754,0.4309050905985854,1.0,111/477,17.25%,KCNIP4;NRXN1;CDH18;BGLAP;SYT1;PCLO;SYT5;KCNIP1;CDH8;CDH20;CDH9;CDH10;ENPP2;ADGRL3;CABP4;SLC25A23;IGFBP3;MMP12;GEM;RYR3;SLC25A13;SPOCK1;RP2;DNER;ASTN2;GNAI1;SYT12;SYT11;TKT;OXSR1;HPCA;CLEC3B;DCHS1;CDH19;PCDHA4;NCS1;PITPNM1;STK11;CALM2;MAP2K7;CDH12;SPHK1;GSN;PADI1;TRIM27;NUDT18;RYR2;SRPK1;RPH3A;CDH7;GJB2;ENPP3;STK26;ATP4A;PPP3CA;S100A6;CDH17;PLA2G4E;PADI2;PGS1;HMGCLL1;CDH24;TESC;CPNE1;SLIT3;SLIT1;ANXA8;ANXA8L1;CDHR3;C2CD5;MCTP2;TNNC1;CIB2;SYT4;CDH2;PPP3R1;SLC8A1;TCHH;HMGCL;SRI;HRC;RASGRP1;IDH3A;MYL2;TPPP;CASQ1;NUDT16;CISD3;BRSK2;SYT3;RCN3;APOE;ACVR1C;NDUFAB1;TESMIN;AASDHPPT;PSPH;CDH22;GALNT3;POSTN;ADAM8;ASAH2;CETN3;PCP4;CABYR;CDH13;EFCAB11;SYT9;MSH2;PGP;DHX36
prerank,platelet-derived growth factor binding (GO:0048407),0.5116903927083317,1.2965818094428123,0.14912280701754385,0.42860493505545255,1.0,6/11,15.31%,COL2A1;COL1A1;PDGFA;COL1A2;COL3A1;PDGFRA
prerank,store-operated calcium channel activity (GO:0015279),-0.5577997852154383,-1.2928032211279856,0.13454545454545455,0.4491133067342852,1.0,4/10,16.74%,STIM2;TRPC4;TRPC6;TRPC3
prerank,damaged DNA binding (GO:0003684),-0.37659747700320845,-1.2891532307398372,0.12815884476534295,0.45394832462508405,1.0,19/44,26.66%,CREBBP;ERCC2;RBBP8;RAD18;OGG1;RPA3;RPA1;PNKP;XPC;ERCC3;FANCG;RPS3;SDE2;RPA2;DCLRE1B;NTHL1;HMGB1;DCLRE1A;CRY2
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.5238240293758278,-1.284829590834032,0.1695501730103806,0.4604259997890652,1.0,2/11,3.11%,SGMS1;SGMS2
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.41876130860116745,-1.2846970993587443,0.14102564102564102,0.4569876817211884,1.0,7/27,8.42%,ITPR1;CNNM2;SLC12A2;ITPR2;SLC9B2;CNNM4;ATP2A3
prerank,zinc ion binding (GO:0008270),-0.28009049326837965,-1.282614045703437,0.033277870216306155,0.458371314415205,1.0,103/293,26.38%,MYRIP;KLF7;SHANK3;MNAT1;NSD1;SEC24B;ZEB1;KLF4;CLIP1;TAB3;MSRB3;LIMS1;IFIH1;RXRA;PTPN1;KDM2A;TNFSF10;KAT6A;WDFY1;RNF125;ACE;CTCF;TET2;SAMHD1;SEC24A;PDE2A;GCH1;SIRT5;PAM;ECE1;NAPEPLD;SEC24D;PDXK;ARHGEF2;CRIP2;PRDM2;PHF5A;RASSF1;TP53;ENPEP;ZCCHC4;ZMYND8;ACER3;CHD3;HDAC4;SLU7;ADAM33;SIRT3;PLSCR1;KDM7A;ZFYVE1;RC3H1;SLC30A5;TAB2;SKI;KDM5B;RPS27;HDAC10;HPF1;GDA;ZMYND11;ERAP1;SOD1;KDM1B;CZIB;TES;SIAH1;NUDT12;RNF2;NPEPPS;PIAS4;PPARG;BAZ1B;TRIM28;MDM2;BLM;RABIF;CALB1;TET3;APIP;SEC24C;BBOX1;PGGT1B;USP16;MSRB2;RCHY1;ACE2;RBAK;POLR2L;ADA;MT1B;MT1G;MT1E;MT1A;MT1M;MT1H;MT1X;MT1F;TIMM10;RABGGTB;QPCTL;ARIH2;CDADC1
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.48197755487646426,1.2819626611764365,0.1588785046728972,0.4542994570178208,1.0,8/13,25.66%,TRMT10B;TRMT10A;TRMT11;FTSJ1;TRMT5;THUMPD3;TRMT1L;THUMPD2
prerank,protein kinase activator activity (GO:0030295),-0.34937885438646493,-1.2812012832999156,0.1001788908765653,0.45808762272226417,1.0,17/60,14.78%,AFAP1L2;ABI1;FAM20A;IQGAP1;PAK2;DDX3X;GPRC5C;RICTOR;GAS6;STK3;IRGM;RPLP1;RGCC;RPTOR;MTCP1;WNT11;MARK2
prerank,CoA-ligase activity (GO:0016405),0.4817411074663195,1.2797727645263863,0.164079822616408,0.4537894210983794,1.0,3/14,7.60%,ACSS2;ACSBG1;ACSS1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.4133716464496259,1.2793104177157386,0.14012738853503184,0.44931105417179396,1.0,7/26,12.27%,B3GALT1;B3GALT4;B3GALT5;B4GALNT3;CHSY3;EXTL2;CHSY1
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",-0.3972050030425999,-1.2758055464040459,0.13074204946996468,0.46741638135327346,1.0,14/33,25.96%,ERI3;XRN1;EXOSC2;EXOSC3;XRN2;PARN;PDE12;USB1;EXOSC5;ANGEL2;DIS3L2;EXOSC7;TOE1;CNOT8
prerank,carboxypeptidase activity (GO:0004180),0.37981250313332326,1.2735756529219202,0.12663755458515283,0.45624722596917133,1.0,9/35,14.22%,AGBL4;CPB2;CPA2;CPE;AGBL1;CPN1;AEBP1;CPA4;CPA3
prerank,peptidase activator activity (GO:0016504),-0.43353009901010614,-1.273188160286593,0.15789473684210525,0.47002711742218256,1.0,12/22,35.89%,CAV1;PSME2;VSIR;APH1A;CASP8AP2;PSME1;ADRM1;NLRC4;PCOLCE2;MAL;CLPX;VCP
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.42733204782560485,1.2729071932844171,0.16079295154185022,0.45249169770415754,1.0,6/21,10.02%,PDE4B;PDE3B;PDE1B;PDE10A;PDE1A;PDE11A
prerank,transcription corepressor binding (GO:0001222),-0.41135270232855875,-1.2703499645378027,0.1490566037735849,0.47347300950092847,1.0,8/27,10.52%,ZBTB16;ESR1;NEK6;ZBTB7A;SUZ12;CTBP2;EHMT1;PER3
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.5406516737030561,-1.2701615465844533,0.1848013816925734,0.4702512698813223,1.0,5/10,16.18%,ATM;PIK3C2A;PIK3CD;PIK3CB;PIK3R3
prerank,death domain binding (GO:0070513),-0.5256827154982908,-1.2689034885228292,0.2,0.46958991947544837,1.0,5/11,15.11%,MCL1;IRGM;DAPL1;CRADD;DAP
prerank,calcium-dependent phospholipid binding (GO:0005544),0.35619773256530535,1.2679212032016172,0.12293144208037825,0.45876351779678853,1.0,13/49,11.30%,SYT1;PCLO;SYT5;SYT12;SYT11;RPH3A;CPNE9;PLA2G4E;CPNE1;ANXA8;C2CD5;MCTP2;SYT4
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.5160537088809269,-1.2658836453127025,0.1847457627118644,0.4735866012821843,1.0,5/11,23.27%,CASP12;CASP8;CFLAR;CASP2;CASP1
prerank,1-phosphatidylinositol binding (GO:0005545),-0.4792379979627208,-1.264711630635127,0.18339100346020762,0.4729265618640806,1.0,7/15,17.53%,WDFY1;SNX9;SCARB1;PICALM;WDFY3;ZFYVE1;ZFYVE16
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.5291009851960148,-1.2618799452849794,0.17627118644067796,0.47593157721733487,1.0,5/10,23.27%,CASP12;CASP8;CFLAR;CASP2;CASP1
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.5116212408475785,-1.2617765250460078,0.20146520146520147,0.4727458443519959,1.0,6/12,25.00%,CDK13;CDK12;MAPK1;CDK6;CCNK;BRD4
prerank,ubiquitin protein ligase binding (GO:0031625),-0.2776651138177392,-1.2595430084572874,0.03547297297297297,0.47478986165533904,1.0,84/254,24.52%,FOXO1;RB1;SNCAIP;MFHAS1;FZD6;TRAF5;GSK3B;PRKACB;UBE2K;JAK1;NEK6;YWHAE;FHIT;MID1;EGFR;MAP1LC3B;FZD4;RBX1;TNFRSF1B;NFKBIA;AMBRA1;CUL3;RNF40;TCP1;SNX9;JUN;SMAD2;CUL2;ARRDC1;YWHAZ;USP2;UBE2J2;DET1;CASP8;USP13;TP53;AXIN2;GABARAP;IKBKE;TXNIP;SMAD7;SPOPL;RAD18;PA2G4;ATXN3;CD40;ERLIN2;SLF2;MAGEC2;UQCRC1;SMAD6;RPL5;UBE2L3;HERC2;SKI;SUMO1;HDAC6;PATZ1;SPOP;NDUFS2;IKBKG;WASHC1;RPA2;USP7;PIAS4;UCHL1;FANCL;BRCA1;TRIM28;VCL;MDM2;DBT;DIO2;LTBR;HSP90AA1;RELA;KCNH2;BECN1;RIPK1;RALB;FZD5;ARRB1;TRIB3;HSPA1B
prerank,calcium channel regulator activity (GO:0005246),0.37059883867998006,1.2591186806340433,0.13986013986013987,0.4733783422184866,1.0,11/37,12.78%,NRXN1;GEM;NPY2R;CALM2;CACNB3;CACNG8;NPY;INAFM2;CACNG4;SRI;SGK1
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.27541435812883946,-1.2577046682344166,0.031825795644891124,0.4757418185798555,1.0,87/269,24.52%,FOXO1;RB1;SNCAIP;MFHAS1;FZD6;TRAF5;GSK3B;PRKACB;UBE2K;JAK1;DTX3L;NEK6;YWHAE;FHIT;MID1;EGFR;MAP1LC3B;FZD4;RBX1;TNFRSF1B;NFKBIA;AMBRA1;CUL3;RNF40;TCP1;SNX9;JUN;SMAD2;CUL2;ARRDC1;YWHAZ;USP2;UBE2J2;DET1;CASP8;USP13;TP53;AXIN2;GABARAP;STAT2;IKBKE;TXNIP;SMAD7;SPOPL;RAD18;PA2G4;ATXN3;CD40;ERLIN2;SLF2;MAGEC2;UQCRC1;SMAD6;RPL5;UBE2L3;HERC2;SKI;SUMO1;HDAC6;PATZ1;SPOP;CDK5RAP3;NDUFS2;IKBKG;WASHC1;RPA2;USP7;PIAS4;UCHL1;FANCL;BRCA1;TRIM28;VCL;MDM2;DBT;DIO2;LTBR;HSP90AA1;RELA;KCNH2;BECN1;RIPK1;RALB;FZD5;ARRB1;TRIB3;HSPA1B
prerank,mRNA 5'-UTR binding (GO:0048027),-0.4196175345177502,-1.2576527954235772,0.1651705565529623,0.4724058030953007,1.0,14/24,32.77%,DDX3X;LARP1;RPS14;RPL26;SYNCRIP;RPL5;RPS7;CCT5;IGF2BP2;LARP6;UTP23;SHMT1;RPS13;RPL41
prerank,MAP-kinase scaffold activity (GO:0005078),-0.5182150290819907,-1.2552940970220825,0.18579234972677597,0.47454912551221223,1.0,4/11,13.80%,AKAP13;IQGAP1;SH3RF1;KSR1
prerank,Notch binding (GO:0005112),-0.4342705886655427,-1.2509490560672285,0.19099099099099098,0.4814887285866813,1.0,10/22,21.17%,JAG2;CUL3;AAK1;NOTCH4;GALNT11;TCIM;JAG1;CCN3;KCTD10;DLL4
prerank,cell-cell adhesion mediator activity (GO:0098632),0.36200479698162474,1.2499175718546878,0.1308411214953271,0.4884026119643338,1.0,10/42,8.42%,LRRC4C;CNTN6;CNTN4;DSCAML1;DSCAM;NTNG1;MYPN;VSTM2L;EMB;CNTN2
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.511138750781411,-1.2492706296695313,0.21441441441441442,0.48220488357029784,1.0,4/11,7.87%,ITPR1;ITPR2;TRPC4;TRPC6
prerank,phosphatidylglycerol binding (GO:1901611),-0.49683743371550093,-1.2485382295328702,0.17594254937163376,0.48056203986271634,1.0,6/13,24.24%,PITPNC1;PLTP;GSDME;UQCC3;PITPNA;STOML2
prerank,carboxylic acid binding (GO:0031406),0.3654668700329911,1.247398736200569,0.1735159817351598,0.48866079893582814,1.0,10/38,13.88%,GLRA3;GRIN2B;AKR1C1;GLRA1;EPDR1;GNMT;GRM7;MAG;GLUD1;GRIN3A
prerank,ATP hydrolysis activity (GO:0140603),-0.3678846773483638,-1.2472651550512948,0.14664310954063603,0.4802033269349382,1.0,18/41,30.64%,DDX3X;RNF213;TOR1B;MYO18A;ABCB10;CHD3;DNA2;RUVBL2;KIF26A;TOR3A;HSP90AA1;HSPA1B;DHX9;ABCG4;KIF14;CHD1L;TDRD9;DDX4
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.3163862957203808,1.245987677547106,0.11583924349881797,0.4865670639638666,1.0,10/73,10.43%,NPSR1;HCRTR1;SORCS1;SORCS3;GPR37;KISS1R;GIPR;TSHR;LGR5;VIPR2
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.486604679859554,1.244721088468271,0.18907563025210083,0.4843004582394186,1.0,2/11,2.73%,AKR1D1;AKR1C1
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.489222624941541,-1.2442672553734417,0.20689655172413793,0.4839016951658943,1.0,5/13,19.85%,LPCAT1;AGPAT4;AGPAT3;AGPAT1;LCLAT1
prerank,phosphotyrosine residue binding (GO:0001784),-0.3762554735476494,-1.2434829806750642,0.16291161178509533,0.4823859051581716,1.0,14/37,16.18%,CRK;SHE;LDLRAP1;YES1;PIK3R1;IRS1;ABL1;SHB;PLCG2;NCK2;PTPN3;RASA1;GRB2;PIK3R3
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.3836828853772505,-1.243188002222046,0.1568627450980392,0.4798338027051614,1.0,11/32,23.45%,SLC6A6;SLC7A5;SLC38A5;SLC1A5;SLC36A4;SLC43A1;SLC1A1;SLC6A7;SLC1A4;SLC3A2;SLC38A6
prerank,potassium channel regulator activity (GO:0015459),0.34720562050291837,1.2426191021844522,0.14377682403433475,0.48362862499460785,1.0,6/49,6.37%,KCNIP4;DPP10;KCNIP1;DPP6;WNK2;WNK3
prerank,miRNA binding (GO:0035198),-0.3988809340690794,-1.2408798201986804,0.1618181818181818,0.4820180823001763,1.0,7/30,14.80%,TUT7;PUM1;ZC3H7B;TUT4;AGO2;RC3H1;HNRNPA1
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.5126359228220948,-1.2405774380607606,0.2037037037037037,0.4793998986868425,1.0,6/11,21.60%,DAB2IP;PPEF2;STK38;TCF3;SASH1;ROR2
prerank,semaphorin receptor activity (GO:0017154),-0.5046060015720325,-1.2400185934622063,0.20964749536178107,0.4774512320439458,1.0,3/11,8.44%,NRP2;PLXND1;PLXNA4
prerank,outward rectifier potassium channel activity (GO:0015271),0.5004186467293869,1.2354227114992051,0.19730941704035873,0.4939424890453231,1.0,2/11,2.42%,KCND2;KCNA5
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.32071280487980114,-1.2344340901722863,0.1224105461393597,0.4876437481808715,1.0,24/72,24.25%,HIP1;PARD3;FCHO2;STXBP6;KCNJ2;SVIL;ANXA2;MARK1;LDLRAP1;PLCB1;KCNQ1;PICALM;PLEKHA4;CGAS;HIP1R;GSDME;TULP1;ANXA9;OSBPL2;PHLDA3;AMER1;TULP3;FZD7;SNX18
prerank,water transmembrane transporter activity (GO:0005372),0.4875803386897358,1.230066579043915,0.2071269487750557,0.5007650277474811,1.0,2/11,4.58%,PDPN;AQP4
prerank,exopeptidase activity (GO:0008238),0.34118368077904226,1.2297569930566263,0.13695652173913042,0.49632915161831054,1.0,10/50,9.98%,DPP10;DPP6;MME;TRHDE;CPA2;CPE;METAP2;KDM8;DPEP1;JMJD7
prerank,amyloid-beta binding (GO:0001540),0.31198663369433105,1.2288254520854613,0.136986301369863,0.49317953198514175,1.0,14/79,8.83%,GRIA3;NLGN1;GRIN2B;GRIA4;CACNA1B;GRIN2A;APBA2;CACNA1A;ITM2C;GRIA1;SORL1;BACE1;PGRMC1;GRIA2
prerank,cyclic nucleotide binding (GO:0030551),0.4159426757712832,1.2284565037309079,0.17209302325581396,0.48912348172451736,1.0,8/21,19.08%,PDE4B;HCN1;PDE10A;SLC19A1;PDE11A;POPDC2;POPDC3;PDE4D
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.5039568037761342,-1.2230842787761775,0.22419928825622776,0.5107671846805693,1.0,3/11,10.04%,NAA16;NAA80;NAA15
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.3789831619230536,-1.2228573850549977,0.16666666666666666,0.507943731880118,1.0,10/35,16.68%,DYRK1A;LYN;YES1;BMX;ABL1;PTK2;FRK;PKDCC;CSK;FYN
prerank,nuclease activity (GO:0004518),-0.3402881769456466,-1.222076953543317,0.14513274336283186,0.5066489720367088,1.0,20/52,23.04%,RNASE7;SAMHD1;MRE11;N4BP2;RNASE3;XRN2;OGG1;DNA2;RNASE12;PNKP;PLSCR1;PARN;PDE12;N4BP1;WRN;REXO1;EXOG;REXO5;DIS3L2;NTHL1
prerank,lipase activity (GO:0016298),-0.36266936614869555,-1.2215468573479833,0.16376306620209058,0.5046508965108512,1.0,18/43,36.22%,ABHD2;LIPA;MGLL;LPL;LIPE;SMPD2;DAGLB;DDHD2;LCAT;PNPLA8;PNPLA2;LYPLA1;ABHD15;LIPH;SEC23IP;PLBD1;ABHD12;PLB1
prerank,neuropeptide receptor binding (GO:0071855),0.46454844725718075,1.2194711963824396,0.22727272727272727,0.5037742251394471,1.0,5/14,23.48%,SHANK1;NPY;NTS;GAL;AGRP
prerank,RNA polymerase core enzyme binding (GO:0043175),-0.36987068866194894,-1.215096989650958,0.17657657657657658,0.5169234478894903,1.0,11/33,28.73%,ZNF326;RTRAF;RPRD2;SPTY2D1;CDC73;AGO2;ELOF1;SUPT4H1;DHX9;HNRNPU;ELP2
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.4098823623965295,1.2133563082180427,0.19815668202764977,0.5125169875174034,1.0,5/22,10.51%,CPSF1;EXOSC9;CPEB1;ELAVL4;CPEB3
prerank,NAD-retinol dehydrogenase activity (GO:0004745),-0.46078985370754066,-1.2125412724581257,0.2185792349726776,0.5197289198186331,1.0,13/14,53.96%,RDH10;RDH12;ADH1A;RDH11;AKR1A1;DHRS9;DHRS3;RDH16;HSD17B6;SDR9C7;ADH4;ADH7;RDH5
prerank,SUMO binding (GO:0032183),-0.47325471109624245,-1.2103527356086157,0.2189655172413793,0.5213978029603792,1.0,7/13,19.43%,RNF111;UBA2;SERBP1;SIMC1;HERC2;CASP8AP2;RNF4
prerank,ephrin receptor binding (GO:0046875),-0.42211640823809377,-1.2100601767946544,0.2065972222222222,0.5189581091050907,1.0,7/21,6.21%,ANKS1A;LYN;PTPN1;CRK;CBL;ABL1;CHN1
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.327833026457092,1.2072867543359647,0.16515837104072398,0.5213215457515377,1.0,11/55,8.91%,SLC24A4;SLC24A2;ATP2B4;ATP2B2;PKD1L2;CACNA1D;SLC8A2;RYR2;TMCO1;TRPM1;PKD1L1
prerank,dynactin binding (GO:0034452),0.46182749164122366,1.2052060131851736,0.21929824561403508,0.5210418631664293,1.0,7/12,19.85%,BICD1;BBS4;MAPT;HTT;BICDL1;HOOK3;SNX5
prerank,phosphatase binding (GO:0019902),-0.29846860699426014,-1.2033573113910236,0.136986301369863,0.531702909353958,1.0,26/105,12.73%,CTSC;IQGAP1;MTMR3;JAK1;ITGA1;MAP3K5;EGFR;CDKN1B;PXN;PIK3R1;DLG1;MAST2;SHOC2;CHCHD3;PTK2;STAT6;CDH5;SMAD2;MAPK1;CNST;FLT4;PPP1R3C;TP53;IKBKE;CEACAM1;PPP6R3
prerank,histone deacetylase activity (GO:0004407),-0.4265608612125187,-1.1999129281433332,0.21908127208480566,0.5368410039054776,1.0,10/19,26.59%,MIER1;HDAC1;HDAC4;SIRT3;MIER2;HDAC6;HDAC10;MIER3;SUDS3;HDAC5
prerank,phospholipid transfer activity (GO:0120014),-0.41963955191471036,-1.1997607307304834,0.23076923076923078,0.5339661819423905,1.0,3/21,1.27%,PITPNC1;CERT1;PLTP
prerank,transition metal ion binding (GO:0046914),-0.2526699541933824,-1.1987550057829486,0.05152979066022544,0.5331471221753117,1.0,131/397,26.38%,MYRIP;KLF7;SHANK3;MNAT1;NSD1;SEC24B;ZEB1;NOS3;KLF4;CLIP1;TAB3;MSRB3;LIMS1;IFIH1;XPNPEP3;RXRA;PTPN1;ATOX1;KDM2A;TNFSF10;KAT6A;WDFY1;RNF125;ACE;LOXL3;CTCF;TET2;ABL1;SAMHD1;SEC24A;PDE2A;GCH1;SIRT5;PAM;ECE1;NAPEPLD;SEC24D;PDXK;ARHGEF2;CRIP2;PRDM2;PHF5A;AOX1;RASSF1;TP53;ENPEP;ZCCHC4;ZMYND8;FDX1;KDM3A;ACER3;CHD3;HDAC4;SLU7;ADAM33;SIRT3;PLSCR1;KDM7A;CYP2R1;ZFYVE1;RC3H1;SLC30A5;XPNPEP1;JMJD6;TAB2;SKI;COX17;KDM5B;RPS27;MGAT2;HDAC10;HPF1;AOC3;GDA;ZMYND11;CCS;ERAP1;SOD1;WRN;KDM1B;LARGE1;CZIB;TES;SIAH1;NUDT12;COA6;RNF2;GALNT1;NPEPPS;B4GALT1;PIAS4;PPARG;GYG1;BAZ1B;ABCE1;TRIM28;DOHH;MDM2;BLM;RABIF;CALB1;TET3;NOS1;APIP;SEC24C;BBOX1;PGGT1B;USP16;PIM1;XYLT2;MSRB2;RCHY1;ACE2;RBAK;POLR2L;ADA;MT1B;MT1G;MT1E;MT1A;MT1M;MT1H;MT1X;MT1F;LCN2;TIMM10;RABGGTB;ENDOU;QPCTL;ARIH2;CDADC1
prerank,regulatory RNA binding (GO:0061980),-0.3640998597461853,-1.1964596171429551,0.19851576994434136,0.5357806250955296,1.0,8/38,14.80%,TUT7;PUM1;ZC3H7B;DICER1;TUT4;AGO2;RC3H1;HNRNPA1
prerank,protein tyrosine kinase activity (GO:0004713),-0.2925336164782285,-1.1936984652840499,0.1423670668953688,0.5396487699909905,1.0,21/108,12.16%,FLT1;TEK;IGF1R;TIE1;DYRK1A;ROR1;INSR;LYN;JAK1;KDR;MERTK;EGFR;YES1;BMX;ABL1;PTK2;EPHA4;FLT4;FRK;JAK2;PKDCC
prerank,symporter activity (GO:0015293),0.5062451887063097,1.1929565564901443,0.24549549549549549,0.5437938027784349,1.0,4/10,9.50%,SLC5A12;SLC4A4;SLC46A2;SLC28A2
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.3671093764815523,-1.1921616535983515,0.19107142857142856,0.54007580464851,1.0,13/34,25.24%,FAM20A;IQGAP1;DDX3X;RICTOR;STK3;IRGM;MTCP1;ALS2;IGF2;PARP16;CAB39L;CCNK;CAB39
prerank,phosphoric ester hydrolase activity (GO:0042578),0.3346477850748713,1.191922150509116,0.18036529680365296,0.5409978799274375,1.0,17/49,19.23%,ATP1A2;MPPED2;PPP5C;PLCXD3;DUSP4;SBF1;SMPDL3B;HDHD2;DUSP8;DUSP15;PTPRO;FRA10AC1;PGP;SMPD1;ENPP6;ACP2;APEX1
prerank,endodeoxyribonuclease activity (GO:0004520),-0.422544246815742,-1.191011717256492,0.21739130434782608,0.5400194433359594,1.0,10/20,33.33%,MRE11;RBBP8;ENDOV;DNA2;RPS3;EXOG;EXO1;APLF;RAD50;ENDOG
prerank,phospholipase inhibitor activity (GO:0004859),-0.5091011913659999,-1.1881107928681125,0.2591240875912409,0.5438974880568711,1.0,4/10,20.02%,ANXA2;ANXA4;ANXA1;ANXA9
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.4844922135843346,1.1874084251532424,0.27045454545454545,0.5465333781496984,1.0,3/11,8.44%,SLC25A23;SLC35B2;SLC19A1
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.44707496665996804,-1.185422572387559,0.2639138240574506,0.5472375943070493,1.0,7/15,23.81%,SETD3;ASH2L;PRDM9;KMT2C;WDR82;WDR5;RBBP5
prerank,phospholipase binding (GO:0043274),0.45673201459971485,1.1840483543487816,0.2494331065759637,0.5490834272081927,1.0,2/13,1.83%,BLNK;DGKQ
prerank,nuclear export signal receptor activity (GO:0005049),-0.488357135170856,-1.1827060625888566,0.2574430823117338,0.5507572354846104,1.0,5/11,17.87%,NUP42;CSE1L;XPO7;XPO4;NUP214
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),-0.3588032541913834,-1.181763998001905,0.21847246891651864,0.5499102937407491,1.0,11/33,28.73%,ZNF326;RTRAF;RPRD2;CDC73;LLPH;AGO2;ELOF1;SUPT4H1;DHX9;HNRNPU;ELP2
prerank,low-density lipoprotein particle binding (GO:0030169),-0.44253131222394,-1.1815228366146944,0.25274725274725274,0.5473556367945306,1.0,5/16,11.23%,PLTP;THBS1;SCARF1;SCARB1;STAB1
prerank,protein homodimerization activity (GO:0042803),-0.23943812737648168,-1.181345506558784,0.0463258785942492,0.5446850482296053,1.0,131/590,18.89%,HIP1;ABCG2;DAB2IP;FOXP2;CPQ;RBPMS;ZBTB16;GHR;PECAM1;ZHX3;SRR;EXT1;PKD2;MCL1;MYH9;NOD1;ST6GAL1;XPNPEP3;ATG7;F11R;TBX1;LRRK2;SYNE1;MAP3K5;ZDHHC3;MID1;CAMK2G;TFRC;ZHX2;PIP4K2A;SP1;FZD4;IDH1;ANO1;CEP57;IL6R;HES1;RASIP1;PDE2A;LRP6;SLIT2;TGFB2;GCH1;RABEP1;HPS4;PIP4K2B;RNF40;SPPL3;BNIP3;ECE1;ERN1;ABCB9;SNX9;ABCD3;ZBTB4;RAB11FIP3;TRPC6;S100A16;PDXK;PEX7;ABCB10;TPST2;FLT4;LDB1;AOX1;ST3GAL2;TPD52;STARD3;SMAD4;ADAM10;AKT1;CHMP4B;CHMP4A;MYOM1;FLNA;GSTM2;TPD52L1;FBLN5;SYT6;STK10;TRIM14;TBC1D22A;TMEM266;TMEM192;MTCL1;IRAK1;MGLL;ACTN1;SFPQ;S100A1;CEACAM1;LPL;LRRFIP1;TPM1;ACTN4;CAT;GBP4;CYP2R1;MZF1;ABCB7;GRHL1;TCF3;XPNPEP1;STARD3NL;HIP1R;ACOX1;PRDM9;DARS2;TPR;TERF2;COQ9;DGAT2;HOGA1;SLK;IRAK2;MGAT2;ALS2;TFAP4;ARNT;GBP5;HPGDS;CASQ2;PEX11A;WRN;NRF1;PLN;IKBKG;MKLN1;MTHFD1L;IKBKB;DEFA6
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.4462655613570597,-1.1788742283870008,0.25461254612546125,0.547924648207234,1.0,5/15,19.85%,LPCAT1;AGPAT4;AGPAT3;AGPAT1;LCLAT1
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.4662448806178178,-1.1741439924274273,0.2729007633587786,0.556347889795167,1.0,2/12,6.02%,ENTPD1;ENTPD6
prerank,cation channel activity (GO:0005261),0.28800115639060503,1.1733155385829008,0.13318284424379231,0.570292526758514,1.0,14/94,8.91%,TRPM3;HCN1;SLC24A4;SLC24A2;UNC80;KCNA2;PKD1L2;TMEM63A;CACNA1D;RYR2;TMCO1;CACNA1E;TRPM1;PKD1L1
prerank,nucleotidyltransferase activity (GO:0016779),-0.41097338919410636,-1.1728100463592965,0.26278659611992944,0.5565625282111708,1.0,9/19,22.11%,TUT7;TENT4B;TENT4A;TUT4;REV1;TENT2;CGAS;TERT;MOCS3
prerank,ligand-gated calcium channel activity (GO:0099604),0.40067310452613003,1.1689521092691628,0.22444444444444445,0.575980817039106,1.0,4/19,7.41%,GRIN2B;RYR3;GRIN2A;RYR2
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.4588012759396682,1.1679601869088048,0.28440366972477066,0.5732436429619321,1.0,3/12,3.71%,PDE4B;PDE3B;PDE1B
prerank,peptidoglycan binding (GO:0042834),-0.49462100104930923,-1.1660684803492822,0.28544061302681994,0.5706958098205537,1.0,7/10,35.99%,NOD1;RNASE7;PGLYRP1;NOD2;JCHAIN;NLRP3;TLR2
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.46278744722624143,-1.165493161544402,0.2787456445993031,0.5689710609199524,1.0,4/13,12.88%,ZGRF1;DICER1;ENDOV;DNA2
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.4726343712961725,-1.164316658086184,0.285451197053407,0.5687631645848003,1.0,5/12,23.27%,NOD1;ATP2A3;CTSH;CASP8AP2;CASP1
prerank,glucuronosyltransferase activity (GO:0015020),-0.41502049936562535,-1.1636227142350684,0.2597864768683274,0.5672081247228971,1.0,2/19,3.70%,EXT1;CSGALNACT1
prerank,phosphatase activator activity (GO:0019211),-0.438262729259271,-1.1618828869617905,0.2722689075630252,0.5683482184699422,1.0,7/14,27.44%,PPP2R5A;PHACTR4;FRS2;PPP2R5E;BMP2;PPP2R5D;PPP2R5C
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.41114679220568634,-1.1617576326285017,0.26791808873720135,0.5654779225550343,1.0,7/20,20.73%,SLC39A10;SLC30A10;SLC39A8;SLC39A11;SLC30A5;SLC39A6;SLC30A1
prerank,BMP binding (GO:0036122),-0.4640763788530587,-1.1513896020776826,0.2986111111111111,0.5880675545946888,1.0,3/11,8.98%,ENG;BMPR2;GREM2
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.4654092576702938,-1.1498588582251652,0.2904929577464789,0.5887664766687923,1.0,6/12,27.03%,PAN3;PARN;CNOT2;TOE1;CNOT8;CNOT1
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.4237916791299404,1.1480197056532853,0.28045977011494255,0.6183236916255163,1.0,6/14,20.45%,ISCA2;ACO1;NFU1;CIAO3;EXO5;ACO2
prerank,adenylate cyclase binding (GO:0008179),0.4719035328366934,1.147695193562934,0.31130063965884863,0.6135896078076316,1.0,2/10,5.75%,AKAP6;CALM2
prerank,neuropeptide hormone activity (GO:0005184),0.3866906303267097,1.1467908166237104,0.25165562913907286,0.6106468600379317,1.0,4/22,10.26%,PNOC;NPY;PENK;CCK
prerank,NF-kappaB binding (GO:0051059),-0.3809222258448452,-1.1462835623912417,0.26217228464419473,0.594272109319285,1.0,9/24,22.61%,GSK3B;HDAC1;NFKBIA;ANXA4;RNF25;MTDH;CDK5RAP3;TAF4B;RELA
prerank,nucleotidase activity (GO:0008252),-0.43090793359030016,-1.1449282475945193,0.2831541218637993,0.5944301428220906,1.0,8/15,26.79%,NT5C2;NT5E;NT5C1A;BPNT1;NT5C3B;ACP3;NT5DC1;NT5C
prerank,semaphorin receptor binding (GO:0030215),-0.3777490890917766,-1.142780624483018,0.2553191489361702,0.5964237244328888,1.0,12/23,24.83%,SEMA6A;SEMA3C;SEMA7A;SEMA3G;SEMA6B;SEMA4C;SEMA5B;SEMA4A;SEMA3E;SEMA4G;SEMA5A;PLXNB1
prerank,nucleosomal DNA binding (GO:0031492),-0.39810053033287507,-1.1426534723021615,0.2895174708818636,0.593635374820802,1.0,6/21,14.82%,HDAC1;SMARCC1;SMARCE1;SMARCC2;ACTB;H3-3A
prerank,double-stranded RNA binding (GO:0003725),-0.3035410069194332,-1.1403854989023472,0.22743055555555555,0.5961678249310448,1.0,15/70,14.59%,MBNL1;EIF4H;IFIH1;DDX3X;TFRC;MSN;PRKRIP1;DICER1;DDX60;ACTN1;MTDH;STRBP;LRRFIP1;AGO2;RC3H1
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.47425434653014814,-1.1397390804228011,0.29695885509839,0.5944352203784553,1.0,4/10,14.90%,STAMBP;OTUD4;ATXN3;TNFAIP3
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.29409717073896224,-1.1395998511657461,0.20318021201413428,0.5916437924320181,1.0,29/78,26.15%,USP9X;CTSC;CASP12;USP24;USP2;CASP8;USP13;CAPN2;CFLAR;USP40;USP15;USP18;PDIA3;USP34;CTSZ;USP10;LGMN;CTSH;USP7;UCHL1;USP1;CTSF;CASP2;CTSO;USP16;CASP1;USP12;GPAA1;CAPN15
prerank,cAMP binding (GO:0030552),0.46058794009541537,1.1386105061812268,0.3034934497816594,0.6267063234100686,1.0,3/11,5.18%,PDE4B;HCN1;PDE10A
prerank,PDZ domain binding (GO:0030165),0.30748163108667304,1.1366426936977472,0.21973094170403587,0.626497112941402,1.0,9/61,4.85%,GRID2;NLGN1;SLC22A4;ATP2B4;ATP2B2;KIDINS220;CXXC4;GRIA1;CXADR
prerank,FMN binding (GO:0010181),-0.4683408020772345,-1.13638169842963,0.29697986577181207,0.5967285594709355,1.0,6/11,23.94%,NOS3;POR;MTRR;NOS1;PNPO;PPCDC
prerank,lipoprotein particle binding (GO:0071813),-0.40471339731453354,-1.1346354809428385,0.29475587703435807,0.59791693151381,1.0,6/20,12.72%,PLTP;THBS1;SCARF1;SCARB1;STAB1;LPL
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.43773153045567864,-1.1291618894400306,0.3123844731977819,0.6084892190903478,1.0,7/14,32.92%,NOD1;ATP2A3;CTSH;CASP8AP2;CASP1;RPS27L;MAL
prerank,protein kinase C binding (GO:0005080),-0.32885184463160894,-1.1268391966409221,0.2719449225473322,0.6114118443193574,1.0,9/43,8.02%,GRK5;CAVIN2;PRKD2;ADAM9;PDLIM5;IRS1;ABL1;PARD6G;ADCY4
prerank,ATP binding (GO:0005524),-0.24673996921499283,-1.1263315821181823,0.16080402010050251,0.6095149429353811,1.0,57/266,17.01%,SNRK;MAP3K20;ACVRL1;SRR;INSR;MYH9;PEX1;DAPK1;TLK2;PRKACB;MARK1;RPS6KA5;SIK1;MAP3K5;MAP4K3;NEK6;TLK1;UBA2;CARS2;STK3;ABL1;MAST2;PIP4K2B;ABCC6;ERN1;ABCB9;PRAG1;CDC42BPA;ABCD3;MYO18A;MYO1F;TAP2;PDXK;N4BP2;AKT3;PXK;LATS2;SMC4;AKT1;NOL9;EIF2B2;SIK3;WNK4;STK38;CDK6;PNKP;MKNK2;KSR1;KCNJ8;MAP4K4;MARK2;ABCF2;DARS2;ABCF3;SRPK2;GALK1;CDC42BPB
prerank,alanine transmembrane transporter activity (GO:0022858),-0.4503026155521578,-1.1238335262832533,0.30335097001763667,0.6126803935423347,1.0,5/12,21.38%,SLC6A6;SLC38A5;SLC36A4;SLC1A4;SLC3A2
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.45378140897676944,1.121972086261282,0.315668202764977,0.6587161485042428,1.0,3/12,8.44%,SLC25A23;SLC35B2;SLC19A1
prerank,mannose binding (GO:0005537),0.4485960205411128,1.1209563218741208,0.3390191897654584,0.655992850940331,1.0,5/12,19.90%,CD207;MBL2;LMAN1;ACR;COLEC11
prerank,RNA polymerase II complex binding (GO:0000993),-0.33816770464525076,-1.1200605267068318,0.2754385964912281,0.6191515845017259,1.0,11/32,28.73%,ZNF326;RTRAF;RPRD2;CDC73;AGO2;ELOF1;SUPT4H1;DHX9;BRD4;HNRNPU;ELP2
prerank,kinase inhibitor activity (GO:0019210),-0.3448993915098065,-1.1194083177448362,0.29357798165137616,0.6177007410896485,1.0,9/33,15.03%,PARVA;CDKN1B;NCK1;LRP6;SH3BP5L;PRKRIP1;TAOK3;SPRY4;GMFB
prerank,actinin binding (GO:0042805),-0.3934953988983587,-1.1193473292962839,0.3151969981238274,0.6147544770759709,1.0,11/21,22.61%,PKD2;PROM1;PDLIM5;NFKB1;CSRP2;SYNPO2;RARA;MAGI1;PPARG;PKD2L1;RELA
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.36310390471135034,-1.118611823569488,0.3071297989031079,0.6135250264221289,1.0,3/28,2.64%,DAB2IP;EDA;TRAF5
prerank,poly(U) RNA binding (GO:0008266),-0.3944193987870789,-1.116485327988949,0.3089887640449438,0.6160181136979515,1.0,11/20,33.36%,RBMS1;RBMS2;PABPC4L;DIS3L2;KHDRBS1;ATXN1;PABPC1;SSB;RBM11;PABPC5;PABPC1L
prerank,muscle alpha-actinin binding (GO:0051371),-0.42111841667834793,-1.112914769193621,0.33214285714285713,0.6216774645143799,1.0,5/15,13.34%,PKD2;PDLIM5;PDLIM1;SYNPO2;PDLIM3
prerank,SUMO transferase activity (GO:0019789),-0.4205057524138288,-1.111356794062523,0.3274956217162872,0.6225829163412351,1.0,7/16,21.28%,RANBP2;NSMCE2;HDAC4;PIAS2;PIAS4;TRIM28;MDM2
prerank,protein kinase inhibitor activity (GO:0004860),-0.3241060956144878,-1.110650256655678,0.27717391304347827,0.6213499421083708,1.0,10/42,15.03%,PARVA;SPRED2;CDKN1B;NCK1;SH3BP5L;PRKRIP1;TAOK3;RPTOR;SPRY4;GMFB
prerank,calcium-release channel activity (GO:0015278),-0.3999224954239645,-1.1020720509703987,0.3314814814814815,0.6406416229509109,1.0,8/17,26.10%,ITPR1;PKD2;ITPR2;MCOLN1;TRPA1;MCOLN2;TPCN2;TPCN1
prerank,hormone activity (GO:0005179),0.29865400055287594,1.1009280585254617,0.29910714285714285,0.704596566557676,1.0,8/54,12.80%,PNOC;CHGB;NPPC;TRH;NPY;PENK;CCK;METRNL
prerank,N-acetyltransferase activity (GO:0008080),-0.3853153940076014,-1.1008483929685355,0.3268892794376098,0.640633617340005,1.0,4/19,11.31%,KAT2B;NAA80;SMARCE1;GNPNAT1
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.2766900803349406,-1.0997514407561246,0.27087198515769945,0.6401575181230057,1.0,28/91,24.25%,HIP1;PARD3;FCHO2;STXBP6;KCNJ2;SVIL;ANXA2;MARK1;SH3PXD2B;LDLRAP1;PLCB1;KCNQ1;PICALM;WIPI1;PLEKHA4;CGAS;HIP1R;GSDME;TULP1;ANXA9;WDR45B;OSBPL2;PHLDA3;KIF16B;AMER1;TULP3;FZD7;SNX18
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.44501712028519064,-1.099126260088045,0.3471698113207547,0.6387436434653615,1.0,3/12,11.34%,DDI2;SPPL3;PSEN1
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.407601031438202,-1.0962587853765122,0.33629893238434166,0.6400267574483973,1.0,3/16,0.33%,PTPRG;PTPRB;PTPRM
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.407601031438202,-1.0962587853765122,0.33629893238434166,0.6400267574483973,1.0,3/16,0.33%,PTPRG;PTPRB;PTPRM
prerank,purine ribonucleoside triphosphate binding (GO:0035639),-0.2300373109773034,-1.0950714960843826,0.1885245901639344,0.6400424853254993,1.0,142/431,28.59%,SNRK;MAP3K20;ACVRL1;SRR;INSR;MYH9;RAC1;PEX1;RHOJ;DAPK1;MFHAS1;RHOBTB1;TLK2;PRKACB;MARK1;RPS6KA5;ARF3;RND3;RAB7A;SIK1;LRRK2;MAP3K5;MAP4K3;NEK6;TLK1;RAB2A;RASL12;UBA2;CARS2;STK3;ABL1;DNM2;MAST2;ATL2;RHOQ;GCH1;PIP4K2B;ABCC6;RAP1A;GBP6;ERN1;ABCB9;PRAG1;CDC42BPA;ABCD3;MYO18A;MYO1F;TGM2;TAP2;RAP1B;PDXK;RAB27A;RAB5A;N4BP2;AKT3;PXK;LATS2;RRAS;SMC4;AKT1;NOL9;EIF2B2;SIK3;WNK4;STK38;RHOA;ARL4A;DRG1;GBP4;RHOC;RHOG;CDK6;PNKP;MKNK2;KSR1;KCNJ8;MAP4K4;MARK2;RAB32;ABCF2;DARS2;RERG;ABCF3;SRPK2;GALK1;CDC42BPB;LSG1;GBP5;RAP2A;MTHFD1L;RRAS2;RAP2C;KRAS;NRAS;CDK11B;HSPA14;LIG4;ARL5C;ABCE1;ARHGEF5;BLM;P2RY1;TUBD1;MAP3K6;PMVK;PNPLA8;HSP90AA1;ARL4C;TOP1;PRPS2;TUBE1;HSPA13;MTG2;RALB;PIM1;ARL2;GBP3;RHEB;HSPA1B;NOA1;DHX9;REM1;PEX6;ARF5;ERCC6;DMPK;TRNT1;MKNK1;RAN;RND1;KIF14;TRIP13;RAB38;TUBG2;HNRNPU;RAP2B;RAB22A;ATP1A1;GNL1;RHOT2;PFKL;TGFBR1
prerank,MHC class II protein complex binding (GO:0023026),0.44174616053920424,1.0947018628118612,0.38074398249452956,0.716778100732388,1.0,4/11,9.23%,MS4A1;ATP1B1;CD81;PKM
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.4372558022432692,-1.0945517395283575,0.3408695652173913,0.6383937224340285,1.0,7/12,24.03%,INSR;PIK3R1;IRS1;SOCS2;IGF1;IGF2;ARRB1
prerank,ribosomal small subunit binding (GO:0043024),-0.4035116454911871,-1.0935817210884922,0.35,0.6378238428725399,1.0,4/17,9.11%,EIF4H;DDX3X;LARP1;PTCD3
prerank,cytokine receptor activity (GO:0004896),-0.279851638368594,-1.0904307515181175,0.2759259259259259,0.6429997429533926,1.0,21/83,22.37%,IL1R1;OSMR;GHR;IL17RD;IFNAR1;IL6ST;FZD4;IL6R;CCR9;LIFR;IL4R;IL17RA;IL17RE;IL10RB;CMKLR1;IL20RB;IFNGR2;F3;IL13RA1;IFNAR2;IL3RA
prerank,pentosyltransferase activity (GO:0016763),-0.3266776849877595,-1.090216935494469,0.30350877192982456,0.6405699680291512,1.0,19/36,36.20%,ZC3HAV1;TIPARP;PARP4;SIRT5;PARP14;SIRT3;PARP11;ART3;LARGE1;PARP16;PARP6;PARP9;PNP;TNKS2;UPP1;PARP3;TNKS;LARGE2;LACC1
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.36396734952446175,-1.0885795494850454,0.3345070422535211,0.6417173190949386,1.0,8/23,22.11%,HIP1;SH3PXD2B;WIPI1;PLEKHA4;HIP1R;WDR45B;PHLDA3;KIF16B
prerank,translation initiation factor activity (GO:0003743),-0.3331823369957473,-1.087164052922517,0.32821497120921306,0.6423371825273634,1.0,15/36,33.43%,EIF3H;EIF3E;EIF3C;EIF3B;EIF2B2;AGO2;EIF3F;EIF3A;EIF3I;EIF5B;EIF4G3;COPS5;EIF4A2;EIF2B4;EIF2B5
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",-0.28681687736338285,-1.0836909437365412,0.3285968028419183,0.6480174563202781,1.0,11/69,10.04%,CREBBP;KAT6B;KAT2B;ZDHHC6;PLA2G4A;KAT6A;ZDHHC3;NAA16;CERS4;NMT1;NAA15
prerank,acid-thiol ligase activity (GO:0016878),0.41823171462552866,1.0818407957033254,0.3648960739030023,0.7480151789584241,1.0,3/13,11.78%,ACSS2;ACSS1;AASDH
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.34487594975113767,-1.0814017686479662,0.3542039355992844,0.6510151543043499,1.0,12/27,31.12%,SLC26A7;SLC26A2;ANO1;SLC39A8;SLC25A11;SLC26A11;ANKH;SLC5A5;LRRC8A;SLC22A8;SLC26A6;SLC25A10
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.30949174437689914,-1.080511021808377,0.34054054054054056,0.6502180800324723,1.0,9/48,7.87%,SLC12A7;PIEZO2;PKD2;TRPM6;TRPM7;SLC12A2;ABCC9;TRPM4;TRPC6
prerank,Hsp70 protein binding (GO:0030544),0.33144813626608877,1.079848462293017,0.3434125269978402,0.7473016513902424,1.0,12/31,20.19%,PACRG;GPR37;DNAJC8;RNF207;METTL21A;PPID;CYP1A1;HIKESHI;DNAJB2;IQCG;DNAJB1;DNAJC18
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.24074393164432464,-1.077421315383489,0.26547231270358307,0.6552685897543257,1.0,100/248,30.64%,GNB1;MYH9;RAC1;RHOJ;DNM3;RHOBTB1;GNAI3;RND3;RAB7A;LRRK2;DDX3X;RAB1A;RNF213;RAB2A;RASL12;GNA12;RAB5B;DNM2;ATL2;TOR1B;RHOQ;GCH1;IRGM;RAP1A;GBP6;MYO18A;RAP1B;ABCB10;RAB27A;RAB5A;RRAS;SRPRA;EFTUD2;EEF2;GNA14;CHD3;RAB8B;RHOA;DNA2;DRG1;GBP4;RHOC;RHOG;GSPT1;RAB23;RAB24;RAB32;RUVBL2;RERG;AGAP3;KIF15;RAB11A;KIF26A;LSG1;GBP5;TOR3A;MYL6;RAP2A;GPN2;RRAS2;RAP2C;KRAS;NRAS;GFM2;NKIRAS2;HSP90AA1;SAR1A;MTG2;RALB;GNB2;KIF18B;ARL2;GBP3;RAB19;RHEB;GNG3;HSPA1B;DHX9;GNGT2;RAB6B;ABCG4;GNA11;RAN;GPN3;RND1;KIF14;RAB38;RAP2B;RAB22A;GNL1;RHOT2;RAB21;RAB18;CHD1L;GNG8;TDRD9;ARL8B;RAP1GAP;RAB31;DDX4
prerank,G protein-coupled receptor binding (GO:0001664),0.25188958884240825,1.0772062535491234,0.2605633802816901,0.7486508202037006,1.0,25/132,15.82%,GNAO1;BICD1;WNT7B;PACRG;GNAI2;GIP;TAFA5;PSMC5;PNOC;GNAI1;CALCA;GNAL;GNAT3;NPY;HOMER1;PENK;ARR3;WNT6;CCL5;RSPO1;BBS1;NTS;WNT4;GPRASP2;DVL2
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.33435194034368526,-1.0765727654034973,0.3345132743362832,0.6545135620264864,1.0,10/33,20.91%,DCUN1D3;RNF125;UBA2;PPARA;RNF144B;DCUN1D2;RPS3;SIAH1;DCUN1D5;FOXL2
prerank,protein phosphatase 2A binding (GO:0051721),-0.3680842148537878,-1.0764466477955026,0.37056737588652483,0.6518602797457153,1.0,6/23,12.97%,DAB2IP;FOXO1;MFHAS1;STRN3;TP53;CTTNBP2NL
prerank,calcium channel inhibitor activity (GO:0019855),-0.445324398266808,-1.0750039120466042,0.37777777777777777,0.6526637863806086,1.0,2/11,6.40%,ITPR1;MCUB
prerank,acetylcholine receptor activity (GO:0015464),0.35937115063108455,1.074641871473871,0.3583690987124464,0.7500281931119123,1.0,2/22,5.19%,CHRM2;CHRM3
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.3005988051523331,-1.0745976661319714,0.3295668549905838,0.6507199622712084,1.0,12/55,10.66%,SLC6A6;SLC7A1;SLC7A5;SLC16A12;SLC25A32;SLC38A11;SLC19A2;SLC38A5;SLC16A9;SLC16A1;SLC13A3;SLC16A6
prerank,endopeptidase activator activity (GO:0061133),-0.45646247336531515,-1.0743301518925745,0.3875,0.648576362090604,1.0,5/10,19.70%,PSME2;VSIR;APH1A;PSME1;ADRM1
prerank,cGMP binding (GO:0030553),-0.4494186766336016,-1.073965396058112,0.39965397923875434,0.6467203043791668,1.0,2/11,6.05%,RAPGEF2;PDE2A
prerank,protein heterodimerization activity (GO:0046982),0.2400981490296238,1.071651400806116,0.2700892857142857,0.7530602122433213,1.0,34/178,14.40%,TENM4;ATP1A2;TENM1;NPAS3;QTRT2;NPAS1;PHB2;TENM3;ADCY8;RRAGA;BCL2;GABBR2;TENM2;ATP1B1;NAE1;ADD2;HSF1;ADRA2C;NOLC1;PIK3R2;ADRA2A;PDGFA;IL12A;FXR2;PRMT5;BUD23;ADRA1A;ARNT2;SRI;FZD9;MIGA2;BDKRB2;TAF1;PSMF1
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.37126003896198584,-1.0685414739147316,0.36528028933092227,0.6572505797883057,1.0,6/20,19.85%,LPCAT1;AGPAT4;AGPAT3;AGPAT1;DGAT2;LCLAT1
prerank,GTP binding (GO:0005525),-0.2469529973338493,-1.0655296607306282,0.31239388794567063,0.6620520288979541,1.0,60/172,28.45%,INSR;RAC1;RHOJ;MFHAS1;RHOBTB1;ARF3;RND3;RAB7A;LRRK2;RAB2A;RASL12;DNM2;ATL2;RHOQ;GCH1;PIP4K2B;RAP1A;GBP6;TGM2;RAP1B;RAB27A;RAB5A;RRAS;EIF2B2;RHOA;ARL4A;DRG1;GBP4;RHOC;RHOG;RAB32;RERG;LSG1;GBP5;RAP2A;RRAS2;RAP2C;KRAS;NRAS;ARL5C;ARHGEF5;TUBD1;ARL4C;TUBE1;MTG2;RALB;ARL2;GBP3;RHEB;NOA1;REM1;ARF5;RAN;RND1;RAB38;TUBG2;RAP2B;RAB22A;GNL1;RHOT2
prerank,protein tyrosine kinase binding (GO:1990782),-0.2812496227593544,-1.0651966964444683,0.3368606701940035,0.6600859542286139,1.0,33/71,29.08%,ITGB1;PTPN14;BMPR2;DOCK4;PTPN1;CRK;CBL;GAS6;NCK1;CDH5;TJP2;EPHA4;GRB14;TP53;CEACAM1;DUSP3;NEDD9;ELMO2;ANGPT1;NOX4;HYAL2;DUSP22;TOB1;PTPN11;HSP90AA1;CD247;MAP3K7;KHDRBS1;PTPN2;TRIM6;TREM2;ANGPT4;PHYHIP
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.4366733557421703,1.0637340523372099,0.3869565217391304,0.7696191383924038,1.0,4/10,23.45%,ANKRD13B;FAAP20;DNAJB2;IDE
prerank,epidermal growth factor receptor binding (GO:0005154),0.3344147078198343,1.0624758629122155,0.36486486486486486,0.7670702649724178,1.0,4/25,8.97%,ERBB4;CCDC88A;EFEMP1;SHC1
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.3860113518368341,1.0619208199443366,0.3607305936073059,0.7627022801513283,1.0,4/15,13.80%,SLC25A13;SLC1A2;SLC17A6;SLC1A3
prerank,anion transmembrane transporter activity (GO:0008509),-0.4262345319888532,-1.0606954280369458,0.39750445632798576,0.6686067262152809,1.0,3/12,8.86%,ABCG2;SLC39A8;SLCO2B1
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.4068412282153755,-1.0590027083423044,0.3996316758747698,0.670057424202113,1.0,3/15,7.50%,SLC26A7;SLC26A2;SLC39A8
prerank,NAD+ binding (GO:0070403),-0.42234311151227666,-1.0579099758701207,0.4011299435028249,0.6699667165122315,1.0,3/12,13.46%,ZC3HAV1;SIRT5;SIRT3
prerank,signaling receptor complex adaptor activity (GO:0030159),0.3090813941186843,1.0577899630358472,0.3699788583509514,0.768472820310632,1.0,5/38,3.95%,MAGI2;GRIP1;BLNK;SHANK1;CD3G
prerank,guanyl ribonucleotide binding (GO:0032561),-0.2413647863341601,-1.0577335799809737,0.311336717428088,0.6674836154485096,1.0,67/196,28.45%,RAPGEF2;INSR;RAC1;RHOJ;MFHAS1;RHOBTB1;GNAI3;ARF3;RND3;RAB7A;LRRK2;RAB2A;RASL12;MIEF1;RAB5B;PDE2A;DNM2;ATL2;RHOQ;GCH1;PIP4K2B;RAP1A;GBP6;TGM2;RAP1B;RAB27A;RAB5A;RRAS;EIF2B2;RAB8B;RHOA;ARL4A;DRG1;GBP4;RHOC;RHOG;RAB32;RERG;LSG1;GBP5;RAP2A;RRAS2;RAP2C;KRAS;NRAS;ARL5C;ARHGEF5;TUBD1;ARL4C;TUBE1;MTG2;RALB;ARL2;GBP3;RHEB;NOA1;RAB9B;REM1;ARF5;RAN;RND1;RAB38;TUBG2;RAP2B;RAB22A;GNL1;RHOT2
prerank,chemokine activity (GO:0008009),0.32964488171684503,1.056823661564094,0.37719298245614036,0.7651042162171001,1.0,7/31,14.71%,CXCL16;CCL28;PF4;CCL13;CCL5;CCL2;CCL7
prerank,thioesterase binding (GO:0031996),-0.4359559094017913,-1.0528616468982825,0.40555555555555556,0.6767187786812113,1.0,2/11,2.64%,RAC1;TRAF5
prerank,tubulin binding (GO:0015631),0.22266605769769282,1.050905590852748,0.29156626506024097,0.776474079941669,1.0,76/296,19.15%,AGBL4;NAV3;TRIM36;KIF21A;SNPH;EML2;PACRG;NEFM;KIF17;APC2;CCDC88A;CDK5;TTLL12;UNC5C;MTUS2;SYBU;KIF26B;RCC2;DNM1;ARHGEF7;MAP2;TERF1;MAP1S;AGBL1;EML5;PAK1;BBS4;MAPT;ARL3;NEFH;TPGS1;DCX;GAS2L3;STMN2;SGIP1;KIF5A;MAP1B;KIF3A;DYNC1I1;TPPP3;GJB6;TTLL5;MAPRE3;TPPP;KIF1C;TUBGCP2;GOLGA2;HDGFL3;RACGAP1;HOOK1;STMN4;GAS8;TOGARAM2;KIF3C;KIF21B;CLASP2;HTT;PPP1R42;IFT81;KATNA1;CETN3;DLGAP5;KRIT1;NUMA1;MAP1A;KIF22;MAP6;PDCD5;CDK5RAP2;WHAMM;MAP6D1;SUN2;HOOK3;FSD1;REEP4;GJA1
prerank,ion channel inhibitor activity (GO:0008200),-0.31782862887196434,-1.0504482695310817,0.3781190019193858,0.6798281665597995,1.0,9/35,17.41%,ITPR1;NEDD4L;MCUB;NEDD4;STX8;WNK4;RASA1;SCN3B;KCNMB2
prerank,GTPase activity (GO:0003924),-0.24019438679661384,-1.0495360685243484,0.33225806451612905,0.6795278306506779,1.0,73/192,28.45%,GNB1;RAC1;RHOJ;DNM3;RHOBTB1;GNAI3;RND3;RAB7A;LRRK2;DDX3X;RAB1A;RAB2A;RASL12;GNA12;RAB5B;DNM2;ATL2;RHOQ;GCH1;IRGM;RAP1A;GBP6;RAP1B;RAB27A;RAB5A;RRAS;SRPRA;EFTUD2;EEF2;GNA14;RAB8B;RHOA;DRG1;GBP4;RHOC;RHOG;GSPT1;RAB23;RAB24;RAB32;RERG;AGAP3;RAB11A;LSG1;GBP5;RAP2A;GPN2;RRAS2;RAP2C;KRAS;NRAS;GFM2;NKIRAS2;SAR1A;MTG2;RALB;GNB2;ARL2;GBP3;RAB19;RHEB;GNG3;GNGT2;RAB6B;GNA11;RAN;GPN3;RND1;RAB38;RAP2B;RAB22A;GNL1;RHOT2
prerank,magnesium ion binding (GO:0000287),-0.25042481394587496,-1.0488118507357935,0.33754512635379064,0.6786714871760702,1.0,35/135,21.93%,SNRK;MAP3K20;SRR;PRKACB;MARK1;SIK1;LRRK2;MAP3K5;NEK6;IDH1;UBA2;STK3;ABL1;PDE2A;MAST2;ERN1;CDC42BPA;PDXK;SIK3;ENDOV;STK38;PLSCR1;MARK2;MAPK12;SRPK2;CDC42BPB;HPRT1;HPGDS;RAP2A;WRN;NUDT12;CLYBL;GCLC;MAP3K6;DIS3L2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.4286423454611373,1.0479661045455815,0.41723356009070295,0.7793036219144198,1.0,2/10,4.82%,ADARB2;CDA
prerank,3'-5' DNA helicase activity (GO:0043138),-0.38363012459999685,-1.0458607269168445,0.4364937388193202,0.6832246528056861,1.0,9/16,31.28%,NAV2;ERCC3;FANCM;WRN;BLM;DHX9;MCM7;MCM5;MCM2
prerank,GTPase inhibitor activity (GO:0005095),-0.40793498209626033,-1.0437181414813688,0.42084942084942084,0.6859921144967304,1.0,6/13,24.79%,IQGAP1;SLIT2;PDE6D;RTKN;ARL2;GPS2
prerank,3'-5' exonuclease activity (GO:0008408),-0.30085735593408286,-1.04145592357702,0.3739130434782609,0.6888949496516111,1.0,15/45,25.96%,ERI3;MRE11;EXOSC2;EXOSC3;XRN2;PARN;PDE12;USB1;WRN;EXOSC5;ANGEL2;DIS3L2;EXOSC7;TOE1;CNOT8
prerank,microtubule binding (GO:0008017),0.22461559189836716,1.040143182823916,0.3225806451612903,0.795840215242599,1.0,61/222,19.09%,NAV3;KIF21A;SNPH;EML2;NEFM;KIF17;APC2;CCDC88A;CDK5;MTUS2;SYBU;KIF26B;RCC2;DNM1;MAP2;TERF1;MAP1S;EML5;MAPT;ARL3;NEFH;TPGS1;DCX;GAS2L3;SGIP1;KIF5A;MAP1B;KIF3A;DYNC1I1;GJB6;MAPRE3;TPPP;KIF1C;TUBGCP2;CLIP4;GOLGA2;HDGFL3;RACGAP1;HOOK1;MAPRE1;GAS8;TOGARAM2;KIF3C;KIF21B;CLASP2;KATNA1;CETN3;DLGAP5;KRIT1;CAMSAP3;NUMA1;MAP1A;KIF22;MAP6;CDK5RAP2;WHAMM;MAP6D1;SUN2;HOOK3;FSD1;REEP4
prerank,DNA secondary structure binding (GO:0000217),-0.3232588434747717,-1.039962363415854,0.39388489208633093,0.6900853877962259,1.0,14/31,30.50%,ABL1;MEF2C;RBBP8;CLSPN;RAD18;XPC;FANCM;WRN;BLM;YY1;HMGB1;XRCC2;RAD51AP1;RAD51D
prerank,solute:anion antiporter activity (GO:0140323),0.39496529407655273,1.0391390841529864,0.41818181818181815,0.792691754836384,1.0,3/14,5.56%,SLC7A11;SLC26A5;SLC4A2
prerank,galactosyltransferase activity (GO:0008378),-0.4280529148502934,-1.0380995503366053,0.4338235294117647,0.6919521550367841,1.0,4/11,19.42%,A4GALT;B4GALT4;B4GALT5;B4GALT1
prerank,adenyl ribonucleotide binding (GO:0032559),-0.22463133640822291,-1.0376779942927614,0.3487603305785124,0.6902398756991432,1.0,56/291,14.97%,RAPGEF2;SNRK;MAP3K20;ACVRL1;SRR;INSR;MYH9;PEX1;DAPK1;TLK2;PRKACB;MARK1;RPS6KA5;SIK1;MAP3K5;MAP4K3;NEK6;TLK1;UBA2;MIEF1;CARS2;STK3;ABL1;PDE2A;MAST2;PIP4K2B;ABCC6;ERN1;ABCB9;PRAG1;CDC42BPA;ABCD3;MYO18A;MYO1F;TAP2;PDXK;N4BP2;AKT3;PXK;LATS2;SMC4;AKT1;NOL9;EIF2B2;SIK3;WNK4;STK38;CDK6;PNKP;MKNK2;KSR1;KCNJ8;CNBD2;MAP4K4;MARK2;ABCF2
prerank,RNA stem-loop binding (GO:0035613),-0.4149719997027347,-1.037644908449532,0.3992740471869328,0.6874829480183613,1.0,5/12,26.86%,DDX3X;RC3H1;METTL16;DHX9;LARP6
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.4328568791384029,-1.0365017420842157,0.4117647058823529,0.6874637883927801,1.0,2/10,4.72%,KAT2B;CDKN1B
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.4123896261399551,-1.0337500498543937,0.42018348623853213,0.6917287392576481,1.0,3/12,10.05%,DAB2IP;CDH5;VEGFC
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.3613707418346348,-1.0329109915758594,0.41196581196581195,0.6910115838463723,1.0,3/20,1.63%,SENP1;EIF3H;USP9X
prerank,single-stranded DNA binding (GO:0003697),-0.2606916902729816,-1.030961064164053,0.3837011884550085,0.6930880636370943,1.0,41/93,32.33%,STN1;RBMS1;DMC1;TOP3A;SAMHD1;POLR2G;NABP1;MCM9;RBBP8;MCM4;RTF1;RPA3;RPA1;CTC1;XPC;HNRNPA1;FUBP1;RAD23A;RPA2;RAD51AP2;BLM;MCM3;TOP1;PCBP1;MSH3;HMGB1;DHX9;POLR2H;MCM7;CRY2;MCM5;MCM10;HNRNPU;RAD51AP1;TDP1;SUB1;RAD51D;MCM2;NUP35;JCHAIN;MEIOB
prerank,Toll-like receptor binding (GO:0035325),-0.4273277965528486,-1.0298865615364983,0.43040293040293043,0.6930120048524785,1.0,1/11,0.25%,DAB2IP
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.42344566130371863,-1.0291743642379994,0.4260700389105058,0.6920204149421105,1.0,8/11,52.63%,CHRNB1;CHRNA4;CHRNB2;CHRNA9;CHRNA5;CHRNA3;CHRNB4;CHRNA1
prerank,poly-pyrimidine tract binding (GO:0008187),-0.35085784556887356,-1.028363634294709,0.4093457943925234,0.6914691346259588,1.0,12/23,33.36%,RBMS1;RBMS2;PABPC4L;DIS3L2;KHDRBS1;ATXN1;PABPC1;HNRNPU;SSB;RBM11;PABPC5;PABPC1L
prerank,snoRNA binding (GO:0030515),0.3136333634349482,1.0279934656961194,0.40210526315789474,0.8201973643783519,1.0,10/30,25.11%,NOP56;XRCC5;TBL3;NUDT16;TSR1;UTP6;NOP10;ISG20;WDR3;RRP9
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.40484742773301685,-1.0279621776714807,0.4381818181818182,0.6897634283799423,1.0,7/13,26.09%,SLC7A1;SLC38A5;SLC7A7;SLC7A2;SLC66A1;SLC3A1;SLC7A3
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.39000304959590343,1.0261288106512765,0.41007194244604317,0.8198258957322607,1.0,4/14,12.71%,SPOCK3;SPOCK1;TIMP1;FETUB
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.2980436853663825,-1.0179935231359993,0.4188679245283019,0.7123612629706798,1.0,24/42,40.59%,KAT2B;CDKN1B;CCND3;CCNY;CCNC;CCND1;CNPPD1;CDKN2C;CCNYL1;CCNG1;CCNK;CCNE2;CCNJ;CDKN2B;CCNH;CCND2;CCNL1;CDK5R1;CCNE1;CCNA2;CKS1B;CDKN1A;CCNB1;CDKN2D
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.33079973569801857,-1.0145749831497257,0.4473684210526316,0.7180881939240886,1.0,8/27,20.91%,DCUN1D3;RNF125;PPARA;RNF144B;DCUN1D2;SIAH1;DCUN1D5;FOXL2
prerank,TBP-class protein binding (GO:0017025),-0.35199076895835346,-1.0144662775077442,0.4483394833948339,0.7155835795520529,1.0,6/21,15.76%,ESR1;TAF11;TAF1B;PSMC2;DR1;RUVBL2
prerank,retinoic acid binding (GO:0001972),-0.41145495037558133,-1.013144101772665,0.4563758389261745,0.7159737090904917,1.0,3/12,20.86%,RXRA;RARA;NR2F2
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.2872912776192827,1.0100734356624648,0.4110854503464203,0.862813374163178,1.0,8/46,11.60%,MGAT4C;B3GALT1;B3GALT4;B3GALT5;PIGP;MGAT5B;HEXB;EXTL2
prerank,mannosyltransferase activity (GO:0000030),-0.34767432064408965,-1.008603569769445,0.4564393939393939,0.7253928563695292,1.0,5/21,12.20%,TMTC1;TMTC2;ALG12;ALG8;PIGV
prerank,glutamate receptor binding (GO:0035254),-0.36544338491306383,-1.0076215252135998,0.43822393822393824,0.7250815577637586,1.0,2/17,0.77%,HIP1;SHANK3
prerank,myosin V binding (GO:0031489),0.3681296967951679,1.0055922325684565,0.427536231884058,0.8698278786821643,1.0,6/15,21.52%,RAB3C;RAB27B;RAB3A;RAB6A;RAB3B;RAB8A
prerank,ankyrin binding (GO:0030506),0.3571768470197119,1.0055749803632712,0.4367816091954023,0.8636013922894143,1.0,6/19,11.91%,NRCAM;FLNC;CACNA1D;SCN5A;SPTBN4;SLC8A1
prerank,histone methyltransferase binding (GO:1990226),0.40974149423930933,1.003225888846033,0.48903508771929827,0.8644115826223575,1.0,8/11,30.78%,NOP56;LCOR;HSP90AB1;LCORL;PRDM4;CBX3;PHF1;WIZ
prerank,chloride channel regulator activity (GO:0017081),0.3802459084856284,1.0019421107158115,0.42572062084257206,0.8620320785554496,1.0,5/14,17.91%,WNK2;WNK3;VTI1B;SGK1;SGK3
prerank,single-stranded RNA binding (GO:0003727),-0.29470571998671247,-1.0011699786267922,0.4548611111111111,0.7386402809091012,1.0,11/43,15.54%,EIF4H;IFIH1;DDX3X;POLR2G;DDX60;ENDOV;HNRNPF;STRBP;AGO2;HNRNPA1;JMJD6
prerank,kinesin binding (GO:0019894),-0.3202154724473012,-1.000879371748269,0.4719710669077758,0.7365978072200579,1.0,9/27,23.68%,NEK6;TOR1B;CROCC;ACTB;AP1G1;ARHGEF10;PRC1;SPAG9;KIF18B
prerank,cation:chloride symporter activity (GO:0015377),-0.42143221676135934,-0.9986628586626584,0.4567219152854512,0.7397296026434721,1.0,2/10,4.55%,SLC12A7;SLC12A2
prerank,voltage-gated anion channel activity (GO:0008308),0.37418060246733664,0.9986183753558151,0.4813953488372093,0.8665723651159246,1.0,7/15,24.68%,CLCNKA;CLCN2;VDAC2;VDAC1;CLCN5;CLCN1;CLCN6
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.3807937150469254,-0.9983814325587544,0.4852941176470588,0.7377689327450403,1.0,4/14,16.49%,SLC26A7;SLC26A2;SLC25A11;SLC26A11
prerank,exoribonuclease activity (GO:0004532),-0.3964617986281676,-0.9971477740890448,0.45087719298245615,0.7382095492331718,1.0,6/12,25.26%,EXOSC2;EXOSC1;EXOSC3;EXOSC8;EXOSC5;EXOSC7
prerank,MHC protein binding (GO:0042287),0.34015267852154407,0.9965665670398067,0.44583333333333336,0.8668047101789744,1.0,3/20,9.39%,COL2A1;CD81;KIR3DL2
prerank,sterol binding (GO:0032934),0.27051888333409746,0.9955169677120335,0.45662100456621,0.8638977141399246,1.0,18/56,21.41%,INSIG1;SULT2B1;CD81;SYP;ERLIN1;OSBPL6;OSBPL5;VDAC2;SIDT1;OSBPL9;GRAMD1B;OSBPL11;GPR183;SOAT2;VDAC1;GRAMD1C;SOAT1;SCARB2
prerank,H4 histone acetyltransferase activity (GO:0010485),0.4189316427091837,0.9952318669616701,0.45495495495495497,0.8587917244852915,1.0,10/10,58.13%,USP22;NAA40;BRCA2;EP300;NAA50;KAT8;MSL3;HAT1;ATF2;NAA60
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.3318270775937793,0.9942269217510195,0.4870689655172414,0.8558889424611962,1.0,3/21,14.37%,GRIK2;P2RX3;P2RX5
prerank,chemorepellent activity (GO:0045499),0.31794566446489503,0.9938617752674467,0.4469525959367946,0.8511672436402454,1.0,4/25,5.72%,NRG3;NRG1;SEMA6D;SEMA3B
prerank,chemokine receptor binding (GO:0042379),0.29980418837422823,0.992059793255826,0.46593406593406594,0.850969043455817,1.0,7/35,14.71%,CXCL16;CCL28;PF4;CCL13;CCL5;CCL2;CCL7
prerank,solute:sodium symporter activity (GO:0015370),0.3143218173466471,0.9917981540527072,0.460352422907489,0.8459038624164249,1.0,5/27,13.97%,SLC34A1;SLC4A4;SLC4A5;SLC28A2;SLC13A5
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.274414885584313,-0.9870405648110552,0.47330960854092524,0.7608219302687125,1.0,20/53,30.31%,NOS3;DLD;MICAL2;AOX1;ACADL;ACADVL;ACOX1;NOX4;ACOX3;AGPS;KDM1B;POR;KMO;MTRR;NOS1;CRY2;PPOX;MICAL1;STEAP4;FOXRED2
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.28037411448316785,-0.9836734056622044,0.47714808043875684,0.7667420135143059,1.0,16/47,23.45%,SLC47A1;SLC6A6;SLC7A1;SLC7A5;SLC38A11;SLC38A5;SLC1A5;SLC25A44;SLC7A7;SLC36A4;SLC43A1;SLC7A2;SLC3A2;SLC66A1;SLC3A1;SLC38A6
prerank,Tat protein binding (GO:0030957),-0.4216396245428975,-0.98003063160796,0.49722735674676527,0.7730261825099922,1.0,4/10,30.90%,MDFIC;ACTB;SMARCB1;TRIM32
prerank,MHC class I protein binding (GO:0042288),-0.37993203415585863,-0.9763662594460396,0.4936014625228519,0.7795198801485917,1.0,2/13,7.90%,ABCB9;TAP2
prerank,acetylation-dependent protein binding (GO:0140033),-0.3419281030383203,-0.9748427089952131,0.49469964664310956,0.7777236760355272,1.0,4/20,10.44%,MLLT3;BRD2;ATAD2B;ZMYND8
prerank,lysine-acetylated histone binding (GO:0070577),-0.3419281030383203,-0.9748427089952131,0.49469964664310956,0.7777236760355272,1.0,4/20,10.44%,MLLT3;BRD2;ATAD2B;ZMYND8
prerank,nuclear receptor coactivator activity (GO:0030374),-0.2742263660400641,-0.9743938757688232,0.48703703703703705,0.7760148659100133,1.0,14/52,19.92%,TACC1;ZMIZ1;ETS1;MED1;MED13;HELZ2;MED17;FGF2;ACTN1;ACTN4;CARM1;NCOA6;RNF4;SS18
prerank,chloride transmembrane transporter activity (GO:0015108),-0.35606858779383643,-0.972702076285035,0.5064935064935064,0.7775369028716951,1.0,2/16,2.73%,SLC26A7;SLC26A2
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.3303248530058147,-0.9723245899382765,0.49070631970260226,0.7756655443100782,1.0,8/22,18.44%,TAB3;UIMC1;RNF169;IKBKE;RNF168;TNFAIP3;TAB2;IKBKG
prerank,calcium activated cation channel activity (GO:0005227),0.3419396048785554,0.9661998264622669,0.5075593952483801,0.9169678374071261,1.0,3/17,6.21%,KCNMA1;KCNN2;TMEM63A
prerank,ribonuclease activity (GO:0004540),-0.2670435988058374,-0.9633728335003316,0.4974704890387858,0.7957703997848466,1.0,21/56,26.08%,RNASE7;SAMHD1;KHNYN;ERN1;RNASE3;EXOSC2;EXOSC1;DICER1;EXOSC3;RNASE12;AGO2;N4BP1;EXOSC8;EXOSC5;EXOG;DIS3L2;RCL1;SMG6;ELAC2;EXOSC7;ENDOU
prerank,adrenergic receptor binding (GO:0031690),0.34890648085634723,0.9633339136793524,0.498960498960499,0.9197240864293365,1.0,7/16,20.34%,MAGI2;ADRA2C;ADRA2A;DLG4;ARRDC3;PDE4D;APLP1
prerank,microtubule plus-end binding (GO:0051010),-0.3332615599162474,-0.9632898375480837,0.5046040515653776,0.7931408899827648,1.0,6/20,19.18%,CLIP1;DST;DCTN1;PAFAH1B1;FBXW11;CLIP2
prerank,aminopeptidase activity (GO:0004177),0.3118483215472501,0.961736509736319,0.5,0.9187153567710983,1.0,5/26,9.98%,TRHDE;MMP16;METAP2;KDM8;JMJD7
prerank,P-type ion transporter activity (GO:0015662),0.37020879181240773,0.9600146090857558,0.5236139630390144,0.9178706080231382,1.0,2/12,2.92%,ATP2B4;ATP2B2
prerank,MAP kinase kinase activity (GO:0004708),0.3509832953121915,0.958818245701792,0.5123595505617977,0.9153784301373438,1.0,3/15,6.28%,MAPK10;PAK3;MAP2K7
prerank,cysteine-type peptidase activity (GO:0008234),-0.2518804379355084,-0.9579228582987928,0.5523156089193825,0.804221084269161,1.0,27/73,23.88%,USP9X;CTSC;USP24;OTULIN;ATG4A;USP2;CASP8;USP13;CAPN2;USP40;USP15;USP18;PDIA3;USP34;CTSZ;USP10;LGMN;CTSH;USP7;UCHL1;USP1;CTSF;CASP2;CTSO;USP16;CASP1;USP12
prerank,deubiquitinase activity (GO:0101005),-0.24436220746940066,-0.9572212284391137,0.5617173524150268,0.8032606788376296,1.0,27/88,21.02%,USP53;EIF3H;USP9X;USP24;OTULIN;MINDY1;STAMBP;JOSD1;USP2;USP13;OTUD1;USP40;OTUD4;USP15;USP18;ATXN3;TNFAIP3;VCPIP1;USP34;USP10;BRCC3;BAP1;USP7;JOSD2;UCHL1;USP1;EIF3F
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.2999840230390179,0.9570992360321289,0.517162471395881,0.9145205509985261,1.0,6/25,8.86%,AKR1D1;CYP46A1;AKR1C1;CYP26B1;SQLE;CYP27A1
prerank,N-acyltransferase activity (GO:0016410),0.28976931687126084,0.9548134855434589,0.5011135857461024,0.915549552901977,1.0,7/32,13.72%,CERS6;NAT8;CERS1;PLA2G4E;CERS3;CERS2;SIRT7
prerank,four-way junction DNA binding (GO:0000400),-0.3441984160998185,-0.9528949226283897,0.5201465201465202,0.81161332810652,1.0,8/17,30.50%,ABL1;FANCM;WRN;BLM;YY1;HMGB1;XRCC2;RAD51D
prerank,protein kinase regulator activity (GO:0019887),-0.23911756099243767,-0.9514781357122202,0.5636704119850188,0.8123840242031937,1.0,34/95,31.31%,PARVA;GPRC5C;CDKN1B;NCK1;CCND3;SH3BP5L;PRKRIP1;RPLP1;TAOK3;CCNY;RGCC;RPTOR;WNT11;SPRY4;MARK2;GMFB;CCNC;CCND1;CNPPD1;CCNYL1;CCNG1;CCNK;CCNE2;CAB39;APC;CCNJ;DNAJC3;CXCL10;CCNH;WNK1;CCND2;PPP1R1B;CCNL1;CDK5R1
prerank,disordered domain specific binding (GO:0097718),-0.324482340667263,-0.9499484508959251,0.5163043478260869,0.8134412682302717,1.0,6/23,22.46%,RB1;SMAD2;TP53;FYN;MDM2;HSP90AA1
prerank,kinase activity (GO:0016301),0.2295339072511789,0.9470697743191199,0.60381861575179,0.932441440717374,1.0,23/109,14.79%,DGKK;DGKI;PKMYT1;DGKQ;ITPKA;CDK5;CDKL5;POMK;BCKDK;SPHK1;ETNK1;GK;PIK3C2G;SPHK2;PI4KA;IP6K2;IPPK;CKMT2;CHKA;TAF1;FCSK;CDC7;FN3K
prerank,mRNA 3'-UTR binding (GO:0003730),-0.24554610848796102,-0.9456433433630992,0.5519713261648745,0.8212033617749829,1.0,36/79,33.54%,RBMS1;HNRNPA0;LARP1;RNF40;RBMS2;PUM1;SECISBP2;CELF1;TP53;SERBP1;LARP4B;PARN;RC3H1;PABPC4L;RPL5;EXOSC8;RNPS1;ANGEL2;RPS7;RBM24;CCT5;CARHSP1;FXR1;IGF2BP2;ZFP36L1;PABPC1;HNRNPU;UTP23;SECISBP2L;BOLL;CPEB4;RPL41;PUM2;PABPC5;PABPC1L;RNF20
prerank,pyridoxal phosphate binding (GO:0030170),-0.3347871535120901,-0.945338352535742,0.5481099656357389,0.8189897773255251,1.0,9/20,29.63%,SRR;PDXK;ABAT;ACCS;CTH;PNPO;PSAT1;GLDC;SHMT1
prerank,voltage-gated chloride channel activity (GO:0005247),0.3959474217525506,0.9448878219503067,0.5442477876106194,0.9331355494614997,1.0,2/10,7.69%,CLCNKA;CLCN2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.3875888138365976,0.9448745162376575,0.5138888888888888,0.9272519336557997,1.0,3/10,15.38%,DPYSL5;DPEP1;DPYSL2
prerank,aspartic-type peptidase activity (GO:0070001),-0.4009694775459017,-0.9447312527794035,0.5322283609576427,0.8175006683701814,1.0,2/10,11.34%,DDI2;PSEN1
prerank,endopeptidase activity (GO:0004175),-0.20690090379202716,-0.9440856477055861,0.6288998357963875,0.816160217909632,1.0,69/257,24.08%,ADAMTSL3;SENP1;TRABD2B;USP9X;PCSK7;CTSC;ADAMTS2;PSMA2;USP24;DDI2;MMP2;ACE;ADAM9;TASP1;PSEN2;ECE1;RHBDF2;RHBDD3;PSMB4;AFG3L2;PCSK5;USP2;ADAMTS9;CASP8;USP13;ADAM10;ADAMTS4;TPP2;ADAMTS10;ADAMTS5;ADAMTS20;PSEN1;USP40;ADAMTS17;USP15;THSD4;USP18;ADAM33;PDIA3;HGF;PIK3IP1;USP34;CTSZ;PSMB2;USP10;LGMN;PSMB1;PRSS12;PLAT;CTSH;ZMPSTE24;PSMA8;PREP;HTRA3;USP7;UCHL1;USP1;F3;CTSF;MMP11;PSMA7;CASP2;CTSO;USP16;CASP1;THOP1;USP12;ADAMTSL1;ADAMTS7
prerank,phosphate ion binding (GO:0042301),0.3787439821987184,0.9429258373933675,0.5033860045146726,0.9270778042873293,1.0,3/10,10.48%,RPH3A;ADSS2;ADSS1
prerank,cholesterol transfer activity (GO:0120020),-0.3491619290933558,-0.9391611840253622,0.5582706766917294,0.8260461067011456,1.0,4/16,26.19%,PLTP;STARD4;OSBPL2;STARD5
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.3583530137394565,0.938982525502351,0.5295404814004376,0.9326492812294269,1.0,3/14,9.28%,QDPR;PYCR2;ALDH1L2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",-0.259423052242855,-0.9385040754064007,0.5437062937062938,0.8248148430445879,1.0,15/54,18.27%,ACER2;MIER1;HDAC1;SIRT5;TGM2;NADSYN1;NTAN1;ACER3;HDAC4;ASAH1;MIER2;HDAC6;HINT1;HDAC10;MIER3
prerank,phosphoric diester hydrolase activity (GO:0008081),0.2825344292881499,0.9380347836399504,0.5672645739910314,0.9298006019400556,1.0,10/35,12.14%,MPPED2;ENPP2;PLCXD3;SMPD3;SMPDL3B;ENPP3;PDE11A;MPPE1;PLD3;GPLD1
prerank,chloride channel inhibitor activity (GO:0019869),0.3856174044776396,0.9369866118610687,0.5170842824601367,0.9269544595663475,1.0,3/10,10.78%,WNK2;WNK3;VTI1B
prerank,metalloendopeptidase activity (GO:0004222),-0.24517624664942592,-0.9361867137239174,0.5753899480069324,0.8279269452229975,1.0,16/76,12.77%,ADAMTSL3;TRABD2B;ADAMTS2;MMP2;ADAM9;ECE1;AFG3L2;ADAMTS9;ADAM10;ADAMTS4;ADAMTS10;ADAMTS5;ADAMTS20;ADAMTS17;THSD4;ADAM33
prerank,telomerase RNA binding (GO:0070034),-0.30993304066156396,-0.9324709637520898,0.5578358208955224,0.834129595180731,1.0,10/22,29.47%,TENT4B;XRN1;PARN;TEP1;TERT;SMG6;PINX1;NAF1;HNRNPU;GAR1
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.29427066248942657,-0.9299760499515084,0.581081081081081,0.8375163601930921,1.0,5/31,5.94%,SLC12A7;PKD2;SLC12A2;ABCC9;KCNK5
prerank,GDP binding (GO:0019003),-0.2509646789312636,-0.9296429697829076,0.6159420289855072,0.8355030903617989,1.0,28/63,30.62%,GNAI3;RAB7A;RAB2A;RASL12;MIEF1;RAB5B;RAP1A;RAP1B;RAB27A;RAB5A;RRAS;RAB8B;RERG;RAP2A;RRAS2;RAP2C;KRAS;NRAS;RALB;RHEB;RAB9B;RAN;RAP2B;RAB22A;RAB21;RAB18;ARL8B;RAB31
prerank,receptor ligand activity (GO:0048018),0.20021599408681776,0.9277679840259446,0.6885644768856448,0.9471643894200178,1.0,33/245,13.39%,NRG3;NRG1;TAFA1;OSGIN1;CLEC11A;WNT7B;FGF6;TAFA5;TAFA2;GDF1;NBL1;CHGB;SEMA6D;SEMA3B;NPPC;NPY;COLEC10;GRN;TIMP1;FGF5;VEGFA;PDGFA;IL12A;CCK;HMGB2;WNT6;LEFTY1;CCL5;GDF11;METRNL;THPO;BDNF;FGF20
prerank,protease binding (GO:0002020),-0.2294664025271832,-0.9248547135486589,0.599644128113879,0.844388918390102,1.0,24/99,20.64%,VWF;ITGB1;GSK3B;ANXA2;DVL3;ITGA3;RNF139;CFLAR;ADAMTS4;TP53;CRADD;SLC2A13;TIMP3;COMP;FLOT1;TNFAIP3;SERPINC1;SUMO1;RAD23A;ADRM1;ANXA9;PTEN;F3;ITGB3
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",-0.29645739571560437,-0.9244776074832363,0.5602189781021898,0.8424331526817387,1.0,10/28,27.97%,DICER1;DBR1;ENDOV;AGO2;EDC3;DROSHA;ELAC2;RPP30;EXO1;POP4
prerank,retinoid binding (GO:0005501),0.3117647939420044,0.9243280412750619,0.5875299760191847,0.9511773922850704,1.0,3/22,11.11%,PTGDS;CYP26B1;ALDH1A2
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.39278154984964686,-0.9240362504709106,0.5953237410071942,0.8407028229104533,1.0,3/10,14.06%,KDM2A;RIOX2;KDM7A
prerank,ionotropic glutamate receptor binding (GO:0035255),0.379941860349749,0.9239276103673967,0.5392781316348195,0.9467049066090051,1.0,4/10,16.99%,IGSF11;SHANK1;DLG4;SHANK2
prerank,GABA receptor binding (GO:0050811),-0.3750869163873522,-0.9225057430001573,0.578268876611418,0.8419773775459358,1.0,5/11,35.27%,TRAK1;GABARAP;ARFGEF2;LHFPL4;GABARAPL2
prerank,snRNA binding (GO:0017069),0.2574197993054523,0.9217172910629876,0.5737704918032787,0.9470525388936237,1.0,15/42,22.93%,SF3B3;LSM7;TUT1;SNRPB2;HEXIM1;CCNT1;SNRNP70;SNRPC;SNRPD3;LSM8;PRPF8;LSM4;NCBP2;CDK9;ISG20
prerank,omega peptidase activity (GO:0008242),0.2292698726460365,0.9204550898246046,0.6297117516629712,0.9451643332705529,1.0,17/89,12.76%,USP29;OTUD7A;ASRGL1;USP28;USP25;USP21;CYLD;USP48;USP31;USP38;OTUD7B;MPND;PSMD14;USP11;USP50;USP22;USP5
prerank,sodium:proton antiporter activity (GO:0015385),-0.38117989356135173,-0.9189016647107245,0.5815217391304348,0.8481226444717566,1.0,3/11,11.32%,SLC9A2;SLC9B2;SLC9A5
prerank,metal ion:proton antiporter activity (GO:0051139),-0.36257568236028687,-0.9178721644387339,0.5851449275362319,0.8479637092372289,1.0,3/13,11.32%,SLC9A2;SLC9B2;SLC9A5
prerank,gap junction channel activity (GO:0005243),-0.3166711617531246,-0.916978930674115,0.5898876404494382,0.8472257201013383,1.0,2/22,1.33%,GJC1;GJD3
prerank,mRNA binding (GO:0003729),-0.20316506605602752,-0.9162849620464792,0.7018739352640545,0.8462072365280203,1.0,90/249,30.95%,RBPMS;RBFOX2;RBMS1;METTL14;DDX3X;HNRNPA0;LARP1;THOC2;RBM5;RPS14;NOVA2;HNRNPR;KHNYN;UPF3B;RNF40;NUP98;SF3B6;RBMS2;SAMD4A;PUM1;HNRNPM;SECISBP2;HNRNPAB;CELF1;SF3B1;RPL26;TP53;SNIP1;SERBP1;LARP4B;PARN;MARF1;AGO2;RBM20;RC3H1;N4BP1;SYNCRIP;PABPC4L;TPR;RPL5;ADARB1;EDC3;FUBP1;RPS3;RBM4B;DCP1A;RNPS1;ANGEL2;PTBP3;TRA2B;RPS7;RBM25;RPL13A;RBM24;MRPL13;EIF3A;RBM15;PCBP1;SRBD1;KHDRBS1;DHX9;CCT5;CARHSP1;FXR1;NCBP3;RPS2;IGF2BP2;ZFP36L1;RBM47;RPS26;HNRNPL;DXO;RBPMS2;NANOS1;LARP6;PABPC1;HNRNPU;HDLBP;TDRD7;UTP23;PPIE;EIF4G3;SHMT1;SRSF6;SSB;RPS13;SECISBP2L;SHFL;BOLL;LUC7L2
prerank,cation transmembrane transporter activity (GO:0008324),-0.26162998076647836,-0.9157969834741336,0.6097560975609756,0.8445171689305921,1.0,14/48,23.45%,SLC6A6;SLC7A1;SLC7A5;SLC38A5;SLC1A5;SLC36A4;SLC1A1;SLC7A2;PKD2L1;SLC6A7;SLC1A4;SLC3A2;SLC66A1;SLC38A6
prerank,receptor tyrosine kinase binding (GO:0030971),-0.2539606927715788,-0.9156538816380111,0.6221441124780316,0.8420567942502255,1.0,14/56,16.14%,PTPN14;DOCK4;PTPN1;CBL;GAS6;NCK1;PIK3R1;IRS1;GRB14;TP53;DUSP3;ELMO2;GAB2;ANGPT1
prerank,alkali metal ion binding (GO:0031420),0.34309393452771453,0.9149554705275116,0.571753986332574,0.9548782919573715,1.0,7/13,24.12%,ATP1A2;ATP4A;IMPA1;ACAT1;ADPRH;CAPN3;TDG
prerank,glutathione transferase activity (GO:0004364),-0.31102122112442154,-0.9137124142539946,0.5827338129496403,0.843833529562978,1.0,12/23,44.42%,GSTT1;GSTT2;GSTM2;HPGDS;GSTK1;ALOX5AP;MGST2;GSTM5;GSTA4;GSTM4;LTC4S;GSTP1
prerank,ATPase binding (GO:0051117),-0.24365245182234355,-0.9136336385487742,0.6193895870736086,0.8412724862029018,1.0,16/71,18.24%,CAV1;PKD2;ESR1;EGFR;EZR;CHMP4A;SLC2A13;PTPN3;PSEN1;S100A1;ATXN3;ATP6V1E1;DNAJC10;BBC3;ATP6V0A1;PLN
prerank,ribosome binding (GO:0043022),-0.26135695629339084,-0.9129205629663075,0.6102003642987249,0.8401175762511544,1.0,9/46,16.52%,NAA16;EIF3C;RPSA;NOMO1;NAA15;SERBP1;EEF2;MRPS27;NCLN
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.3685907844588746,-0.9106976543423546,0.5963302752293578,0.8427441652232485,1.0,3/12,11.32%,SLC9A2;SLC9B2;SLC9A5
prerank,wide pore channel activity (GO:0022829),-0.3120077459212295,-0.9101365538858023,0.5977653631284916,0.8411986718682837,1.0,2/23,1.33%,GJC1;GJD3
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.34623391129657277,-0.9100879316483994,0.5861456483126111,0.8385690953987777,1.0,4/15,16.18%,PIK3R1;SOCS2;PIK3R6;PIK3R3
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.23434380566690938,0.9072324459125823,0.6643192488262911,0.9702641563085409,1.0,12/74,10.42%,DGKK;DGKI;DGKQ;POMK;SPHK1;ETNK1;PKM;GK;PIK3C2G;SPHK2;PI4KA;IPPK
prerank,LRR domain binding (GO:0030275),0.3386942558766436,0.9056569554679658,0.5506607929515418,0.9689464871247847,1.0,2/14,2.34%,ROBO1;CRX
prerank,frizzled binding (GO:0005109),-0.2763454046108085,-0.9055313165030611,0.5963963963963964,0.8462124879608487,1.0,7/34,13.32%,DVL3;ZNRF3;RNF43;LRP6;WNT16;WNT11;MYOC
prerank,RNA methyltransferase activity (GO:0008173),-0.31688562150458177,-0.9034279893554737,0.601113172541744,0.8485870583238587,1.0,5/19,20.23%,METTL4;TGS1;TRDMT1;TRMT9B;TRMT12
prerank,thiol-dependent deubiquitinase (GO:0004843),0.22768321622692614,0.9010091007077349,0.6704288939051919,0.9758880939803639,1.0,16/83,12.76%,USP29;OTUD7A;USP28;USP25;USP21;CYLD;USP48;USP31;USP38;OTUD7B;MPND;PSMD14;USP11;USP50;USP22;USP5
prerank,manganese ion binding (GO:0030145),0.2502220835368799,0.899643810235627,0.6457399103139013,0.9740305583465662,1.0,13/48,17.96%,MPPED2;B4GALT7;ARG2;MGAT5B;ATP13A2;MPPE1;HMGCL;NUDT16;ADPRM;GALNT3;GALNT2;MGAT1;IMPA1
prerank,phosphatase inhibitor activity (GO:0019212),-0.31288929941676236,-0.8987537431706715,0.583904109589041,0.856713546008434,1.0,9/20,32.55%,PPP1R2;SAG;PTN;ARPP19;SET;BOD1L1;STYX;PPP1R1B;BOD1
prerank,general transcription initiation factor binding (GO:0140296),-0.2963182733662724,-0.897330334663913,0.6049382716049383,0.8572448126701411,1.0,8/25,23.24%,ESR1;TAF11;TAF1B;PSMC2;DR1;RUVBL2;RELA;TAF13
prerank,proton transmembrane transporter activity (GO:0015078),0.2624294848743315,0.8954551549872931,0.6331096196868009,0.9792888370844445,1.0,7/39,15.60%,COX6A2;UQCR10;SLC46A1;ATP6V1B2;UQCRH;COX6A1;SLC4A11
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.25197039447359737,-0.894110547704098,0.6456140350877193,0.8619213314529725,1.0,15/51,20.90%,SLCO2A1;SLCO1C1;SLC7A5;SLCO3A1;SLC5A6;SLCO2B1;MFSD2A;SLC25A11;SLC35E4;SLC35E3;SLC20A2;ANKH;SLCO4A1;SLC35D1;SLC5A5
prerank,ADP binding (GO:0043531),-0.303920867213174,-0.894052650861395,0.6446428571428572,0.8593004254612889,1.0,4/25,7.78%,MYH9;MIEF1;ERN1;MYO18A
prerank,single-stranded DNA helicase activity (GO:0017116),0.3101436761505304,0.8928349116122181,0.5894495412844036,0.9807902619324408,1.0,2/19,4.13%,WRNIP1;HELQ
prerank,RNA cap binding (GO:0000339),0.32374083772859846,0.8922862114856959,0.5986078886310905,0.976540065908943,1.0,8/16,25.69%,DCPS;EIF4E2;CYFIP2;CYFIP1;NCBP2;EIF4E;EIF4E3;EIF4A1
prerank,leucine zipper domain binding (GO:0043522),-0.38541665572473793,-0.8921685342199326,0.5956678700361011,0.861031004332925,1.0,3/10,14.04%,ERC1;AATF;ATF4
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.33945695612387977,-0.8909921725767428,0.6307977736549165,0.8609409035972545,1.0,2/15,3.63%,SH3PXD2B;PLA2G4A
prerank,growth factor receptor binding (GO:0070851),-0.22506868451532389,-0.8909877013455068,0.6919014084507042,0.8582371820948929,1.0,15/95,14.62%,HIP1;IL1R1;PDGFD;PTPRJ;IL6ST;IL6R;FGF1;ERN1;FGF7;VEGFC;PSEN1;JAK2;FGF2;PLSCR1;GRB2
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.3431294840321047,0.8890004880526987,0.6034858387799564,0.979481786649349,1.0,2/13,3.02%,CCDC88A;RANBP1
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.3477912466491729,0.8886608672986133,0.6083916083916084,0.9748041654983278,1.0,7/12,24.94%,DCPS;EIF4E2;CYFIP2;CYFIP1;NCBP2;EIF4E;EIF4E3
prerank,Hsp90 protein binding (GO:0051879),-0.2745787367885117,-0.8873726746513616,0.6230088495575221,0.8636134141855224,1.0,10/33,18.97%,NR3C1;KDR;SLC12A2;PPEF2;ERN1;UNC45B;PTGES3;HDAC6;RPS3;NOD2
prerank,steroid hydroxylase activity (GO:0008395),0.3200230607919299,0.8848734499641795,0.6334056399132321,0.9788956862357168,1.0,3/16,9.79%,CYP46A1;CYP27A1;CYP11B1
prerank,WW domain binding (GO:0050699),0.2794564882174082,0.8836111531977112,0.6255924170616114,0.9765427098012265,1.0,9/26,23.47%,ENAH;TCEAL6;TRAF4;TCEAL3;LITAF;SCNN1A;TCEAL1;WBP11;DAZAP2
prerank,sterol transfer activity (GO:0120015),-0.3241213819796652,-0.8832717155891191,0.6425855513307985,0.8701256809848726,1.0,4/17,26.19%,PLTP;STARD4;OSBPL2;STARD5
prerank,hexosyltransferase activity (GO:0016758),-0.21850260074401454,-0.8830568588152546,0.7321428571428571,0.8678576264917272,1.0,23/101,21.71%,GBE1;EXT1;TMTC1;GCNT2;A4GALT;TMTC2;CSGALNACT1;MGAT4B;B3GNT2;B4GALT4;ALG12;MFNG;PIGV;B4GALT5;HAS1;GBA2;LARGE1;B4GALT1;POGLUT3;GYG1;OGT;POMT1;CHPF2
prerank,copper ion binding (GO:0005507),-0.26026068460992213,-0.8809760641084539,0.6618705035971223,0.8698333266353286,1.0,21/42,37.65%,ATOX1;LOXL3;PAM;TP53;COX17;AOC3;CCS;SOD1;COA6;SUMF1;TYR;ATP7B;IL1A;PARK7;SCO2;CUTC;HEPH;MT3;LACC1;SNCB;AOC2
prerank,NAD binding (GO:0051287),-0.2846587317221592,-0.880560697235102,0.6728624535315985,0.8679722998150156,1.0,5/26,14.53%,ZC3HAV1;SIRT5;BDH2;SIRT3;NUDT6
prerank,phospholipase A2 activity (GO:0004623),0.2918874656318851,0.8804742441143918,0.655421686746988,0.9789540387878813,1.0,4/26,10.06%,PLA2G7;PLA2G3;PLA2G4E;PLA2G6
prerank,phospholipase activity (GO:0004620),-0.23846444049327306,-0.8804504743437529,0.6666666666666666,0.8654976027531224,1.0,26/67,36.75%,PLCB4;PLA2G4A;PLCB3;NAPEPLD;PLCE1;GDPD1;MGLL;LPL;PDIA3;GDPD3;SMPD2;PLA2G12A;DDHD2;PNPLA8;PLA2G4F;LYPLA1;GDE1;LIPH;PLAAT1;SEC23IP;PLCL1;PLCB2;PLBD1;ABHD12;PLB1;PNPLA6
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.3569696469025162,-0.8792314409320657,0.6535714285714286,0.8654230048634779,1.0,3/12,13.97%,TENT4B;TENT4A;TENT2
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.3574295710647572,0.8767505574229156,0.6206896551724138,0.9822928025696228,1.0,4/10,15.73%,PKP2;CXADR;CD47;SIRPA
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.3221759468993851,-0.8762789442205592,0.6330434782608696,0.8691986596820481,1.0,5/16,20.54%,SLC1A5;SLC13A3;SLC25A11;SLC1A1;SLC1A4
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.29663330393046583,-0.8738092839817333,0.6441005802707931,0.8715168996142947,1.0,9/21,23.44%,WASF2;KCNQ1;EZR;ARFGEF1;ACBD3;WASF1;ARFGEF2;AKAP1;AKAP9
prerank,cardiolipin binding (GO:1901612),0.3693715591626966,0.8728424256126937,0.6209302325581395,0.9863161864910891,1.0,1/10,2.00%,MME
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.2384658399418701,0.8728300027450825,0.6978922716627635,0.9809698115231706,1.0,13/57,16.64%,COX6A2;UQCR10;NDUFA1;UQCRH;NDUFA10;CYBRD1;NDUFA5;NDUFS8;NDUFB5;NDUFC1;COX6A1;NDUFS7;NDUFB6
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.318892930932743,0.8697044799829434,0.6350210970464135,0.9828449749145531,1.0,5/16,18.31%,HAAO;ALOX12;TDO2;ALOX5;BCO2
prerank,rRNA binding (GO:0019843),0.24935424945389234,0.8693833576523252,0.7208237986270023,0.9783038248475359,1.0,7/42,10.23%,RPLP0;MTERF4;ANG;MRPL16;ERAL1;PPAN;NOP53
prerank,serine-type endopeptidase activity (GO:0004252),0.2219361907024187,0.8677589146668983,0.7482678983833718,0.9768762773996535,1.0,12/80,14.69%,C1RL;CELA3A;TYSND1;RHBDL2;RHBDL3;KLK1;KLK6;PCSK2;HTRA2;PCSK6;ACR;CLPP
prerank,heme binding (GO:0020037),0.22874602854017834,0.8669709141316543,0.7236842105263158,0.973513409076065,1.0,12/65,15.30%,CYP46A1;NR1D1;CYP24A1;CYP26B1;CYP51A1;PGRMC1;CYP27A1;CYP11B1;HCCS;THAP4;EIF2AK1;TDO2
prerank,myosin II binding (GO:0045159),0.36419430726884366,0.8658402138306781,0.6559139784946236,0.9709127243050399,1.0,3/10,12.35%,STXBP5L;GSN;LLGL1
prerank,metalloaminopeptidase activity (GO:0070006),0.3145399666180662,0.8654525377113641,0.623059866962306,0.9667732257140503,1.0,2/16,2.37%,TRHDE;MMP16
prerank,iron ion binding (GO:0005506),0.2373364269597497,0.8648013006278288,0.6912442396313364,0.9629462568784027,1.0,12/48,17.17%,MELTF;FBXL5;ALKBH3;DNAJC24;ISCA2;HAAO;TET1;SCD5;NFU1;ALOX5;ALKBH2;SCD
prerank,MAP kinase activity (GO:0004707),-0.3343482989624258,-0.8637459202473519,0.6440972222222222,0.8897096076555673,1.0,5/14,23.50%,MAPK1;MAPK8;MAPK12;MAPK7;MAPK11
prerank,NADPH binding (GO:0070402),0.3333218337119302,0.8618626303903884,0.6258064516129033,0.9648239966870836,1.0,1/13,2.42%,QDPR
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.35158101636851946,0.8591579452313347,0.6199095022624435,0.9657919359258642,1.0,2/11,14.01%,DCPS;NUDT16
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.3582246933135221,-0.8591515481106492,0.6629213483146067,0.8968495305596672,1.0,2/11,17.23%,PPP1R2;PPP1R1A
prerank,ubiquitin-dependent protein binding (GO:0140036),0.3542001400717806,0.8590140211402139,0.6238532110091743,0.9611256495478886,1.0,4/10,23.45%,ANKRD13B;FAAP20;DNAJB2;IDE
prerank,exonuclease activity (GO:0004527),-0.2501307469691601,-0.8581575059872887,0.7121464226289518,0.8962434912626926,1.0,17/46,28.68%,MRE11;EXOSC2;EXOSC1;EXOSC3;XRN2;PDE12;EXOSC8;WRN;REXO1;EXOSC5;EXOG;DCLRE1B;REXO5;EXOSC7;DXO;EXO1;APLF
prerank,nuclear import signal receptor activity (GO:0061608),-0.3281997920353347,-0.8577983762545147,0.6465201465201466,0.8942077644058398,1.0,3/15,14.45%,KPNA4;KPNA3;KPNA1
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.30257752968245605,0.8560814154513849,0.6976190476190476,0.9625250389485376,1.0,4/18,14.06%,HSD17B12;FAR1;ALDH1A2;AKR1B10
prerank,cholesterol binding (GO:0015485),0.23819947038571632,0.85508696471253,0.7086092715231788,0.9597713384843314,1.0,14/47,21.41%,SULT2B1;CD81;SYP;ERLIN1;OSBPL6;OSBPL5;VDAC2;SIDT1;GRAMD1B;SOAT2;VDAC1;GRAMD1C;SOAT1;SCARB2
prerank,sulfuric ester hydrolase activity (GO:0008484),0.33290692829810536,0.8543559156469371,0.6349557522123894,0.956537777190447,1.0,2/12,8.34%,ARSI;ARSG
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.35265344105447227,0.85426147182957,0.6199095022624435,0.9470226232810858,1.0,3/10,16.11%,DUSP4;DUSP8;DUSP7
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.35265344105447227,0.85426147182957,0.6199095022624435,0.9470226232810858,1.0,3/10,16.11%,DUSP4;DUSP8;DUSP7
prerank,chemokine binding (GO:0019956),-0.27225607190664386,-0.8512134445966096,0.7015706806282722,0.9044720279146121,1.0,8/30,24.66%,ITGB1;CCR9;FGF2;ITGA4;ACKR3;ITGB3;ACKR1;HMGB1
prerank,alpha-actinin binding (GO:0051393),-0.28024717423849077,-0.8507095896659528,0.6849557522123894,0.9027014117555696,1.0,9/24,20.33%,PKD2;PDLIM5;PDLIM1;SYNPO2;PDLIM3;RARA;MAGI1;PPARG;PKD2L1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.28243923400316295,0.8468143248942609,0.6607929515418502,0.9584770465475195,1.0,7/22,19.06%,ATP6V1B2;ATP6V0C;ATP6V0D2;ATP6V0A2;ATP6V0D1;ATP6V1C1;ATP6V1A
prerank,CARD domain binding (GO:0050700),-0.32221750707110886,-0.8448935284183764,0.6607460035523979,0.9118599072517165,1.0,5/14,23.27%,NOD1;IRGM;MAVS;NOD2;CASP1
prerank,hormone receptor binding (GO:0051427),0.3154640958938627,0.8442480608579762,0.6528384279475983,0.9589622289257255,1.0,3/14,10.26%,TYK2;NPPC;CCK
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.3003594145226117,0.843118632255855,0.6845637583892618,0.9564005052607868,1.0,5/17,15.01%,AKR1C1;TECR;DHCR24;DPYD;MECR
prerank,tropomyosin binding (GO:0005523),-0.31244378972884834,-0.842398351558278,0.6924460431654677,0.9141126285235368,1.0,6/16,27.18%,TMOD3;NEBL;LMOD1;CALD1;SMTNL2;TNNT3
prerank,CXCR chemokine receptor binding (GO:0045236),-0.3437690686608136,-0.8384062187084799,0.6672661870503597,0.9193394836360824,1.0,7/11,40.44%,YARS1;CXCL12;CXCL10;CXCL5;ITCH;CXCL1;PPBP
prerank,pseudouridine synthase activity (GO:0009982),-0.3177467614071589,-0.8347128110750743,0.7103825136612022,0.9235650948729635,1.0,5/13,29.09%,RPUSD4;PUS10;TRUB1;PUSL1;RPUSD2
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.26506364225797147,-0.833968290221442,0.7310469314079422,0.9222589758510077,1.0,5/29,10.75%,SLC26A7;SLC26A2;SLC1A5;SLC13A3;SLC25A11
prerank,lysine N-methyltransferase activity (GO:0016278),-0.2882456682768618,-0.8326230841486038,0.7119266055045872,0.9221002141163668,1.0,5/20,16.06%,SETD2;SETD3;EHMT1;KMT5A;ANTKMT
prerank,monocarboxylic acid binding (GO:0033293),0.29220900780600556,0.8284973829266933,0.6902439024390243,0.9821105028622955,1.0,2/18,5.87%,AKR1C1;CYP26B1
prerank,poly(A) binding (GO:0008143),-0.28792485669170603,-0.8282712156191249,0.71875,0.92781779099381,1.0,6/21,15.39%,RBPMS;RBMS1;DDX3X;RBMS2;ZC3H14;PABPC4L
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.23547804035929698,0.8234601419831358,0.7573033707865169,0.9874720183384768,1.0,5/38,12.03%,SPOCK1;TFPI2;SERPIND1;SERPINA2;SERPING1
prerank,ion gated channel activity (GO:0022839),-0.27503055031780355,-0.8230227306301576,0.7437275985663082,0.9351154285905012,1.0,6/24,13.29%,TRPM4;ANO1;TTYH2;ANO6;ANO8;TMEM63B
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.2641595755716859,-0.822288341866332,0.7358490566037735,0.9335944004579148,1.0,13/29,32.79%,ACER2;ACER3;OVGP1;GBA2;HYAL2;ENGASE;GLA;HPSE;ABHD10;HYAL3;LCT;GANAB;NEU3
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.3104261985645047,0.8198073879527811,0.6945701357466063,0.9897922658990327,1.0,2/14,2.80%,KCNA5;KCNJ3
prerank,kinase activator activity (GO:0019209),-0.25890558044929046,-0.8161150161979962,0.7354014598540146,0.9422248528803008,1.0,6/30,14.78%,GPRC5C;RPLP1;RGCC;RPTOR;WNT11;MARK2
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.3107572394695093,-0.8155705589744753,0.7169117647058824,0.940525569646156,1.0,8/14,43.44%,NCF2;NOX4;KMO;MICAL1;AIFM1;NCF1;NCF4;DUOX1
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.29259462106357725,0.8154213882478071,0.7210401891252955,0.9937316626607816,1.0,5/16,12.18%,MTMR2;MTMR10;MTMR11;MTMR7;INPP5F
prerank,potassium:proton antiporter activity (GO:0015386),0.3304849872332832,0.8139464514387794,0.6924778761061947,0.9919358421259176,1.0,2/10,5.25%,SLC9A7;SLC9A9
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.2630644945470122,-0.8123707314734822,0.7452991452991453,0.9435573148368069,1.0,9/26,32.55%,PPP1R2;SAG;PPP1R1A;PTN;ARPP19;SET;BOD1L1;PPP1R1B;BOD1
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.3312112659759283,-0.8121151560876052,0.7189189189189189,0.9412342644876334,1.0,5/11,27.46%,KCNQ1;KCNJ8;KCNE4;KCNH2;KCND3
prerank,solute:proton symporter activity (GO:0015295),-0.3029975985779887,-0.8117125993953775,0.7262969588550984,0.9392101119166127,1.0,4/16,13.25%,SLC39A8;SLC17A5;SLC2A13;SLC2A9
prerank,anion:anion antiporter activity (GO:0015301),0.2927248968365961,0.811164690637399,0.7315436241610739,0.9921365720972083,1.0,4/17,8.63%,SLC26A5;SLC4A2;SLC19A1;SLC25A4
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.22565476461960865,-0.8084800341126891,0.8027444253859348,0.9421972361877015,1.0,16/53,23.45%,SLC47A1;SLC7A1;SLC7A5;SLC38A5;SLC1A5;SLC7A7;SLC36A4;SLC43A1;SLC1A1;SLC7A2;SLC6A7;SLC1A4;SLC3A2;SLC66A1;SLC3A1;SLC38A6
prerank,motor activity (GO:0003774),0.2133620566266185,0.8067675176211182,0.8214285714285714,0.9961180128135841,1.0,12/60,15.43%,KIF21A;KIF17;DYNC2H1;KIF26B;KIF5A;KIF3A;DYNC1I1;DYNLRB2;KIF1C;KIF3C;MYO6;KIF21B
prerank,myosin binding (GO:0017022),-0.22347917924468916,-0.8040333944051006,0.8132854578096947,0.9471094989606816,1.0,13/55,17.77%,MYRIP;SHROOM4;TRAK1;SHROOM1;ARFGEF1;RHOA;MYOC;MLPH;RAB11A;KIRREL1;RAB39B;CALD1;GIPC1
prerank,endopeptidase regulator activity (GO:0061135),-0.23855521389526488,-0.8019980858775585,0.8036363636363636,0.9478087153572716,1.0,11/40,23.75%,CAST;PROS1;PSME2;ITIH2;VSIR;APH1A;TFPI;PSME1;ADRM1;RECK;ITIH3
prerank,transferrin receptor binding (GO:1990459),-0.3413388533987692,-0.7996445394098809,0.7449908925318761,0.9488770022201962,1.0,3/10,18.83%,HFE;IKBKG;IKBKB
prerank,endopeptidase inhibitor activity (GO:0004866),-0.20591277835636754,-0.7991137515109643,0.8637137989778535,0.946978723309686,1.0,10/82,12.11%,CAST;ANXA2;APP;SPOCK2;PROS1;NGF;ROCK1;BIRC6;ITIH2;TIMP3
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.33333079001436144,-0.7968025123882111,0.7597864768683275,0.9481586256224758,1.0,1/11,0.16%,LEF1
prerank,"DNA binding, bending (GO:0008301)",-0.3012424202686725,-0.7920990407162725,0.7460595446584939,0.952959309091192,1.0,1/14,0.16%,LEF1
prerank,serine-type peptidase activity (GO:0008236),0.19661033924849203,0.7914396338005313,0.8815165876777251,1.0,1.0,14/96,14.69%,C1RL;CELA3A;TYSND1;RHBDL2;PRSS57;RHBDL3;KLK1;KLK6;TMPRSS7;PCSK2;HTRA2;PCSK6;ACR;CLPP
prerank,microtubule motor activity (GO:0003777),0.21618269219179811,0.7899825542557805,0.8468677494199536,1.0,1.0,10/51,15.43%,KIF21A;KIF17;KIF26B;KIF5A;KIF3A;DYNC1I1;DYNLRB2;KIF1C;KIF3C;KIF21B
prerank,methyltransferase activity (GO:0008168),-0.22720476047585358,-0.788754914758508,0.8511796733212341,0.9555320919528232,1.0,20/46,37.20%,METTL4;SUV39H1;EHMT1;AS3MT;N6AMT1;DNMT1;ARMT1;GAMT;PRMT3;COQ3;METTL27;EEF1AKMT3;DNMT3B;COMTD1;PRMT7;NSUN4;COMT;EEF1AKMT4;GCSH;NNMT
prerank,phospholipase activator activity (GO:0016004),0.32169266388719675,0.7874434437555118,0.745920745920746,1.0,1.0,6/10,28.72%,CCL5;ARHGAP6;BTK;PDPK1;STX4;SRC
prerank,hexosaminidase activity (GO:0015929),-0.31003794173669696,-0.7834955252882664,0.7649253731343284,0.961103892109815,1.0,5/12,31.99%,CEMIP2;HYAL2;HEXA;HYAL3;CEMIP
prerank,pyrophosphatase activity (GO:0016462),-0.21919836226479036,-0.7820918973371598,0.861878453038674,0.9606834878913891,1.0,5/50,8.49%,ENTPD1;DDX3X;ENTPD6;ALPL;BNIP2
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.281435083272281,-0.781525597913257,0.7669724770642202,0.9588055523744685,1.0,4/18,16.18%,PIK3R1;SOCS2;PIK3R6;PIK3R3
prerank,pre-mRNA binding (GO:0036002),0.24765922861795137,0.7810991448728446,0.7973273942093542,1.0,1.0,3/28,5.26%,CELF5;CELF4;CELF2
prerank,chemoattractant activity (GO:0042056),-0.25774911627842445,-0.7794268990390252,0.8278985507246377,0.9592306453574176,1.0,6/26,15.33%,BMP4;FGF7;VEGFC;FGF2;HGF;MIF
prerank,NADP binding (GO:0050661),-0.24471977839618278,-0.7783868682782271,0.8081936685288641,0.9580365866187873,1.0,7/32,22.04%,NOS3;GMDS;CAT;DHCR7;LBR;MTRR;NOS1
prerank,hexose transmembrane transporter activity (GO:0015149),-0.3172548415424743,-0.7775433352723345,0.763668430335097,0.9566419312705925,1.0,2/12,8.91%,SLC2A1;MFSD4A
prerank,sequence-specific mRNA binding (GO:1990825),-0.3284821158114642,-0.7768073057555569,0.7532467532467533,0.955112176453964,1.0,6/10,35.04%,RBM24;DHX9;LARP6;SSB;SHFL;ETF1
prerank,poly-purine tract binding (GO:0070717),-0.2542209821046177,-0.7762057099555575,0.8224137931034483,0.9534151050835237,1.0,4/27,7.26%,RBPMS;RBMS1;DDX3X;RBMS2
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.23750676045888544,-0.7753500375775918,0.8260869565217391,0.9521173146054496,1.0,15/34,36.48%,UBE2K;BIRC6;UBE2J2;UBE2D3;UBE2E2;UBE2L3;AKTIP;UBE2R2;UBE2I;CDC34;UBE2H;UBE2A;UBE2T;UBE2G2;UBE2C
prerank,ubiquitin conjugating enzyme activity (GO:0061631),-0.24380239753173197,-0.7752471535399874,0.8324324324324325,0.9496451114626191,1.0,8/31,21.22%,UBE2K;BIRC6;UBE2J2;UBE2D3;UBE2E2;UBE2L3;AKTIP;UBE2R2
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.251555832684204,0.7748926534927539,0.8303571428571429,1.0,1.0,4/24,10.33%,CAMK1G;CAMK4;CAMK2B;MYLK3
prerank,O-acyltransferase activity (GO:0008374),-0.24272779419710705,-0.7729484882917326,0.8181818181818182,0.9503517157638246,1.0,7/30,21.54%,PLA2G4A;LPCAT1;MBOAT1;DGAT2;LPCAT3;PIGW;LCAT
prerank,fatty acid synthase activity (GO:0004312),0.3156907398144336,0.7729301926819169,0.7567567567567568,1.0,1.0,2/10,9.18%,ELOVL4;OXSM
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.3302186509364977,-0.7679661854900615,0.7830882352941176,0.9549034633129831,1.0,4/10,25.71%,DSE;GNE;FUOM;GALM
prerank,ribosomal large subunit binding (GO:0043023),-0.31309673024933277,-0.7647110135608896,0.7850098619329389,0.9568653598763889,1.0,4/11,27.52%,LTN1;RBM3;NEMF;NMD3
prerank,translation elongation factor activity (GO:0003746),-0.28911998552365026,-0.7643515275846138,0.7682926829268293,0.9547947383659049,1.0,6/14,26.14%,EEF2;EIF5A;EIF5AL1;GFM2;TUFM;EEF1B2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.2821692904084082,-0.763542819581903,0.8101933216168717,0.950761293491121,1.0,4/16,13.10%,ANO1;TTYH2;ANO6;ANO8
prerank,intracellular chloride channel activity (GO:0061778),-0.2821692904084082,-0.763542819581903,0.8101933216168717,0.950761293491121,1.0,4/16,13.10%,ANO1;TTYH2;ANO6;ANO8
prerank,active ion transmembrane transporter activity (GO:0022853),-0.2333449732186717,-0.762864365108792,0.8443223443223443,0.9492059763627123,1.0,14/37,29.29%,SLCO2A1;SLCO1C1;SLCO3A1;UQCR11;SLCO2B1;UQCRFS1;UQCRC1;COX10;SLCO4A1;NDUFA4L2;COX5A;SLCO1B1;SLC22A8;COX4I2
prerank,mRNA methyltransferase activity (GO:0008174),-0.3123724372196285,-0.7625346203584259,0.7846975088967971,0.9471252393347155,1.0,8/12,47.61%,METTL14;METTL16;CMTR2;TRMT61A;PCIF1;TRMT10C;NSUN2;RNMT
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.2807216414995545,0.7610481113818772,0.780373831775701,1.0,1.0,4/14,9.97%,MTMR2;MTMR10;MTMR11;MTMR7
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.22781086902038378,0.7607399496855376,0.8430493273542601,1.0,1.0,8/34,16.64%,NDUFA1;NDUFA10;NDUFA5;NDUFS8;NDUFB5;NDUFC1;NDUFS7;NDUFB6
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.22781086902038378,0.7607399496855376,0.8430493273542601,1.0,1.0,8/34,16.64%,NDUFA1;NDUFA10;NDUFA5;NDUFS8;NDUFB5;NDUFC1;NDUFS7;NDUFB6
prerank,ATPase activator activity (GO:0001671),0.26118108842455334,0.760475970291843,0.8134171907756813,1.0,1.0,3/20,6.85%,ATP1B1;DNAJB4;DNAJC24
prerank,carboxylic ester hydrolase activity (GO:0052689),0.19223512374060905,0.7571140391660753,0.9292452830188679,1.0,1.0,9/85,11.42%,ENPP2;PGLS;CA2;PGAP1;H6PD;PLA2G7;PLA2G4E;PLA2G6;LIPC
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.29973694292524494,0.7528791400158363,0.7722342733188721,1.0,1.0,2/11,7.41%,RYR3;RYR2
prerank,adenylyltransferase activity (GO:0070566),-0.26130700603825285,-0.7516109950555093,0.8378870673952641,0.9596855531440881,1.0,4/21,13.97%,TENT4B;ABL1;TENT4A;TENT2
prerank,lysophospholipase activity (GO:0004622),-0.26440961440688926,-0.7478530533436832,0.8132635253054101,0.9620172842790029,1.0,4/20,13.54%,PLA2G4A;GDPD1;MGLL;GDPD3
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.29499654717810275,0.7434093310946969,0.7957244655581948,1.0,1.0,12/12,70.52%,ELOVL4;OPN4;GNAT2;OPN1SW;OPN5;OPN3;RHO;GPR88;OPN1MW3;OPN1MW;RRH;GPR52
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.3046770366728501,0.7428794509497726,0.7787810383747178,1.0,1.0,1/10,5.24%,SLC6A11
prerank,UDP-glycosyltransferase activity (GO:0008194),0.19383595528042158,0.7413185258687762,0.9223744292237442,1.0,1.0,6/70,7.41%,MGAT4C;B3GALT1;B3GALT4;B3GALT5;B4GALNT3;CHSY3
prerank,alpha-tubulin binding (GO:0043014),-0.23519789878720448,-0.739932842142141,0.8594594594594595,0.9693948026820507,1.0,15/31,31.31%,SETD2;DIP2B;TTLL7;DNAL1;FYN;HDAC6;WASHC1;TRPV4;ARL4C;EML4;INO80;DLEC1;EFHC2;ARL8B;CDK5R1
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.3066130021330759,0.7366176552040954,0.7821350762527233,1.0,1.0,2/10,11.98%,PKIB;PRKAR1B
prerank,fibroblast growth factor binding (GO:0017134),-0.25345929687312474,-0.7343379777110073,0.8348794063079777,0.9735993244954242,1.0,6/21,20.64%,THBS1;CEP57;FGFBP3;API5;FGFR4;ITGB3
prerank,glucose transmembrane transporter activity (GO:0005355),0.2671460426489901,0.7341508058095811,0.8210290827740492,1.0,1.0,4/17,11.28%,SLC2A4;SLC2A10;SLC2A8;SLC2A5
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.21844270954012546,-0.7330469757127076,0.9084249084249084,0.9725668024600921,1.0,18/40,37.20%,METTL4;PCMTD1;SUV39H1;SETD3;AS3MT;N6AMT1;DNMT1;ARMT1;GAMT;PEMT;DNMT3B;METTL18;COMTD1;PRMT7;COMT;ICMT;FBL;NNMT
prerank,ribonuclease P RNA binding (GO:0033204),-0.306162723047835,-0.7278106604173058,0.8317399617590823,0.9763458981619894,1.0,6/10,49.65%,RPP30;POP4;RPP40;RPP14;RPP25;RPP38
prerank,protein phosphatase activator activity (GO:0072542),0.2752868379906377,0.7268326361287945,0.8186046511627907,1.0,1.0,2/13,5.75%,IGFBP3;CALM2
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.27567884506488294,0.7244124164360111,0.8212669683257918,1.0,1.0,1/13,1.49%,IDI2
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.29431421968660393,-0.7242150191417447,0.8115671641791045,0.9780064276974985,1.0,5/11,32.11%,SLC17A5;SLC2A9;SLC5A3;SLC23A1;SLC23A2
prerank,RNA polymerase binding (GO:0070063),-0.25841664971086936,-0.7224288393013237,0.8173758865248227,0.9773803963544528,1.0,6/18,26.88%,NEDD4;STOM;PKN2;BRCA1;DHX9;PHRF1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.22105736694581546,-0.721588938094155,0.8870967741935484,0.9757930790074799,1.0,9/35,20.63%,FTO;DUS1L;DUS4L;PUS10;MRPL58;TRDMT1;TRMT9B;TRMT12;TRPT1
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.22208888875851213,0.7213813275874393,0.8924485125858124,1.0,1.0,5/28,12.78%,MAPK10;PAK3;MAP2K7;RPS6KB1;SGK1
prerank,DNA polymerase binding (GO:0070182),-0.2607160268140589,-0.7202408930861335,0.8448275862068966,0.9747166570485565,1.0,6/18,24.76%,PTGES3;FANCD2;HSP90AA1;SMG6;HMGB1;FANCI
prerank,channel activity (GO:0015267),0.2053133722575866,0.7195506693526225,0.892018779342723,1.0,1.0,3/41,4.58%,PDPN;BCL2;AQP4
prerank,inward rectifier potassium channel activity (GO:0005242),0.23271913377071682,0.7193425463902452,0.8728448275862069,1.0,1.0,4/24,11.47%,KCNJ3;KCNN2;KCNJ6;KCNN3
prerank,DNA replication origin binding (GO:0003688),0.2374378738904086,0.7191228245037751,0.8485477178423236,1.0,1.0,4/23,10.09%,DDX11;MCM8;CDC45;POLA1
prerank,enoyl-CoA hydratase activity (GO:0004300),-0.30326056042523925,-0.7123212513124675,0.8458715596330275,0.9806117775804885,1.0,5/10,34.76%,HADHB;ECHS1;EHHADH;ECI1;ECHDC3
prerank,telomeric DNA binding (GO:0042162),-0.21876602425111763,-0.7101015921896695,0.9092526690391459,0.9805082749461727,1.0,12/32,27.94%,STN1;UPF2;HMBOX1;RPA1;CTC1;TERF2;WRN;TERT;BLM;SMG6;HNRNPD;SMG1
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.25846131857761534,0.7086975734109602,0.8624454148471615,1.0,1.0,2/15,8.90%,PLA2G3;PLA2G4E
prerank,peptidase inhibitor activity (GO:0030414),-0.22037055303417702,-0.7074209938041968,0.9144385026737968,0.9806646024928678,1.0,9/33,26.54%,CAST;PROS1;ITIH2;SIMC1;TFPI;GPC3;RECK;ITIH3;PCSK1N
prerank,methylation-dependent protein binding (GO:0140034),-0.1947701534538791,-0.707176412272286,0.9500924214417745,0.978427194462477,1.0,21/57,34.43%,CHD1;KMT2E;CDYL;SUZ12;SGF29;ZMYND8;TDRD3;KDM7A;ZMYND11;ATRX;WDR5;RBBP5;MBTD1;GLYR1;PHF19;CHD8;ING5;KDM4A;CBX5;BPTF;MORC3
prerank,endonuclease activity (GO:0004519),-0.20157333075600964,-0.7036672345720761,0.9402730375426621,0.9795235178956825,1.0,14/49,26.08%,KHNYN;ERN1;MRE11;N4BP2;DICER1;OGG1;PNKP;AGO2;RPS3;EXOG;RCL1;NTHL1;SMG6;ENDOU
prerank,FAD binding (GO:0071949),-0.23487319970781842,-0.7032869817230021,0.8963730569948186,0.9773599937971688,1.0,11/24,37.65%,MICAL2;AGPS;KDM1B;KMO;MTRR;CRY2;MICAL1;STEAP4;AIFM1;NQO2;DAO
prerank,MAP kinase phosphatase activity (GO:0033549),0.27393451906750743,0.6974163183553965,0.8727678571428571,1.0,1.0,3/12,16.11%,DUSP4;DUSP8;DUSP7
prerank,gated channel activity (GO:0022836),-0.27148657478453253,-0.6925698794904115,0.8582677165354331,0.9854949017336557,1.0,3/14,13.29%,PIEZO2;TMEM266;TMEM63B
prerank,titin binding (GO:0031432),0.26326871294995274,0.6910866581020007,0.8802660753880266,1.0,1.0,5/13,27.74%,CALM2;MYBPC1;CAPN3;CALM1;CALM3
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.2214852481904546,0.6882001956043594,0.908256880733945,1.0,1.0,7/27,16.03%,SLC9A7;SLC9A9;SLC8A2;SLC8A3;SLC8A1;SLC4A11;SLC8B1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.21735397308989224,0.6826337168438902,0.9055793991416309,1.0,1.0,5/29,11.98%,YWHAG;PKIB;SPRED1;HEXIM1;PRKAR1B
prerank,hydro-lyase activity (GO:0016836),-0.203605968745603,-0.6811022512128895,0.9541284403669725,0.9933629666524415,1.0,4/41,4.79%,HADHB;GMDS;CA4;CDYL
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.22445612892089978,0.6810561360842909,0.9068736141906873,1.0,1.0,6/22,16.11%,DUSP4;MTMR2;SBF1;DUSP8;DUSP15;DUSP7
prerank,protein phosphatase regulator activity (GO:0019888),0.18110024374361353,0.6785010023128785,0.9663461538461539,1.0,1.0,7/53,10.09%,PPP2R2B;PPP1R7;PPP2R2C;CALM2;PPME1;RCAN2;PPP1R16A
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.26894175959813355,-0.6780302669026017,0.8520499108734403,0.993475511862183,1.0,5/12,25.44%,PIK3R1;IRS1;GAB2;FRS2;SH2B2
prerank,gamma-tubulin binding (GO:0043015),-0.22873370071098692,-0.6765711232272809,0.9157706093189965,0.9921127554917997,1.0,5/22,16.89%,CENPJ;DDX3X;NDRG1;TUBGCP4;TUBGCP5
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.20997577738886333,-0.6746809681702021,0.9256637168141593,0.9911086435056279,1.0,10/32,23.32%,KDM2A;TET2;FTO;RIOX2;KDM7A;TMLHE;TET3;ALKBH5;BBOX1;ALKBH4
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.22576076966230363,0.6735131717491599,0.9208791208791208,1.0,1.0,4/22,14.69%,SYT1;CLU;APOE;LANCL1
prerank,methylated histone binding (GO:0035064),0.1773660767894249,0.6730177611577042,0.9782135076252724,1.0,1.0,14/62,18.55%,ZCWPW1;CHD5;TTLL12;UHRF1;KDM8;JMJD7;THAP7;CXXC1;TAF1;PHF13;L3MBTL2;CBX8;MORC4;ING1
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.2538425590037762,-0.6728462178670189,0.9113924050632911,0.9900901528009987,1.0,9/14,49.65%,TSEN34;ELAC2;RPP30;POP4;RPP40;RPP14;RPP25;TSEN2;RPP38
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.2705165396963165,-0.669455357750676,0.8802177858439202,0.9903737070717729,1.0,3/12,14.75%,AOX1;FDX1;ISCA1
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.2734809374259538,-0.6693592037533239,0.8801498127340824,0.98794122196483,1.0,2/12,13.58%,TRAF5;BABAM2
prerank,cAMP response element binding (GO:0035497),-0.28229667028906974,-0.669045421369272,0.8773234200743495,0.9857254847856035,1.0,2/10,7.60%,CREB3L2;JUN
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.2741509099774296,-0.6688990388252178,0.8872458410351202,0.9833610591650651,1.0,4/12,22.61%,HDAC1;H3-3A;RUVBL2;RELA
prerank,deoxyribonuclease activity (GO:0004536),0.24796857179153686,0.6647509525077268,0.8796296296296297,1.0,1.0,6/14,25.73%,MAP1S;DNASE1L1;APEX1;ERCC5;DNASE1L2;ZRANB3
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.16989386024360123,0.664146147296336,0.9863325740318907,1.0,1.0,12/75,16.79%,AKR1C1;DCXR;H6PD;HSD17B7;NSDHL;CBR1;LDHB;UGDH;AKR1B10;PHGDH;PGD;MDH1
prerank,lipase activator activity (GO:0060229),0.27032480407235865,0.6634392315492943,0.8811659192825112,1.0,1.0,4/10,22.18%,CCL5;ARHGAP6;BTK;PDPK1
prerank,tRNA methyltransferase activity (GO:0008175),0.23840764875715703,0.6624034617584035,0.9080717488789237,1.0,1.0,7/16,25.66%,TRMT13;FTSJ1;METTL2A;METTL2B;TRMT5;THUMPD3;THUMPD2
prerank,N-methyltransferase activity (GO:0008170),-0.23396418808247604,-0.6623707549311085,0.9412811387900356,0.9859157019726713,1.0,8/20,31.49%,SETD3;ZCCHC4;N6AMT1;METTL5;TRMT1;METTL15;PEMT;METTL18
prerank,carboxy-lyase activity (GO:0016831),-0.2234727418335697,-0.6616271043544718,0.9179389312977099,0.9840123777956924,1.0,7/23,25.96%,CSAD;BCKDHA;AZIN1;DDC;PPCDC;MVD;FAHD1
prerank,tRNA binding (GO:0000049),0.18940421452135595,0.6584560208389768,0.9637526652452025,1.0,1.0,10/43,20.89%,TRMT10B;SARS2;PTCD1;TRMT10A;CARS1;EEF1A1;PUS1;AARS2;ELP1;NSUN6
prerank,ribonuclease P activity (GO:0004526),0.26101694915254237,0.6554247865914896,0.8876889848812095,1.0,1.0,11/11,73.92%,PRORP;POP7;POP5;RPP21;POP1;RPP38;RPP25;RPP14;RPP40;POP4;RPP30
prerank,microtubule minus-end binding (GO:0051011),-0.25522708812989947,-0.6545945468723574,0.88909426987061,0.9864432039451679,1.0,3/13,16.89%,MACF1;TUBGCP4;TUBGCP5
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.22737998300597828,-0.6516040044684643,0.9289719626168225,0.983685724486178,1.0,7/21,24.36%,CDK13;CDK12;CDK10;CDK6;CDK11B;CDK14;CCNK
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.22737998300597828,-0.6516040044684643,0.9289719626168225,0.983685724486178,1.0,7/21,24.36%,CDK13;CDK12;CDK10;CDK6;CDK11B;CDK14;CCNK
prerank,fibroblast growth factor receptor binding (GO:0005104),0.2215281555803622,0.6500759299083857,0.9270588235294117,1.0,1.0,4/21,17.54%,FGF6;FGF5;FGF20;FGF22
prerank,U6 snRNA binding (GO:0017070),0.241179497428267,0.6488350015405215,0.9222222222222223,1.0,1.0,5/14,20.62%,LSM7;TUT1;LSM8;PRPF8;LSM4
prerank,sulfotransferase activity (GO:0008146),-0.20236560438380669,-0.6483221286788574,0.9547038327526133,0.9836204560402194,1.0,8/33,20.64%,CHST15;TPST2;CHST11;SULT1A1;HS3ST1;GAL3ST2;HS6ST1;CHST7
prerank,beta-tubulin binding (GO:0048487),0.20108532871350382,0.6471403576096693,0.952054794520548,1.0,1.0,6/31,15.61%,PACRG;MAP1S;BBS4;GJB6;RACGAP1;HTT
prerank,cytokine activity (GO:0005125),0.15127703496482667,0.6431943272372731,0.9976190476190476,1.0,1.0,17/131,14.71%,NRG1;WNT7B;CXCL16;GDF1;CCL28;PF4;TIMP1;VEGFA;IL12A;CCL13;WNT6;LEFTY1;CCL5;GDF11;CCL2;WNT4;CCL7
prerank,purinergic nucleotide receptor activity (GO:0001614),0.23766979999804996,0.6396248179880417,0.9295774647887324,1.0,1.0,3/15,19.03%,P2RX3;P2RX5;PTAFR
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.21036608927295966,-0.6357547188477078,0.9431616341030196,0.9891129335445581,1.0,9/24,33.98%,ZDHHC6;ZDHHC3;ZDHHC1;ZDHHC4;GLUL;ZDHHC12;GOLGA7B;ZDHHC9;ZDHHC22
prerank,mechanosensitive ion channel activity (GO:0008381),-0.2583751850634737,-0.6347369737950007,0.9239766081871345,0.9872191059295283,1.0,1/12,0.70%,PIEZO2
prerank,ubiquitin binding (GO:0043130),-0.1661256533549685,-0.6335400973504898,0.9982078853046595,0.9854693552331881,1.0,20/73,26.89%,DDI2;RAE1;NEDD4;USP13;RNF168;VPS36;TNFAIP3;N4BP1;ILRUN;UBXN11;RAD23A;IKBKG;ADRM1;UCHL1;MDM2;BUB3;USP16;UBXN7;UBXN2A;ASCC2
prerank,hyaluronic acid binding (GO:0005540),-0.26098201226852535,-0.6308520698940229,0.9015817223198594,0.9847013793167021,1.0,5/10,31.99%,LAYN;HYAL2;LYVE1;IMPG2;CEMIP
prerank,antiporter activity (GO:0015297),-0.2174517026976326,-0.6259686624281415,0.9282051282051282,0.9851010448023052,1.0,6/20,31.12%,SLC25A11;SLC35E4;SLC35E3;SLC35D1;SLC35C1;SLC25A10
prerank,ATPase regulator activity (GO:0060590),-0.18375812649541326,-0.6215458258113176,0.9772727272727273,0.9852258868614107,1.0,8/38,18.89%,DNAJC1;DNAJA2;DNAJB6;FNIP2;DNAJC10;SIL1;PLN;DNAJC19
prerank,endoribonuclease activity (GO:0004521),-0.19397624916317135,-0.6140827759810238,0.9668989547038328,0.9866737763535919,1.0,9/32,26.08%,KHNYN;ERN1;DICER1;ENDOV;AGO2;EXOG;RCL1;SMG6;ENDOU
prerank,lipoprotein particle receptor binding (GO:0070325),0.194472014974263,0.6124343849453402,0.9583333333333334,1.0,1.0,1/27,0.51%,SYT1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.24743052410023236,0.6076813676830075,0.9348314606741573,1.0,1.0,2/11,13.32%,PFN1;BAG1
prerank,adenyl nucleotide binding (GO:0030554),0.24743052410023236,0.6076813676830075,0.9348314606741573,1.0,1.0,2/11,13.32%,PFN1;BAG1
prerank,chemokine receptor activity (GO:0004950),-0.20232126616549043,-0.607349759898217,0.9701754385964912,0.9874969969376918,1.0,10/24,43.39%,CCR9;ACKR3;CMKLR1;GPR75;GPR17;CCRL2;CXCR6;CCR1;CCR10;CXCR5
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),-0.23199598166635274,-0.6046786558470184,0.9581818181818181,0.9863403749521626,1.0,14/14,76.83%,CAPN2;CAPN15;CAPN11;CAPN12;CAPN10;CAPN8;CAPNS2;CAPN9;CAPN6;CAPN1;CAPN13;CAPN5;CAPNS1;CAPN3
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.2507689845289409,-0.5947190384983412,0.9338235294117647,0.9882307242437633,1.0,2/10,16.83%,NCF2;NOX4
prerank,receptor antagonist activity (GO:0048019),0.211931707621431,0.5938982558541561,0.9645232815964523,1.0,1.0,16/17,61.83%,CCL5;ESR2;DKK3;DKK4;IL18BP;IL1RN;DKK1;ADH7;WFIKKN2;DKKL1;LRPAP1;AGTR2;FST;WFIKKN1;PXDN;IGSF1
prerank,O-methyltransferase activity (GO:0008171),-0.2429033977237844,-0.5800275348631163,0.9583333333333334,0.9915681671687696,1.0,3/10,35.97%,CMTR2;COQ3;COMT
prerank,potassium ion leak channel activity (GO:0022841),0.2097920044703107,0.5777599927364581,0.9544419134396356,1.0,1.0,4/15,21.99%,KCNK12;KCNK10;KCNK9;KCNK4
prerank,carbohydrate kinase activity (GO:0019200),-0.2360983250439196,-0.5727734132146486,0.9591078066914498,0.9918127193531455,1.0,3/11,16.63%,GALK2;GNE;GALK1
prerank,ferrous iron binding (GO:0008198),0.19459863998533844,0.5725011170545838,0.9838709677419355,1.0,1.0,3/21,10.02%,ALKBH3;DNAJC24;HAAO
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.2158334354586229,-0.5720028567626629,0.9666048237476809,0.9897178730620745,1.0,5/15,39.51%,CCR9;CMKLR1;GPR17;CCRL2;CCR1
prerank,CCR chemokine receptor binding (GO:0048020),0.17888948910985053,0.5642026177818528,0.9804347826086957,1.0,1.0,7/28,22.20%,CCL13;CCL5;CCL2;CCL7;CNIH4;CX3CL1;CCL14
prerank,5'-3' RNA polymerase activity (GO:0034062),-0.18217328530889987,-0.5628553649231866,0.9913194444444444,0.9902700577664898,1.0,11/27,34.32%,POLR2G;TENT2;POLR3F;TERT;MED20;POLR2C;POLR2L;POLR3K;POLR1H;POLR2E;POLR3A
prerank,palmitoyltransferase activity (GO:0016409),0.17128624318048963,0.5454251207478538,0.9883449883449883,1.0,1.0,6/28,16.68%,ZDHHC8;ZDHHC13;ZDHHC20;ZDHHC24;ZDHHC7;YKT6
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.21229339517765383,0.5431957276985143,0.9705215419501134,1.0,1.0,2/13,11.11%,ALDH1L2;ALDH1A2
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.19796014046222976,0.5397252475753578,0.9781659388646288,1.0,1.0,2/15,11.11%,ALDH1L2;ALDH1A2
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",-0.23078917834959276,-0.5396019717105165,0.9605263157894737,0.9941570241967905,1.0,3/10,27.65%,DCLRE1B;DCLRE1A;EXO1
prerank,leak channel activity (GO:0022840),0.1826449889830013,0.5296698753190595,0.9770114942528736,1.0,1.0,5/18,21.99%,KCNK12;KCNK10;KCNK9;NALCN;KCNK4
prerank,CoA hydrolase activity (GO:0016289),-0.19815772452339397,-0.5292284096159366,0.9732620320855615,0.9942024352750752,1.0,10/16,48.62%,ACOT9;ACOT6;ACOT11;NUDT7;ACOT13;HIBCH;ACOT12;ABCD1;BAAT;ACOT4
prerank,cytochrome-c oxidase activity (GO:0004129),0.1951317805292001,0.5229200224781334,0.9751693002257337,1.0,1.0,2/15,14.80%,COX6A2;COX6A1
prerank,acyl-CoA hydrolase activity (GO:0047617),0.179999576104606,0.5069306090130054,0.995260663507109,1.0,1.0,3/17,13.51%,PLA2G6;ACOT2;ACOT7
prerank,ubiquitin-specific protease binding (GO:1990381),0.16800653184273318,0.4931661310623947,0.9934497816593887,1.0,1.0,19/19,83.22%,LCOR;SELENOS;RHBDD2;DERL2;AMFR;BAG6;SYVN1;SART3;PRKN;SPATA2;DERL3;DERL1;CLTC;VCP;PARK7;CHMP3;PTEN;RAD23A;SUMO1
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.1613502044956023,0.4736503169513249,0.9976359338061466,1.0,1.0,3/21,14.05%,POLD4;POLA1;POLE4
prerank,C-C chemokine receptor activity (GO:0016493),-0.16348110835782642,-0.46782931756908913,0.9964912280701754,1.0,1.0,9/21,46.47%,CCR9;ACKR3;GPR75;CCRL2;CXCR6;CCR1;CCR10;CXCR5;CXCR2
prerank,C-C chemokine binding (GO:0019957),-0.1572245171431849,-0.4581559040194805,1.0,0.9989862861672006,1.0,9/22,46.47%,CCR9;ACKR3;ACKR1;CCRL2;CXCR6;CCR1;CCR10;CXCR5;CXCR2
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.18229755178907708,0.4559140357097278,0.9904306220095693,1.0,1.0,11/11,81.78%,HMCES;APEX1;HMGA2;NEIL2;APEX2;NEIL1;NEIL3;ALKBH1;APLF;NTHL1;RPS3
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.14313124656682663,0.4540953512965821,1.0,1.0,1.0,5/27,17.90%,POLR3H;POLR2D;POLR1A;POLRMT;POLR1B
prerank,DNA polymerase activity (GO:0034061),0.1411787779942446,0.4234779370043582,1.0,0.9986669417941588,1.0,3/22,14.05%,POLD4;POLA1;POLE4
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.1398626363733192,-0.3816917433440533,0.9982046678635548,0.999686274103094,1.0,1/16,4.68%,CD38
